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ABSTRACT

VASOPRESSIN ANATOMY OF THE MOUSE BRAIN
FEBRUARY 2010
BENJAMIN D. ROOD, B.S., BATES COLLEGE
M.S., UNIVERSITY OF MASSACHUSETTS AMHERST
Ph.D., UNIVERSITY OF MASSACHUSETTS AMHERST
Directed by: Geert J. de Vries

The nine amino acid peptide vasopressin acts as a neurohormone in the periphery
and a neurotransmitter / neuromodulator in the central nervous system. Historically,
research on vasopressin neurons and their projections to the pituitary has helped lay the
groundwork for our understanding of peptidergic neurotransmission. Currently, our
research on central vasopressin projections is driving a revolution in our understanding of
social behavior. Vasopressin affects a number of social behaviors from social memory to
aggression to affiliative behavior, such as pair-bonding. Further, with the addition of
more and more transgenic mouse models of disease states, anxiety and depression related
disorders, and social behavior dysfunction, it is important now more than ever to have a
clear knowledge of the mouse vasopressin system, which derives from a number of
distinct nuclei within the brain. Here, I map out vasopressin immunoreactivity in the
mouse brain, and delineate the subset of brain regions with gonadal steroid hormonedependent vasopressin immunoreactivity. Such projections are thought to derive from
the bed nuclei of the stria terminalis and medial amygdala in the telencephalon. Finally,
based on data from mice with lesions of the suprachiasmatic nucleus, I outline the subset
of regions that likely receive vasopressin from this source. Our research on the anatomy
of the vasopressin system of mice and our attempts to delineate the site of origin of the
many vasopressin fibers found throughout the brain suggest that a significant amount of
the vasopressin innervation deriving from cells in the bed nuclei of the stria terminalis
and medial amygdala project to areas in the midbrain involved in serotonin and dopamine
transmission, such as the dorsal raphe and ventral tegmental area. These transmitter
systems play a crucial role in the control of anxiety and depression levels as well as
motivated behavior and emotional regulation. Our results strongly suggest that a direct
link exists between these systems, and future plans include an examination of this
possibility. It is our hope that this work will further our understanding of the role of
vasopressin and other transmitter systems in the regulation of social behaviors.
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CHAPTER 1
THE VASOPRESSIN SYSTEM

1.1 Introduction
A number of prominent disorders (e.g., autism, schizophrenia, obsessivecompulsive disorder, anxiety, depression etc.) are characterized by disruptions of social,
emotional, or cognitive behavior. Behaviors altered in these disorders are controlled or
regulated by many areas of the brain. Understanding the connections between brain areas
implicated in behavior and the neurochemical properties of those areas is crucial to the
ability to treat psychological disorders. Research, especially in the last two decades, has
identified vasopressin as an important factor in the control of social behavior. To
understand how vasopressin controls social behavior under natural conditions it is
important to first understand the anatomy of the vasopressin system.
1.2 Vasopressin is a peptide
Vasopressin is a nine amino acid peptide (Cys-Tyr-Phe-Gln-Asn-Cys-Pro-ArgGly) produced in a number of nuclei in the brain. The functional properties of
vasopressin were first described in the late 1800's (Oliver and Schafer, 1895), the peptide
was first isolated in 1951 (Turner et al., 1951), and the gene was sequenced in 1982
(Land et al., 1982). The vasopressin gene located on chromosome 20 in humans and
chromosome 2 in mice codes for a pre-propeptide made up of vasopressin, neurophysin
II, and vasopressin-associated glycopeptide (Land et al., 1982). Vasopressin is cleaved
from the pre-propeptide and has functional signaling activity following extracellular
release. Neurophysin II and vasopressin-associated glycopeptide are packaged with
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vasopressin and co-released, but have no known signaling activity (Gainer et al., 1977;
Russell et al., 1981).
1.3 Vasopressin acts as a neurotransmitter
There are three primary requirements for a substance to be classified as a
neurotransmitter. The substance must be present in pre-synaptic neurons, particularly in
the synaptic terminals; it must be released from those terminals in a calcium dependent
manner; and it must bind to a post-synaptic receptor thereby affecting the function of that
post-synaptic cell. The first evidence for neurosecretory neurons projecting centrally
came in the 1950's and 1960's when researchers observed Gomori stained cells within the
central nervous system (Scharrer, 1951; Barry, 1961). In the 1970's, the development and
refinement of immunocytochemistry allowed the first visualization of neurophysin
containing neurons and fibers (Swaab and Pool, 1975; Vandesande and Dierickx, 1975;
Swanson, 1977). More specific antibodies and staining procedures allowed researchers
to further distinguish between vasopressin and oxytocin staining.
Some of the first analyses of the distribution of vasopressin-containing cells and
fibers in the brain were done in 1978 using brain sections from male Wistar rats and
"home-made" antisera to vasopressin neurophysin (Buijs, 1978; Buijs et al., 1978).
Neurophysin containing cell bodies were found in the paraventricular, supraoptic, and
suprachiasmatic nuclei of the hypothalamus (Buijs et al., 1978). In addition, vasopressinimmunoreactive (-ir) fibers were observed in numerous central nervous system regions
from the forebrain to the spinal cord (Buijs, 1978; Sofroniew and Weindl, 1978a;
Sofroniew and Weindl, 1978b). The fibers observed were postulated to derive from the
three nuclei observed. We now know that other vasopressin-producing regions also
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contribute to the diverse projections sites. Nevertheless, these early reports demonstrated
that vasopressin was indeed present in neurons and neuronal processes throughout the
central nervous system.
Shortly after the description of the neuronal vasopressin projections, electron
microscopic evidence demonstrated that vasopressin immunoreactivity was found in
synapses within areas populated by vasopressin-ir fibers. More specifically, vasopressin
immunoreactivity was observed in synapses, identified by the increased density at the
synaptic cleft, of the lateral septum, lateral habenula, and medial amygdala (Buijs and
Swaab, 1979). Synaptic release was demonstrated subsequently, in 1982 (Buijs and Van
Heerikhuize, 1982). Briefly, tissue was collected from the lateral septum and the nucleus
of the solitary tract, areas that display vasopressin-ir terminals, and the lateral
hypothalamus, where vasopressin fibers travel from the paraventricular nucleus to the
median eminence but do not form terminals. When tissue from the lateral septum or
nucleus of the solitary tract was incubated in a solution containing both calcium and high
levels of potassium, vasopressin levels four times greater than detection limits could be
measured by radioimmunoassay. Basal vasopressin, in the absence of potassium, was
below the detection limits of the assay. When calcium was removed from the medium,
vasopressin could not be detected. The tissue from the lateral hypothalamus, which does
not have terminals, did not result in measurable release of vasopressin. These results
demonstrated calcium dependent release of vasopressin from nerve terminals in the brain.
The introduction of tritiated vasopressin allowed scientists to accurately measure
the binding characteristics of vasopressin without disrupting the function of binding sites
(Dorsa et al., 1983). Radiolabeled-vasopressin was found to bind to areas throughout the
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rat brain including the nucleus of the solitary tract, lateral septum, nucleus accumbens,
diagonal band, and stria terminalis (Baskin et al., 1983; Dorsa et al., 1983). The specific
binding of vasopressin to the brain suggested the existence of vasopressin receptors.
Since the first demonstration of vasopressin binding sites, three types of vasopressin
receptors have been identified and cloned: V1a, V1b, and V2 (Lolait et al., 1992; Morel
et al., 1992; Saito et al., 1995). Further, the V1a receptor was found to be most
prominent in the central nervous system, and its distribution has been mapped for
multiple species using both in situ hybridization and receptor autoradiography (Ostrowski
et al., 1992; Ostrowski et al., 1993; Insel et al., 1994; Ostrowski et al., 1994; Wang et al.,
1997).
1.4 Location of vasopressin production
In nearly every mammalian species studied to date, three regions of the brain
consistently produce vasopressin: the paraventricular, supraoptic, and suprachiasmatic
nuclei of the hypothalamus (De Vries and Panzica, 2006). While these cell groups are
the most prominent and consistent across species, they rarely if ever are the only sources
of vasopressin. Two other brain regions, the bed nucleus of the stria terminalis (BNST)
and medial amygdala, express vasopressin in most species, although exceptions do exist
(Miller et al., 1999; Rosen et al., 2007). Aside from these five brain regions, vasopressin
cells have been observed in various other nuclei of the forebrain, hypothalamus,
midbrain, brainstem, and spinal cord in various species.
In mice, vasopressin-producing cells have been described in three other regions of
the brain: the anterior commissural nucleus, the periventricular nucleus, and the "mouse"
accessory nucleus (Castel and Morris, 1988). Cells in each of these regions are described
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as magnocellular similar to neurons found in the paraventicular and supraoptic nuclei.
Cells of the suprachiasmatic nucleus, BNST, and medial amygdala are smaller and
described as parvocellular (Castel and Morris, 1988). Islets of cells similar to those seen
in the mouse have been observed in other species such as the guinea pig, cat, and
macaque (Caverson et al., 1987; Caffe et al., 1989; Dubois-Dauphin et al., 1989). Some
islets, particularly the nucleus circularis, appear to be associated with a blood vessel
passing through the hypothalamus (Caverson et al., 1987; Dubois-Dauphin et al., 1989).
1.5 Regulation of vasopressin gene expression
One of the hallmarks of vasopressin expression is the diverse manner by which
the vasopressin gene is regulated. The regulation of vasopressin gene expression seems
therefore coupled to the function of the brain region that synthesizes it.
In the supraoptic nucleus of the rat, for example, osmotic stimuli result in an
increase in gene expression (Murphy and Carter, 1990). The supraoptic nucleus sends
most of its efferent projections to the neural lobe of the pituitary (Caverson et al., 1987).
Vasopressin release from the posterior pituitary alters blood pressure by binding to
receptors in blood vessels throughout the body and increases water retention by the
kidneys by binding to receptors located in the renal tubules (Turner and Pallone, 1997).
Cells in the suprachiasmatic nucleus, which are important for the expression of
circadian and seasonal rhythms, rhythmically express multiple genes due to a negative
feedback system (Jin et al., 1999). Briefly, the proteins CLOCK and BMAL1
heterodimerize, bind to an E-box transcription site (i.e., a region of DNA with the
nucleotide sequence CACGTG), and initiate the transcription of (m)Per genes. The
mPER protein binds to CLOCK and disrupts CLOCK's heterodimerization with BMAL1,
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thereby preventing its own transcription. As levels of mPER decline, CLOCK and
BMAL1 once again result in the production of new mPER. Several genes, including
vasopressin, contain the E-box regulatory sequence and can be regulated by CLOCK,
BMAL1, and mPER (Jin et al., 1999). Vasopressin expression in the suprachiasmatic
nucleus has a diurnal rhythm with a peak in expression during the dark phase. Disruption
of the Clock gene results in a loss of the circadian rhythm and a constitutively low
daytime level expression of vasopressin (Jin et al., 1999).
The first suggestion that vasopressin might be hormonally regulated came in
1981, when a sex difference in vasopressin-ir fiber density was observed in the lateral
septum (de Vries et al., 1981). Subsequent studies showed that castration eliminated
vasopressin peptide immunoreactivity in the lateral septum and multiple other brain areas
and eliminated vasopressin mRNA expression in the BNST (de Vries et al., 1984;
DeVries et al., 1985; Mayes et al., 1988; Miller et al., 1992). The sex difference in
vasopressin-ir fiber density, which depends on conversion of testosterone to estradiol in
the male brain (De Vries et al., 1994), persists when testosterone levels are clamped at
similar levels in male and female rats and mice, suggesting a developmental or
organizational process (De Vries et al., 1994; Rood et al., 2008); although gonadal steroid
hormones are required for the expression of vasopressin in adulthood and other sex
differences not examined in these studies could be due to activational effects of steroid
hormones (de Vries et al., 1984). Further, neonatal castration of male rats lowers, and
injection of testosterone during the first week of life in female rats increases, the
vasopressin-ir fiber density observed in the presence of steroid hormones in adulthood,
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reducing or eliminating the sex difference in both cases (Wang et al., 1993; Han and De
Vries, 2003).
The differences in the regulation of vasopressin expression present a unique
opportunity for researchers to explore the regulation of gene transcription and
mechanisms of cellular differentiation that lead to differential gene transcription. For the
purposes of this manuscript, the hormonal regulation of gene expression will be used as a
tool. Vasopressin expression in the BNST and medial amygdala can be eliminated by
removing gonadal hormones. This provides an efficient technique, namely gonadectomy,
for studying the projections of these nuclei within the nervous system.
1.6 Location of vasopressin-containing fibers
The location of vasopressin-ir fibers, axons, and terminal boutons has been
examined in at least 20 mammalian species (De Vries and Panzica, 2006). Below, I will
highlight some of the similarities and differences that are found across species. Because
the rat vasopressin system is the most well studied, and the mouse vasopressin system is
the focus of this proposal, I will pay special attention to those species in the narrative.
Vasopressin-ir fibers, or immunoreactivity of the vasopressin-associated peptides
neurophysin II or vasopressin-related glycopeptide, have been observed in every level of
the central nervous system (i.e., telencephalon, diencephalon, mesencephalon,
metencephalon, myelencephalon, and spinal cord) in multiple species. Hypothalamic
regions have areas of dense fibers in addition to the multiple magnocellular and
parvocellular vasopressin-producing cell groups. The lateral hypothalamus contains thick
fibers descending from the paraventricular nucleus toward the supraoptic nucleus and
eventually to the neurohypophysis (DeVries et al., 1985; Caverson et al., 1987; Castel
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and Morris, 1988). In rats, small fibers and terminals are found throughout the
hypothalamus especially in the lateral hypothalamus, preoptic area, arcuate nucleus,
periventricular nucleus, and dorsomedial hypothamalamic nucleus (DeVries et al., 1985).
The ventromedial hypothalamus has almost no fibers in the rat (DeVries et al., 1985).
This observation is noteworthy in that it is one of the few observations where fibers are
explicitly reported to be absent. Much of the data regarding the location of vasopressin
fibers are incomplete. Thus, when an author does not report on the fibers it could mean
that there were no fibers located in a brain region, the researchers did not look at that
region, or the authors just did not mention the presence of fibers in their report. For
example, although Castel and Morris (1988) give a detailed description of neurophysin
II-ir cells and fibers in the forebrain, they reported neurophysin II-ir fibers in the "rostral
to caudal extent of the amygdala" without identifying individual nuclei, and they did not
report on midbrain or hindbrain fibers.
In addition to the hypothalamus, vasopressin is present throughout many ventral
forebrain structures associated with the limbic system, such as the lateral septum, ventral
pallidum, diagonal band of Broca, and the medial septum (DeVries et al., 1985).
Vasopressin-ir fibers are observed in many of these same regions in the mouse (Castel
and Morris, 1988; Rood et al., 2008), and fibers have been reported in some of these
areas for other mammalian species (Caffe et al., 1989; Dubois-Dauphin et al., 1989;
Crenshaw et al., 1992). Vasopressin innervation of the cortex is sparse at best in most
species studied. In the rat scarce fibers are found in the cingulate, prefrontal, entorhinal,
and endopiriform cortices (DeVries et al., 1985). Castel and Morris (1988) report the
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presence of neurophysin II-ir fibers in the cortex, but do not describe the specific location
of fibers.
Vasopressin is found in the thalamus of rats and mice, primarily in midline nuclei,
and the epithalmaus (DeVries et al., 1985; Castel and Morris, 1988; Rood et al., 2008)
and in various nuclei throughout the midbrain and brain stem (DeVries et al., 1985; Caffe
et al., 1989; Dubois-Dauphin et al., 1989). Vasopressin-ir fibers have not yet been
described in the midbrain or brainstem of the mouse.
Many areas of the brain connected with the limbic system, which control
emotional and memory processes, contain vasopressin-producing cell bodies (i.e., BNST
and medial amygdala) and vasopressin-ir fibers (e.g., lateral septum, amygdala,
hippocampus, cingulate cortex, mediodorsal thalamus, ventral pallidum, etc.). In
addition, vasopressin immunoreactivity in many of these areas is hormone dependent
(i.e., gonadectomy leads to a loss of fiber immunoreactivity; (DeVries et al., 1985)) and
sexually dimorphic (i.e., males exhibit more vasopressin immunoreactivity than females;
(de Vries et al., 1981; Mayes et al., 1988; De Vries and al-Shamma, 1990; Rood et al.,
2008).
As discussed above, vasopressin is produced in at least five distinct nuclei in most
species examined: the paraventricular nucleus, supraoptic nucleus, suprachiasmatic
nucleus, BNST, and the medial amygdala. Given the different locations and functions of
these nuclei, it stands to reason that the vasopressin within each area would be involved
in unique functions. I have already discussed how vasopressin expression within
different nuclei is under different transcriptional regulation, and it is reasonable to
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assume that each nucleus would also have a unique pattern of afferent projections suited
to its individual function.
1.7 Site of origin of vasopressin-containing fibers
A few studies have attempted to discern the various projections sites of
vasopressin neurons by assuming the identity of projections based on the appearance of
vasopressin-ir fibers. Castel and Morris (1988) suggested that the thin punctate nature of
fibers observed in the diagonal band of Broca and the lateral septum had the appearance
of those derived from the suprachiasmatic nucleus. However the authors acknowledged
work by De Vries et al. (1983) suggesting that these fibers derived from the BNST, in the
rat. Abrahamson and Moore (2001) also examined vasopressin innervation of the
forebrain and suggested that similar areas, the lateral septum and lateral habenula, likely
received vasopressin innervation from the suprachiasmatic nucleus given the nature of
the fibers and the direction of fiber pathways leaving the suprachiasmatic nucleus. Both
of these groups noted "thick" and "thin" fibers throughout brain (see Figure 2.7). The
thin fibers were posited to come from the suprachiasmatic nucleus, whereas as thick
fibers were suggested to arise from the magnocellular neurons of the paraventricular and
supraoptic nucei. In their description of the guinea pig vasopressin system, DuboisDauphin et al. (1989) further delineated the morphology of axons as being "thick and
varicose", "thin and moderately stained varicose", or "very thin". However, these authors
did not hypothesize the site of origin of the various fibers. One other difference between
these three studies is the peptide examined: vasopressin (Abrahamson and Moore, 2001),
neurophysin II (Castel and Morris, 1988), or vasopressin-associated glycopeptide
(Dubois-Dauphin et al., 1989). Finally, one common conclusion from both Castel and
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Morris (1988) and Abrahamson and Moore (2001) was that the sometimes dense
vasopressin innervation by different size fibers and the inability to follow thin varicose
fibers any distance through sections made interpreting the site of origin difficult at best.
A few empirical studies have more accurately located the site of origin of
vasopressin fibers from the BNST and paraventricular nucleus (De Vries and Buijs,
1983), the suprachiasmatic nucleus (Hoorneman and Buijs, 1982; Watts and Swanson,
1987; Delville et al., 1998), and the medial amygdala (Caffe et al., 1987). Following
SCN lesions vasopressin-ir fibers remained in the lateral septum, lateral habenula,
amygdala, diagonal band of Broca, nucleus of the solitary tract, interpeduncular nucleus,
and dorsal raphe nucleus, but disappeared in the vascular organ of the lamina terminalis,
dorsomedial hypothalmaus, and paraventricular nucleus of the thalamus (Hoorneman and
Buijs, 1982). The authors of this study concluded that the remaining brain regions must
receive their vasopressin innervation from the paraventricular or supraoptic nuclei.
However, vasopressin neurons were discovered to exist in the BNST in 1983 (van
Leeuwen and Caffe, 1983). Subsequently, retrograde tracing of the lateral septum using
horseradish peroxidase resulted in labeled cells in the BNST, but not the paraventricular,
supraoptic, or suprachiasmatic nuclei (De Vries and Buijs, 1983). In addition, lesions to
the BNST, but not the paraventricular nucleus, resulted in a decrease in vasopressin
immunoreactivity in the lateral septum, lateral habenula, diagonal band of Broca,
amygdala, periventricular gray, and locus coeruleus. In contrast, lesions of the PVN
resulted in the loss of fibers in the nucleus of the solitary tract and the nucleus ambiguus,
suggesting that the paraventricular nucleus does have centrally projecting vasopressin
cells in addition to neurosecretory cells projecting to the neurohypophysis (De Vries and
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Buijs, 1983). Finally, lesions of the medial amygdala resulted in a noticeable decline of
vasopressin-ir fibers in the lateral septum and a complete loss of fibers in the ventral
subiculum and other ventral hippocampal structures (Caffe et al., 1987). After amygdala
lesions, decreases in vasopressin immunoreactivity were not observed in the lateral
habenula, mediodorsal thalamus, ventral tegmental area, central gray, dorsal raphe, or
locus coeruleus; however, only qualitative observations were made. In addition,
retrograde tracer injections into the lateral septum and the ventral hippocampus each
resulted in cells co-labeled for vasopressin immunofluorescence in the medial amygdala.
Injections into the lateral septum also resulted in co-labeled cells in the BNST, and no
other nuclei that produce vasopressin had any retrograde-labeled cells following these
tracer injections (Caffe et al., 1987). Evidence suggests that each group of vasopressin
cells has a subset of nuclei to which it projects that does not necessarily overlap with
projections from other vasopressin producing nuclei. However, for most brain regions
evidence for the site of origin of projections is neither conclusive, nor complete.
1.8 Vasopressin receptors
Thus far three different vasopressin receptors have been identified: V1a, V1b,
and V2 (Lolait et al., 1992; Morel et al., 1992; Saito et al., 1995; Ventura et al., 1999).
The V2 receptor is found primarily in the kidney (Ostrowski et al., 1992), and the V1b is
known for its activity in the pituitary gland to potentiate adrenocorticotropin hormone
release (Yates et al., 1971). The V1a receptor on the other hand is found in the brain as
well as in peripheral sites, such as the liver and in blood vessels (Ostrowski et al., 1992;
Ostrowski et al., 1993; Ostrowski et al., 1994). Importantly, at least in the rat, V1a
mRNA is found in many of the same brain regions where vasopressin fibers are located
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(Ostrowski et al., 1994). All three vasopressin receptors are G-protein coupled receptors.
The V1a, in particular, interacts with Gq stimulating phospholipase C, thereby increasing
inositol phospholipid metabolism and ultimately increasing intracellular calcium
(Stephens and Logan, 1986; Shewey and Dorsa, 1988).
The increase in intracellular calcium can mean a number of things for cell
function. Neurons in the facial nucleus of peripubertal rats, the solitary nucleus of adult
rats, and the dorsal cochlear nucleus of guinea pigs all respond to vasopressin with an
increase in intracellular firing (Charpak et al., 1989; Raggenbass et al., 1989; Raggenbass
et al., 1991). In the hippocampus, vasopressin potentiates cAMP turnover induced by
norepinephrine (Brinton and McEwen, 1989). In the lateral septum, one of the most
studied projection sites, vasopressin is thought to directly excite a population of
GABAergic intereurons, which then causes a general inhibition of the projection neurons
of the lateral septum (Allaman-Exertier et al., 2007).
1.9 Functions carried out by vasopressin
The general effects of vasopressin have been studied since long before the
anatomy of the vasopressin system was conceived, even prior to the isolation of the
peptide itself. The first observations of vasopressin activity were in the increase in blood
pressure after injection of pituitary extracts (Oliver and Schafer, 1895). In the early
1900's, pituitary extracts were observed to have anti-diuretic properties as well (Farini,
1913). In the intervening century, vasopressin was isolated, the gene structure was
determined, the localization of vasopressin in the brain was determined, the activity of
vasopressin was ascribed to three receptor types, and a host of vasopressin-modulated
physiological and behavioral functions were identified (reviewed by (Caldwell et al.,
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2008). In short, vasopressin appears to be important for blood pressure, water balance,
thermoregulation, affiliative social behaviors, aggression, and social memory (Ferris et
al., 1984; Naylor et al., 1985; Pittman and Franklin, 1985; Demotes-Mainard et al., 1986;
Dantzer et al., 1987; Young et al., 1999; Lim and Young, 2004; Beiderbeck et al., 2007).
Many of the early studies examining the function of vasopressin on the nervous
system involved injections of vasopressin receptor agonists or antagonists peripherally or
into the lateral ventricles. In 1965, De Wied and colleagues determined that the posterior
pituitary appeared to be important for a conditioned avoidance task. Removal of the
neurohypophysis led to rapid extinction of the avoidance response; animals could not be
conditioned. They found that peripheral injections of pituitary extracts or vasopressin
alone following the conditioning trials could inhibit extinction and restore the
conditioned response (De Wied, 1965; De Wied, 1971). These studies were among the
first to observe a behavioral effect of vasopressin. Since these initial observations, many
studies have focused on the behavioral actions of vasopressin. For example, injections of
vasopressin into the medial preoptic area / anterior hypothalamus facilitate flankmarking, a territorial behavior, in Syrian Hamsters (Ferris et al., 1984); injections of
vasopressin agonist increase and antagonist decrease paternal behavior in prairie voles
(Wang et al., 1994); and injections of vasopressin receptor antisense into the lateral
septum, which decreases vasopressin function in the septum, inhibit social recognition
memory in rats (Landgraf et al., 1995). Although many of the best studied effects of
vasopressin on behavior have focused on the hypothalamus or lateral septum, analyses of
vasopressin projections suggest that vasopressin has effects on many regions throughout
the central nervous system.
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1.10 Summary
Vasopressin, a nine-amino acid peptide produced in the hypothalamus and
extended amygdala, acts as a neurotransmitter and binds to various receptors of which the
V1a is most prominent in the brain. Vasopressin fiber immunoreactivity has been
examined in a number of species, but a thorough accounting for the mouse is still lacking.
Recent research suggests a role for vasopressin in social behaviors many of which are
altered in common psychiatric disorders such as anxiety, depression, schizophrenia, and
autism. In this manuscript, I present research which moves our understanding of the
anatomy of vasopressin projections forward. It is my hope that this work will lead to
critical hypotheses regarding the function and mechanism of action of vasopressin in
social behavior.
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CHAPTER 2
VASOPRESSIN ANATOMY IN INTACT MALES

2.1 Introduction
Vasopressin has become a key player in our attempt to understand the complex
neurobiology of social behavior. Studies over the last three decades have suggested roles
for vasopressin in regulating or controlling social behaviors such as social memory, pairbonding, partner preference, aggression, and communication (Ferris et al., 1984; Dantzer
et al., 1987; Dantzer et al., 1988; Dubois-Dauphin et al., 1989; Compaan et al., 1993;
Insel et al., 1994; Lim et al., 2004; Lim and Young, 2004; Thompson et al., 2006), in
addition to the physiological roles that vasopressin plays in regulating water balance,
blood pressure, thermoregulation, and stress (Oliver and Schafer, 1895; Farini, 1913;
Yates et al., 1971; Banet and Wieland, 1985; Naylor et al., 1985; Pittman and Franklin,
1985; Demotes-Mainard et al., 1986). Anatomical and pharmacological examination of
the vasopressin system has resulted in several hypotheses regarding the influences of
specific brain regions on behavior. Examples with more specific neural correlates
include flank marking, thermoregulation during fever, and social memory.
Flank marking is a territorial behavior displayed by male and female hamsters
that involves a stereotyped pattern of grooming and rubbing of the flanks on objects.
Injections of vasopressin into the medial preoptic area, but not into the lateral ventricles
or other hypothalamic brain regions (e.g., ventromedial hypothalamus), initiate this
pattern of behavior (Ferris et al., 1984; Ferris et al., 1996). In addition, lesions of the
preoptic area / anterior hypothalamic area eliminate flank-marking (Ferris et al., 1986;
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Ferris et al., 1993). A second area, the ventral septal region, is implicated in
thermoregulation. In rats and rabbits with interleukin-1 induced fever, injection of
vasopressin into the ventral septal area, but not the ventral lateral septum (Bernardini et
al., 1983), reduces core body temperature (Naylor et al., 1985; Cooper et al., 1987), even
though vasopressin does not reduce body temperature under normal conditions (Banet
and Wieland, 1985). A third region of much interest is the lateral septum, which has
been studied for its role in memory, especially in the rat. Rats have a tendency to
investigate a familiar animal less than an unfamiliar animal; they are thought to
"remember" the familiar animal. This "social memory" lasts for less than 2 hours in
males and 3 hours in females (Bluthe and Dantzer, 1990). Injections of vasopressin into
the lateral septum extend the duration of this memory in both sexes (Dantzer et al., 1987;
Dantzer et al., 1988; Bluthe and Dantzer, 1990). However, V1a receptor antagonists
blocks recognition in males, but not females (Dantzer et al., 1987; Dantzer et al., 1988;
Bluthe and Dantzer, 1990; Everts and Koolhaas, 1997). In addition, V1a mRNA antisense injections decrease social recognition and overexpression of the V1a receptor,
using an adenoviral vector, facilitates social recognition when injected into the lateral
septum (Landgraf et al., 1995; Landgraf et al., 2003). Finally, and most convincingly,
viral-vector mediated expression of the V1a receptor in the lateral septum rescues social
recognition in V1a knockout mice, which normally have impaired social memory
(Bielsky et al., 2005).
These three examples illustrate a direct functional link between a behavior and
vasopressin. However, the functional link is not always as clear. For example, several
attempts have been made to correlate aggression with vasopressin levels in the brain.
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Long-attack latency (i.e., low aggression) mice have more vasopressin immunoreactivity
in the lateral septum than short-attack latency mice (i.e., high aggression; (Compaan et
al., 1993), and more aggressive rats have less vasopressin in the lateral septum (Everts et
al., 1997). In contrast, highly aggressive California mice have higher levels of
vasopressin in the lateral septum than much less aggressive white-footed mice (BesterMeredith, 1999). The opposing patterns in vasopressin fibers warn against simple
correlations between vasopressin fiber density and vasopressin effects on behavior.
Furthermore, extracellular vasopressin levels in the septum appear to drop, suggesting a
reduction in release, during an aggressive encounter in low-anxiety rats, which are highly
aggressive. However, vasopressin agonists are unable to alter behavior in these rats
(Beiderbeck et al., 2007). In humans, vasopressin administration by intranasal spray
leads to changes in emotive facial movements in response to pictures of faces and
increased anxiety, responses not generally linked to the lateral septum (Thompson et al.,
2006). In order to understand how vasopressin might influence aggression and other
complex social behavior, one must take into account the entirety of the vasopressin
system. The lateral septum, ventral septal area, and medial preoptic area are just the tip
of the iceberg.
Although the anatomy of the vasopressin system has been studied in more than
twenty different mammalian species (De Vries and Panzica, 2006), a thorough
accounting has only been made for a few including the rat and guinea pig. In most
descriptions, authors focus on forebrain areas, but ignore the midbrain and hind brain
regions. In the case of the mouse, two studies have been published in which a brief
description of neurophysin II or vasopressin in the telencephalon and diencephalon is
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given (Castel and Morris, 1988; Abrahamson and Moore, 2001). Given the current
importance of the mouse in transgenic approaches to anatomy, physiology, and behavior,
it is crucial to have a thorough knowledge of the location of vasopressin projections
throughout the mouse brain. In addition, a complete accounting of fiber projections
allows for greater accuracy in making comparisons with other species and in designing
functional hypotheses.
In the following sections, I describe the locations of vasopressin-immunoreactive
fibers and cell bodies throughout the brains of male C57BL6 mice with an emphasis on
describing distinct characteristics of fibers (i.e., small versus medium fibers) and
defining discrete regions of innervation within larger regions (e.g., the posterodorsal
medial amygdal within the amygdala). In addition, I compare the vasopressin innervation
of the mouse brain to previous research in mice and other species. Finally, by defining
the vasopressin innervation throughout the mouse brain, I set the stage for future
discussions on the origins of the various fibers described.
2.2 Methods
2.2.1 Animals
C57BL6 mice were studied in this experiment. Animals were derived from a
breeding colony at the University of Massachusetts. Following weaning, animals were
group-housed (5 or less per cage) with same-sex siblings under a 14:10 light cycle with
lights on at 6:00 am. Animals had ad libitum access to food and water. All procedures
conformed to NIH guidelines and were in accordance with a protocol approved by the
University of Massachusetts IACUC.
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Brains from three gonadally intact male mice were used for the ensuing
descriptions. The brains of 12 gonadally intact male mice from a separate study
(presented in CHAPTER 3) were used to corroborate the observations made in this study.
2.2.2 Tissue collection and processing
The three male C57BL6 mice were sacrificed at approximately 90 days of age by
CO 2 asphyxiation followed by rapid decapitation. Brains were removed rapidly and
placed in 5% acrolein in 0.1 M phosphate buffer. Fixation lasted for four hours at which
time brains were transferred to 30% sucrose in 0.1M phosphate buffer and stored at 4° C
until sectioning. Each brain was sectioned at 30 Pm in one of three planes: coronal,
sagittal, or horizontal. For each brain, every other section was collected for vasopressin
immunohistochemistry. All brain sections reserved for immunohistochemistry were
stored in cryoprotectant at -20° C until staining. Alternate sections were briefly stored in
0.05M Tris-buffered saline until being mounted on slides and Nissl stained. Tissue from
animals used to corroborate results of this study were collected and processed in a similar
manner, except only every third coronal section (30 Pm sections) was collected.
2.2.3 Nissl staining
Brain sections were mounted onto gel coated slides and allowed to dry at least
overnight. Sections were rinsed 2x2 min in distilled water and then 2x2 min in 70%
ethanol followed by a 5 min incubation in thionin. Following thionin staining, sections
were rinsed in distilled water and then then placed in 70% ethananol plus 0.1% glacial
acetic acid for 10 min to remove non-specific staining. Subsequently, tissue was
dehydrated in 95% ethanol (1 min) and 100% ethanol (2x1 min) and finally rinsed in
Hemo-De (Scientific Safety Solvents, Kellar, TX) for 4 min prior to coverslipping.
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2.2.4 Immunohistochemistry
Immunohistochemistry was carried out in mesh-bottomed cups and all
incubations and rinses were done at room temperature except where noted. Sections were
incubated in the following solutions: 3x5 min in Tris-buffered saline (TBS; 0.05 M Tris,
0.9% NaCl, pH 7.6); 0.05 M sodium citrate in TBS for 30 min; 3x5 min in TBS; 0.1 M
glycine in TBS for 30 min; 3x5 min in TBS. Finally, sections were incubated in blocking
solution (20% normal goat serum (NGS), 0.3% Triton-X (Labchem, Inc., Pittsburgh, PA)
and 1% H 2 O 2 in TBS) for 30 min before being transferred to 2 ml Eppendorf tubes
containing primary antibody (2% NGS, 1% BSA, 0.3% Triton-X, and 1:12,000 guineapig anti-vasopressin antiserum (T-5048, Peninsula Laboratories, San Carlos, CA, USA)).
After incubating overnight (~18 h), sections were returned to wells and rinsed with 37° C
TBS containing 1% NGS and 0.02% Triton-X for 3x10 min. Next, sections were
incubated in secondary antiserum (1:250 biotinylated goat anti-guinea-pig IgG (Vector
Laboratories, Burlingame, CA, USA) in TBS with 2% NGS and 0.32% Triton-X) for 1 h
followed by 3x10 min rinses in TBS containing 0.2% Triton-X. Sections were then
incubated for 1 h in avidin–biotin complex in TBS (ABC elite kit, Vector Laboratories)
followed by 3x10 min rinses in TBS. Finally, sections were incubated in DAB with
nickel enhancer (DAB peroxidase substrate kit, Vector Laboratories) for 2.5 min
followed by 4x5 min rinses in TBS. Sections were mounted on gel coated slides and
allowed to dry at least overnight. Sections were subsequently rinsed 3x30 sec with
distilled water and allowed to dry before being coverslipped using Permount
(ThermoFisher)
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Multiple controls for immunohistochemical staining were carried out on sections
from animals used in CHAPTER 3 and CHAPTER 5. Procedures were the same as
described above except for the following alterations to the primary antibody for
individual controls: 1) no primary antibody was added to incubation buffer, 2) antibody
was pre-adsorbed to 50 PM vasopressin (Sigma Aldrich, St. Louis, MO), anti-body was
pre-adsorbed to 50 PM oxytocin (Sigma Aldrich, St. Louis, MO), or 4) several crystals of
thyroglobbulin (Sigma Aldrich, St. Louis, MO) were added to primary antibody buffer.
2.2.5 Analyses and image acquisition
Oberservations were made using a bright field microscope (Nikon Eclipse E600).
Nissl stained section were occasionally used for reference. Photomicrographs presented
throughout were taken with a MicroFire camera (Optronics, Goleta, CA) and
PictureFrame software. Anatomical distinctions made throughout are derived from
nomenclature and regional delineation presented by Franklin and Paxinos in The Mouse
Brain in Stereotaxic Coordinates (2008).
2.3 Results
Before describing immunoreactivity throughout the brain, it is important to first
discuss staining controls (Saper and Sawchenko, 2003). Immunoreactivity observed
throughout the brain resembled immunoreactivity described by numerous other authors in
both the characteristics of fibers (Buijs, 1978; Buijs et al., 1978; Castel and Morris, 1988;
Abrahamson and Moore, 2001) and in the location of fibers (DeVries et al., 1985; Castel
and Morris, 1988). No staining was observed in the absence of primary antibody. Preadsorption with 50 PM vasopressin eliminated staining except for a very faint haze in the
PVN, where vasopressin production is quite high. Pre-adsorption with 50 PM oxytocin
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caused a decrease in the intensity of staining, but did not eliminate staining of fibers.
These results suggest that the antibody was reasonably specific.
One particular staining concern was a peculiar "specific" background artifact
observed in cell bodies in distinct nuclei. This staining (best observed in Figure 2.19F in
the trochlear nucleus) was particular to regions such as the red nucleus (n.), trochlear n.,
occulomotor n., substantia nigra pars reticulata, and other regions with motor system
function or large cholinergic or noradrenergic neurons such as those in the vertical
diagonal band and locus coeruleus. The staining in these cells appeared to be of cell
body substructure, and no fiber staining was present around these cells. In contrast,
vasopressin producing neurons such as those in the paraventicular hypothalamus,
suprachiasmatic nucleus, or BNST stain uniformly except for a nuclear void and have
fibers projecting out from the cells. One possible explanation for this background artifact
comes from the fact that the polyclonal vasopressin antibody used was produced by
injecting vasopressin conjugated to the protein thyroglobbulin. This may have created
some antibodies with different target affinities. In imunohistochemical controls, the
addition of thyroglobbulin to the primary anti-serum led to a large decrease in this artifact
staining in the vertical diagonal band, cortex, and other regions without affecting staining
of vasopressin cells and fibers. We are confident that the rather specific staining artifact
does not affect any of the data presented throughout. On the contrary, the presence of
this artifact enabled us to clearly visualize numerous nuclei throughout the brain thereby
increasing our ability to determine the location of vasopressin-ir fibers and greatly
increasing our anatomical precision.
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2.3.1 Cell bodies in the diencephalon
2.3.1.1 Paraventricular nucleus
In mice, the paraventricular nucleus (PVN) begins rostrally as the fornix bends
ventrally and drops caudally below the upper edge of the third ventricle. At first only a
few large darkly staining neurons are observed bilaterally just below the top of the third
ventricle in the anterior parvicellular PVN (PaAP; Figure 2.1A). Caudally the number of
neurons increases drastically along the upper half of the ventral third ventricle in the
ventral and medial magnocellular PVN (PaV and PaMM; Figure 2.1B). Subsequently a
group of vasopressin-ir neurons appears laterally in the lateral magnocellular PVN
(PaLM) at the top of the third ventricle, the PaV cell group ends, and a less dense group
of immunoreactive cells is seen in the medial parvocellular PVN (PaMP; Figure 2.1C).
After this point, the labeling in the PaLM cell group continues to be dense, but fewer
labeled cells are observed adjacent to the third ventricle in the PaMP (Figure 2.1D). As
the fornix nears the dorsal-ventral midline of the third ventricle, the PVN ends with just a
few scattered vasopressin-ir cells near the top of the ventricle.
2.3.1.2 Supraoptic nucleus
The distribution of vasopressin-ir cells in the supraoptic nucleus (SON) is rather
extensive. Large darkly staining neurons first begin to appear hugging the ventral surface
of the brain just above and lateral to the optic chiasm in the episupraoptic nucleus (Figure
2.2A). As the optic tract begins to curve up into the brain, large, darkly staining neurons
are so densely packed atop the optic tract that they often cannot be distinguished (Figure
2.2B). While most vasopressin-ir neurons in the SON are seen in a distinct cluster just
dorsal and lateral to the optic tract, a string of large neurons spreads medially atop the
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optic tract stopping in the retrochiasmatic region below the anterior hypothalamus
(rostrally) and ventromedial hypothalamus (caudally; Figure 2.2C). As the optic tracts
take a sharp turn dorsally to meet the cerebral peduncles, the large vasopressin-ir neurons
of the SON disappear (Figure 2.2D).
2.3.1.3 Suprachiasmatic nucleus
The suprachiasmatic nucleus (SCN) contains a very dense cluster of small darkly
staining cells, which at times are difficult to tell apart due to an extremely dense halo of
fibers and terminals surrounding the nucleus. Vasopressin-ir cells in the SCN form a
shell around an empty (i.e., no vasopressin-ir cells) core (Figure 2.3B). Densely packed
cells are found in the rostral (Figure 2.3A) and caudal poles (Figure 2.3C). In the middle
of the SCN, vasopressin-ir cells form a shell dorsal, lateral, and medial to a central core.
The ventral part contains fewer cells (Figure 2.3B).
2.3.1.4 Accessory nuclei
In addition to the vasopressin-ir neurons of the above mentioned nuclei, there are
numerous other scattered vasopressin immunoreactive cells throughout the
hypothalamus. Because many of these cells appear similar in size and shape to
magnocellular neurons of the PVN and SON and lie along fiber pathways from these
nuclei, these neurons are often referred to as "accessory nuclei." The accessory cells are
most consistently found in the periventricular region (see figure 2.14E), anterior
hypothalamus (Figure 2.4A), perifornical region (Figure 2.4B), and peduncular lateral
hypothalamus (Figure 2.4C). In general, these areas only have sparse labeling as no more
than a dozen vasopressin-ir cells are generally seen in any single cross section. The
emergence of the anterior hypothalamus caudal to the medial preoptic area is generally
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announced by the presence several large vasopressin-ir neurons halfway between the
PVN and SON. These cells are close to projections of the PVN, and fibers from these
cells can be seen following a similar path to that of other fibers passing through the area
possibly from the PVN. A similar pattern is observed in vasopressin cells in the
perifornical region and peduncular lateral hypothalamus. In addition, within the anterior
hypothalamus, a densely packed cluster of neurons is observed, the nucleus circularis
(Figure 2.4D).
2.3.1.5 Other hypothalamic nuclei
There are three other conspicuous clusters of vasopressin-ir cells in the
hypothalamus. One cell group is located rostral to the PVN just below the fornix in the
striohypothalamic region (Figure 2.5A). This nucleus contains a loosely packed cluster
of immunoreactive neurons. A second conspicuous cell group is observed in more caudal
reaches of the hypothalamus. Just caudal to the last SON neurons, a distinct cluster of
darkly staining neurons is observed along the ventral surface of the brain in the
retrochiasmatic supraoptic nucleus (Figure 2.5B). These neurons are often difficult to see
as they are buried in a dense tangle of medium to large vasopressin-ir fibers passing
through the tuberal part of the hypothalamus. Finally, vasopressin-ir neurons are found
in the ventral lateral preoptic area and are usually large, darkly staining, and tightly
clustered along the ventral brain surface (Figure 2.5C).
2.3.2 Cell bodies in the telencephalon
2.3.2.1 Bed nuclei of the stria terminalis
Outside of the hypothalamus vasopressin cells are found in the bed nuclei of the
stria terminalis (BNST) and medial amygdala (MeA). In the BNST, most of the cells
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observed are small (i.e., parvocellular) and very lightly staining and are found primarily
in two subdivisions of the BNST. The first group of cells is located in the medial
posteromedial BNST (STMPM) just lateral to the fornix. These cells sit just medial to
fibers entering from the stria terminalis (Figure 2.6A and B). A second loose cluster of
cells is observed caudally in the lateral posteromedial BNST (STLPM). This cell group
spreads out in a dorsolateral to ventromedial orientation starting just under the stria
terminalis (Figure 2.6C and D). Aside from these two locations a few lightly staining
small cells are scattered throughout the posterior BNST, and a few isolated cells are
observed in the anteromedial BNST. Finally, occasional single large, darkly staining
neurons are observed in the STMPM and STMPL.
2.3.2.2 Medial Amygdala
A smaller and more loosely organized collection of vasopressin-ir cells is found in
the medial amygdala. These cells, like the BNST, are small and stain very lightly. They
typically appear from rostral to caudal levels of the posterodorsal medial amaygdala and
tend to concentrate on the very lateral edge of the nucleus (Figure 2.6E to H).
2.3.3 Small versus medium fibers
Throughout the description of vasopressin fibers below, I refer to small, medium,
and occasionally large fibers. In addition, I frequently refer to terminal fields. In
general, the characteristics of fibers provide a unique insight into various fiber pathways.
In rats medium fibers are typical of PVN or other hypothalamic pathways, except the
SCN, whereas small fibers are typical of projections from the BNST, MeA, and SCN
(Buijs et al., 1978; De Vries and Buijs, 1983). Small fibers typically have very small
faint processes with small varicosities as seen in the lateral septum (Figure 2.7A; also see
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Figure 2.10F). Small fibers are often associated with punctate staining, which are
referred to as terminal fields. In contrast, medium fibers are larger, have larger
varicosities, and often stain more darkly. In addition these fibers are rarely associated
with the small punctate staining typical of small fiber terminal fields. Instead, these
fibers often have very visible protrusions, which could be boutons of passage, that branch
off the fiber as it passes through an area as in the ventral periaqueductal gray (Figure
2.7B). Large fibers are only seen in a few places such as the medioventral BNST and the
periventricular area (see Figure 2.4A).
2.3.4 Fibers in the telencephalon
2.3.4.1 Cortex
Most of the cortex is devoid of vasopressin-ir fibers; however, a few regions
consistently contain fibers. In the frontal lobe, medium fibers are observed in the midline
cortical nuclei such as the medial orbital, frontal, infralimbic, prelimbic (Figure 2.8A),
and dorsal peduncular cortex. The insular cortex just dorsal to the rhinal fissure contains
sparse fibers at points along its rostral to caudal length (Figure 2.8B). The rostral
cingulate cortex also contains a very sparse innervation, often only a single fiber (Figure
2.8C). The densest innervation of the cortex occurs caudally as the hippocampus reaches
ventrally. Here, there are vasopressin-ir fibers in areas such as the endopiriform,
entorhinal, intermediate endopiriform claustrum, and dorsolateral ectorhinal cortex
(Figure 2.8D).
2.3.4.2 Hippocampus
Dorsally the hippocampus is devoid of vasopressin fibers. Only a rare fiber is
observed in the fimbria. As the hippocampus reaches ventrally at the level of the caudal
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amygdala scattered small fibers are observed in the oriens layer of the hippocampus and
along the border between the hippocampal formation and the amygdala-hippocampal
transition zone (Figure 2.8E and F) and further caudally in the ventral subiculum. Sparse
small fibers are also observed in the molecular layer of CA1. In addition to the small
fibers seen in CA1, medium to large fibers are observed in the caudal molecular layer of
CA1 (LMol) as the sulcus between the hippocampal and dentate gyri stretches ventrally
(Figure 2.8G and H).
2.3.4.3 Basal ganglia
The caudate, putamen, and globus pallidus do not contain vasopressin-ir fibers.
The nucleus accumbens contains a small number of medium fibers mostly in its core
region (Figure 2.9A and B). The ventral pallidum (VP), in contrast, contains mostly
small fibers and terminals. Rostrally, there are densely innervated patches of ventral
pallidum between the shell of the nucleus accumbens and the olfactory tubercle, both of
which do not contain labelled fibers (Figure 2.9A). As the vertical limb of the diagonal
band becomes prominent, the dense patches of fibers in the ventral pallidum seem to
connect to a dense band of vasopressin immunoreactivity between the diagonal band and
the accumbens shell. As the horizontal limb of the diagonal band begins to spread
laterally the VP contains a more moderate innervation of small fibers and terminals
located primarily in the medial portion of the VP underneath the waning nucleus
accumbens (Figure 2.9B). The central region of the VP remains relatively free of fibers
suggesting that the vasopressin innervation of the VP is region specific. Caudally the
innervation of the ventral pallidum becomes increasingly sparse.
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2.3.4.4 Septal Complex
The rostral septum contains sparse medium fibers in all three divisions (ventral,
intermediate, and dorsal; Figure 2.10A). Caudally, as the anterior commissure starts to
pass under the lateral ventricle, a moderate innervation of small fibers and terminals
reaches up around the diagonal band and invades the ventral lateral septum, intermediate
lateral septum, and to a lesser extent the septohypothalamic nucleus (Figure 2.10B). The
fiber plexus in the ventral lateral septum and more caudal septal regions appears to be
continuous with fibers in the ventral septal area, which is described below. The plexus of
small fibers and terminals becomes very dense in the ventral and intermediate lateral
septum as the fibers of the fimbria become visible (Figure 2.10C). At the caudal extent
of the septal complex (Figure 2.10D), some small fibers make their way into the fringes
of the septofimbrial region, although the main body of the fimbria is devoid of
vasopressin fibers. The dorsal lateral septum contains only a very few medium fibers
along its length. One additional feature of the small fibers in ventral and intermediate
lateral septum is the formation of peri-cellular baskets, groups of terminals surrounding
individual cells (Figure 2.10E ad F).
In sharp contrast to the dense innervation of the lateral septum, the medial septum
does not contain vasopressin fibers (Figure 2.10A and B). However, a few medium
fibers rise up just lateral to the medial septum and occupy a region between the medial
septum and the dense small fibers of the lateral septum (Figure 2.10B). In addition,
scattered medium fibers pass through the median preoptic area rostral to the anterior
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commissure and ascend into the subfornical organ. A few fibers even reach the triangular
septal nucleus (Figure 2.10D).
2.3.4.5 Ventral forebrain
Rostral to the appearance of the diagonal band, there are sparse to scattered
vasopressin fibers along the midline in the navicular postolfactory nucleus. These fibers
extend up into the intermediate lateral septum avoiding the shell of the nucleus
accumbens. As the diagonal band emerges a dense band of fibers is observed stretching
from the ventral surface up toward the septal region between the diagonal band and
nucleus accumbens and around the islands of Calleja (Figure 2.9A). Interestingly, the
three regions just mentioned appear to be specifically avoided by vasopressin fibers. The
region that is innervated is unnamed in The Mouse Brain in Stereotaxic Coordinates
(Franklin and Paxinos, 2008), but corresponds to the ventral septal area (not to be
confused with the ventral lateral septum) described in the thermoregulation literature
(Naylor et al., 1985). Rostrally, pockets of vasopressin-ir fibers in the ventral pallidum
are continuous with this fiber plexus (Figure 2.9A), and caudally fibers spread into the
substantia innominata (Figure 2.9B).
2.3.4.6 Bed nuclei of the stria terminalis
Each division of the bed nuclei of the stria terminalis (BNST) presents a unique
pattern of vasopressin-ir fibers. In the anterior BNST just caudal to the nucleus
accumbens (Figure 2.11A), there are medium fibers both above and below the anterior
commissure in the anteromedial (STMA) and medioventral (STMV) divisions. The
lateral nuclei above and below the anterior commissure contain only sparse medium
fibers. At this rostral level, the STMA alone contains a moderate terminal field and small
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fibers. As the anterior commissure decussates (Figure 2.11B), a moderate to dense
innervation of medium fibers is observed in the STMV below the decussation. The
STMA at this level has an increased density of small fibers. The dorsal lateral nuclei still
contain almost no fibers, but small fibers begin to appear in the lateroventral division.
In the posterior BNST, the medial part of the posteromedial nuclei (STMPM)
contains a dense plexus of fibers and terminals just above the incoming fibers of the stria
terminalis and a second less dense plexus closer to the dorsal edge of the nucleus adjacent
to the dorsal third ventricle (Figure 2.11C). The middle of the STMPM contains fewer
fibers. The intermediate (STMPI) and lateral (STMPL) parts of the nucleus on the other
hand contain a larger scattered to moderate distribution of small vasopressin fibers and
terminals (Figure 2.11D and E). Most of the parvocellular BNST vasopressin cells are
located in the STMPM and STMPL, and many fibers appear to travel dorsally into the
stria terminalis and laterally into the extended amygdala, as labelled by Franklin and
Paxinos (2008) and not to be confused with the larger concept of the extended amygdala
(de Olmos and Heimer, 1999), from this region. Finally, as the posterior BNST nuclei
end caudally, moderate to dense fibers and terminals persist ventral to the stria medullaris
and lateral to the fornix in the nucleus of the stria medullaris (Figure 2.11E).
2.3.4.7 Amygdala
Numerous nuclei throughout the amygdala contain small fibers and associated
terminal fields. Rostrally, the extended amygdala has a moderate innervation of small
fibers that appear to extend into the anterior amygdaloid nucleus (Figure 2.12A and B).
The anterior cortical amygdala also contains a light innervation at this level. Fibers do
not make their way into the piriform cortex, cortex-amygdala transition zone, basolateral
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amygdala, lateral olfactory tract (Figure 2.12C and D), bed nucleus of the accessory
olfactory tract, or magnocellular preoptic area, which borders the medial edge of the
amygdala. As the optic tract begins to ascend and separate the amygdala from midline
brain structures, the medial amygdala emerges adjacent to the looping fibers of the SON.
The anteromedial amygdala contains mostly small fibers, although occasional medium
fibers possibly from the adjacent supraoptic nucleus wander into and anteroventral
medial amygdala. The basomedial amygdala also contains a moderate innervation at this
level. Some fibers appear to make their way laterally into the ventral endopiriform cortex
and ventral basolateral amygdala.
Further caudal the SON is no longer present and the posterodorsal (MePD) and
posteroventral medial amygdala replace the anterior medial nuclei along the optic tract
and contain dense small fibers and terminals. In fact, the MePD has the densest
concentration of fibers in the entire amygdala and is the only nucleus with pericellular
baskets similar to those observed in the lateral septum (Figure 2.12F). At this point, the
innervation thins out laterally and only scattered fibers are observed in the posterolateral
cortical amygdala. Near the caudal end of the posterodorsal medial amygdala, a band of
small fibers and terminals spreads out between the lateral and posterior basolateral
amygdala (Figure 2.12G and H), which have been devoid of fibers up until this point. As
the hippocampus joins the amygdala fibers are seen in the amygdalohippocampal area.
As described above fibers are also seen along the amygdala-hippocampus transition as
well.
Up until this point, all of the fibers described in the amygdala have been small
fibers and terminals. There are very few medium fibers. A few stray from the SON. The
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only other notable innervation is a scattered group of fibers in the central nucleus just
dorsal to the rostral MePD (Figure 2.12E). From here sparse medium fibers appear to
enter the medial amygdala or pass through the basomedial amygdala into the ventral
endopiriform nucleus.
2.3.5 Fibers in the diencephalon
2.3.5.1 Hypothalamus
2.3.5.1.1 Preoptic Area
The preoptic region is marked by a rich innervation by vasopressin fibers likely
deriving from multiple sources. The rostral pole of the preoptic area is marked by
scattered small fibers in the medial preoptic area (MPA) appearing just caudal to the
vertical diagonal band (Figure 2.9B). The MPA splits laterally making way for the
vascular organ of the lamina termialis (VOLT) and the median preoptic nucleus at the
midline both of which contain scattered to moderate innervation of medium fibers (Figure
2.13A). Just rostral to the anterior commissure, many medium fibers stretch dorsally
through the median preoptic nucleus, wrapping around the front of the anterior
commissure into the septal region (Figure 2.13B). The MPA continues caudally with a
scattered to moderate innervation and is marked by more terminals than in the VOLT and
median preoptic nucleus. The lateral preoptic area also contains a moderate innervation
of fibers and terminals which spreads laterally into the ventral septal area, which has a
very dense fiber plexus.
Caudal to the crossing of the anterior commissure, there is a dense terminal field
in the parastrial nucleus (Figure 2.13C), which sits just ventromedial to a cluster of
medium to large fibers in the ventral BNST. At this level, the medial part of the preoptic
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nucleus contains scattered fibers. The periventricular nuclei such as the anteroventral
periventricular nucleus, periventricular nucleus, and ventromedial preoptic area contain
moderate to dense small fibers and terminals as well as a small number of large fibers
(Figure 2.13D and E).
2.3.5.1.2 Anterior hypothalamus
Based on cell grouping and fiber trajectories, there appear to be multiple semidistinct groups of vasopressin-ir cells in the PVN. These cell groups send medium to
large fibers out in three main projections through the anterior hypothalamus (AH). The
first fibers leave the ventral paraventricular nucleus rostrally and pass ventrolaterally
toward the lateral edge of the optic chiasm (Figure 2.14A). These fibers are joined by
those from a number of accessory cells located in the AH. The second group exits the
PVN more dorsally and takes a ventrolateral route just below the fornix toward a point
more lateral than the ventral fibers (Figure 2.14B). The third group of fibers, which
extends the furthest caudally (Figure 2.14C), passes over the top of the fornix and
separates into a ventral and dorsal path. The dorsal path turns up into the reticular
nucleus of the thalamus. The ventral path turns ventrally toward the SON. Both dorsal
and ventral routes pass accessory cells whose fibers seem to join the other fibers.
Small fibers are found almost exclusively near the midline except at the most
anterior part of the AH where a moderate plexus is seen just below the fornix. Caudally
this moderate terminal field phases out rather quickly. At the midline the
suprachiasmatic nucleus starts and ends almost entirely at the level of the AH. A dense
cloud of small fibers and terminals spreads dorsally into the subparaventricular zone and
periventricular area, which also contain some large diameter fibers (Figure 2.14A, B, and
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C). Only a few fibers stray into the anterolateral hypothalamus and AH. Many small
fibers appear to enter the PVN. Sagittal sections reveal that the complex of large fibers is
actually quite dense in the periventricular region along the wall of the third ventricle, and
the innervation by small fibers forms the densest plexus of small fibers seen anywhere in
the brain (Figure 2.14D). In addition, sagittal sections reveal multiple trajectories for
fibers coming from the SCN. A sizable contingent travel rostrally with a particularly
heavy stream of fibers aimed in anterodorsal orientation as if pointing at the anterior
thalamus. The densest cloud spreads dorsally into the subparaventricular zone, and a
number of fibers travel caudally in a rather wide swathe near the ventricle (Figure 2.14E).
2.3.5.1.3 Dorsomedial hypothalamus
The dorsomedial hypothalamus (DMH) begins just caudal to the PVN.
Continuous with the caudal PVN, there is a moderate to dense innervation by small fibers
and terminals near the top third of the ventral third ventricle as well as a substantial
number of medium fibers, which are slightly lateral to the smaller fibers. At first this
plexus of small fibers stays close to the ventricle (Figure 2.15A). However, caudally, the
fiber plexus remains moderate to dense, but grows larger spreading almost out to the
fornix (Figure 2.15B and C), which is at the lateral edge of the ventromedial
hypothalamus (VMH). As the small fibers spread laterally a number of medium fibers
appear to spread medially and intermingle with the small fibers in the more lateral part of
the DMH (Figure 2.15C). The VMH is nearly devoid of fibers. Below the fornix and the
rostral VMH, dense collections of medium fibers forge a path toward the median
eminence (Figure 2.15A and B). Caudally, these fibers form a thin sheet as they reach
the median eminence (Figure 2.15D). Finally, the small fibers and terminals adjacent to
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the third ventricle thin out as the ventricle recedes toward the mammillary recess. In
addition to the more dorsal fibers, small and medium fibers are seen in the
retrochiasmatic area rostrally, the arcuate nucleus caudally, and the periventricular
nucleus throughout.
2.3.5.1.4 Lateral hypothalamus
The peduncular lateral hypothalamus (PLH) emerges caudal to the lateral preoptic
area at the level of the anterior hypothalamus and is distinguished by a marked increase
in the density of small vasopressin fibers and terminals (Figure 214A, B, and C and
Figure 2.16A). These fibers occur in a large cloud over much of the lateral hypothalamus
and reach from the fornix medially to the extended amygdala, which also contains small
fibers. This moderate to dense fiber plexus spreads ventrally around the horizontal
diagonal band, which is devoid of fibers. The small fibers and terminals in the PLH
become less dense caudally until they are quite sparse. As the PLH transitions to fewer
small fibers, there is an increase in the number of medium fibers, which appear to be
coming from the PVN and SON based on their trajectory (Figure 2.16B).
2.3.5.1.5 Mammillary bodies
As the caudal aspect of the dorsomedial hypothalamus ends, the mammillary
bodies emerge in a ventral protrusion. The mammillary nuclei themselves are completely
devoid of vasopressin innervation. However, just rostral to the mammillary nuclei a
cloud of small immunoreactive fibers and terminals spreads lateral to medial in a band
that spreads around the fornix from the edge of the brain almost to the midline (Figure
2.16C). Above and below this line more scattered medium fibers are observed in the
ventral premammillary, posterior hypothalamic, parasubthalamic, and retromammillary
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nuclei. The dorsal and ventral tuberomammillary nuclei each have a moderate to dense
innervation in a rather small space, and the arcuate nucleus near the bottom of the third
ventricle only has sparse immunoreactive fibers. As the mammillary nuclei emerge, the
fibers surrounding the fornix are pushed ventrally (Figure 2.16D) until finally all that is
left is a dense terminal plexus in the ventral tuberomammillary nucleus (Figure 2.16E).
The majority of fibers in this region are small, but a number of medium fibers are also
observed.
2.3.5.2 Thalamus
With the exception of medium fibers in the reticular nucleus and sparse medium
fibers in the paraventricular, reuniens, and xiphoid nuclei, most of the vasopressin
innervation in the thalamus consists of small fibers.
The anterior paraventricular nucleus of the thalamus (PVA) appears first in rostral
coronal sections (Figure 2.17A). There is generally a uniformly moderate to dense
plexus of fibers and terminals throughout the PVA. The paraventricular thalamus (PV)
extends caudally following the ventral surface of the dorsal third ventricle all the way to
the posterior commissure. Small and medium vasopressin-ir fibers are found throughout,
although they are most dense rostrally and become sparse at the caudal end of the PV
(Figure 2.17B, C, D, and G).
A second dense plexus of fibers and terminals extends along a similar trajectory
as do fibers to the PV, but sits laterally on either side of the PV rather than following the
midline. This projection appears rostrally at the bend in the stria medullaris (Figure
2.17A). At first a dense plexus of fibers and terminals is observed just dorsal to the less
densely innervated paratenial nucleus (Figure 2.17A). Caudally, this fiber plexus appears

38

to continue into the rostral tip of the mediodorsal thalamus (Figure 2.17B and C).
Continuous with fibers in the mediodorsal thalamus is a band of fibers that invades the
midline innervating the centromedial nucleus as well as other intralaminar nuclei such as
the paracentral, interantordorsal, and interanteromedial nuclei (Figure 2.17B, C, and D).
This band of innervation seems to reach down as far as the rhomboid nucleus (Figure
2.17C). Caudally, the lateral fibers begin to concentrate dorsally almost entirely within
the lateral habenula in a region adjacent to the completely empty medial habenula (Figure
2.17D and G). A sagittal view shows fibers projecting caudally just vental to the stria
medullaris and dense fiber plexuses in the mediodorsal thalamus and lateral habenula
(Figure 2.17H). Figures 2.17F and 2.17G show coronal views of the mediodorsal
thalamus and lateral habenula, respectively.
In the ventral thalamus, small vasopressin fibers and terminals reach up through
the dense paraventricular nucleus to innervate the xiphoid nucleus (Figure 2.17E) and to a
lesser extent the paraxiphoid and reuniens nuclei. These fibers do not extend dorsally
into the other regions such as the rhomboid nucleus. A light innervation of small fibers is
also located in the zona incerta above the fornix (Figure 2.17I)
2.3.6 Fibers in the mesencephalon
2.3.6.1 Tectum
The tectum (i.e., superior and inferior colliculi) is nearly devoid of fibers. The
only exception is a small pocket of small fibers observed at the midline of the superior
colliculus within and above the commissure of the superior colliculus at the level where
small fibers and terminals are found in the dorsomedial periaqueductal gray as described
below.
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2.3.6.2 Tegmentum
Rostrally in the tegmentum, a moderate midline innervation of small fibers in the
ventral tegmental area (VTA), pigmented parabrachial nucleus of the VTA, and
interfascicular nucleus appears as the mammillary bodies recede below (Figure 2.18A).
Caudally, these small fibers continue throughout the interfascicular and
parainterfascicular nuclei (Figure 2.18B). In addition, a number of small fibers spread
laterally into the anteroventral tip of the substantia nigra pars reticulata (Figure 2.18A)
and further out into the substantia nigra pars compacta (Figure 2.18B). Other nuclei such
as the rostral interpeduncular nucleus and red nucleus do not contain any fibers (Figure
2.18B).
Medium fibers are found in most of these areas as well. In fact, a rather
prominent vasopressin-ir pathway passes above the substantia nigra through the
parasubthalamic nucleus and zona incerta and becomes quite dense caudally as the
substantia nigra begins to subside (Figure 2.18C). The location of this caudal plexus is
unclear. It resides in a somewhat ambiguous area where the lateral part of the substantia
nigra, subbrachial nucleus, and midbrain reticular formation come together and a slightly
smaller vasopressin-ir plexus is seen medially in the retrorubral field. Caudally, a few of
these fibers rise dorsally and move medially toward the medial parabrachial nucleus.
As the pontine regions begin to overtake the tegmentum, small immunoreactive
fibers pass from the interfascicular nucleus into the caudal linear raphe nucleus (Figure
2.18D). In addition, some fibers wrap around behind the rostral interpeduncular nucleus
to provide a dense innervation of the caudal part of the interpeduncular nucleus (Figure
2.18E).
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2.3.6.3 Periaqueductal gray and dorsal raphe nuclei
The periaqueductal gray (PAG) is a distinct region that encircles entire cerebral
aqueduct and ends at the 4th ventricle. The vasopressin innervation of the PAG contains
a few prominent small fiber plexuses along its length and contains a number of medium
fibers that appear to pass through. Many of these fibers can be seen entering the rostral
PAG from the caudal hypothalamus as it transitions to the midbrain tegmentum (Figure
2.19A). The first plexus contains a moderate density of small fibers and terminals and is
located in the dorsomedial PAG and spreads out into the dorsolateral PAG (Figure 2.19B
and C). This terminal field only innervates a small region of the rostral PAG. In addition
to this plexus, there are a number of medium to large vasopressin-ir fibers that are seen
close to the aqueduct on all sides. These fibers are typically very short suggesting that
they are merely short pieces traveling orthogonal to the section; this is confirmed in
sagittal sections (Figure 2.19J). In the caudal ventrolateral PAG, medium fibers make a
sharp turn laterally (into the plane of the coronal section; Figure 2.19H and I). Many of
these fibers appear to continue on into the lateral parabrachial nucleus and other caudal
mesencephalic nuclei.
Around the level of the trochlear nucleus, fibers pass from the caudal linear raphe
into the dorsal raphe. At the rostral part of the dorsal raphe, fiber plexuses appear lateral
to the midline (Figure 2.19D and F). Caudally, these laterally located terminal fields join
together into a very dense midline terminal field (Figure 2.19E and F). As the
laterodorsal and dorsal tegmental nuclei, which do not contain vasopressin-ir fibers,
become more prominent, the caudal dorsal raphe is pressed into the midline and a
moderate to dense innervation of small fibers and terminals continues (Figure 2.19H). As
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the 4th ventricle spreads out under the cerebellum, the periaqueductal gray region ends
with the last few fibers turning laterally, into the lateral parabrachial nucleus or dorsally
into the dorsomedial PAG (Figure 2.19H). Sagittal sections at the midline show two
distinct fiber pathways projecting toward the PAG and raphe nuclei (Figure 2.19J). One
pathway runs dorsally at the posterior hypothalamus and up to the rostral PAG as seen in
Figure 2.19A. The second pathway runs ventrally through the interfascilular nucleus,
under the decussation of the superior cerebellar peduncle, over the interpeduncular
nucleus, and up into the dorsal raphe. Both pathways appear to contain both small and
medium fibers.
2.3.6.4 Caudal mesencephalic nuclei
Some fibers that turn laterally into the VLPAG appear to pass on to the lateral
parabrachial nucleus. At this same level, fibers are seen in the medial parabrachial
nucleus. These fibers are separated from the lateral parabrachial nucleus by the superior
cerebellar peduncle and appear continuous with fibers passing through the midbrain
reticular formation rather than those from the ventrolateral PAG. Caudal to this point, the
tegmental nuclei become prominent near the midline and do not contain vasopressin-ir
fibers. Lateral to the tegmental nuclei just inside the superior cerebellar peduncle the
locus coeruleus and Barrington's nucleus emerge (Figure 2.20). Both nuclei contain
medium fibers. As the vestibular nuclei become prominent caudally, the lateral
parabrachial, locus coeruleus, and Barrington's nuclei subside. All remaining fibers
appear to travel caudally adjacent to the ventricle and do not enter into the plane of
section until the solitary nucleus.
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2.3.7 Fibers in the metencephalon
Very few vasopressin-ir fibers are found in the metencephalon. The cerebellum,
deep cerebellar nuclei, vestibular nuclei, pontine nuclei, and pontine reticular formation
are devoid of fibers. However, small fibers and terminals are found in the median raphe
which stretches back between the pontine reticular formation and tectospinal tract from
the tegmentum (Figure 2.21A). Adjacent to the median raphe on either side, a small but
notable plexus is observed in what appears to be the anterior tegmental nucleus (Figure
2.21B). There are no plexuses of medium fibers, but sparse medium fibers do appear in
the subcoerleus and intermediate reticular formation (Figure 2.21C).
2.3.8 Fibers in the myelencephalon
2.3.8.1 Dorsal myelencephalon
Stretching caudally from midbrain reticular formation, sparse vasopressin-ir fibers
pass through the alpha part of the parvicellular reticular formation beneath the vestibular
nuclei just prior to entering the solitary nucleus. At the level of the facial nucleus, the
number of immunolabeled fibers in the solitary nucleus increases compared to that of the
reticular formation (Figure 2.21D and E). Although no coronal sections were collected
beyond this point, sagittal sections reveal that the solitary nucleus in the caudal medulla
contains a moderate to dense innervation of medium fibers (Figure 2.21F and G). These
fibers appear to concentrate in the solitary nucleus and do not reach out into the
hypoglossal nucleus immediately below (Figure 2.21G). Some fibers actually appear to
continue toward the back of the solitary nucleus into the rostral spinal cord, at which
point the sagittal sections end.
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2.3.8.2 Ventral myelencephalon
In the ventral medulla, vasopressin-ir fibers are found mostly at the midline in the
raphe magnus and, caudally, the raphe pallidus (Figure 2.21E, F, and H). In coronal
sections some fibers are seen in a dorsal-ventral orientation passing into the raphe
interpositus and, more caudally, the raphe obscurus. This is especially clear in sagittal
sections. At the caudal level in which the facial nerve travels dorsally, fibers spread out
from the midline into the alpha part of the gigantocellular region. The fibers rarely stray
into the larger gigantocellular region and do not extend past the facial nucleus. Sparse to
scattered fibers are also observed in the intermediate reticular formation from the facial
nerve and caudal. These fibers may be en route to the ventral raphe nuclei described
above. Finally, there are dense projections in the lateral reticular formation (Figure
2.21I) and the caudal part of the spinal trigeminal nucleus (Figure 2.21J).
2.4 Discussion
In general, the pattern of vasopressin immunoreactivity in the mouse brain is quite
similar to that in other species although remarkably more robust in most areas. For
example, innervation of the peduncular lateral hypothalamus is much more pronounced
than that reported for rats (DeVries et al., 1985). Our results are in general agreement
with those in the rat, although there are some subtle differences. For example, the rat has
vasopressin in the olfactory bulbs, olfactory tubercle, and cerebellum, whereas mice do
not. In addition vasopressin fibers are found in the nucleus accumbens and central
amygdala of the mouse, but are not observed in the rat (DeVries et al., 1985).
A direct comparison is difficult to make for most other species, as only a limited
dataset is available for any given species. In general, areas that consistently have
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vasopressin expression in multiple species such as rats, mice, voles, Brazilian opposums,
jerboas, and more include the lateral septum, the perimeter of the diagonal band, medial
amygdala, paraventricular thalamus, lateral habenula, preoptic area, periventricular
region, dorsomedial hypothalamus, midbrain central gray, ventral tegmental area, raphe
nuclei, and locus coeruleus (DeVries et al., 1985; Castel and Morris, 1988; Iqbal and
Jacobson, 1995; Lakhdar-Ghazal et al., 1995; Wang et al., 1996; Abrahamson and Moore,
2001).
Despite the many similarities, there are a number of species differences, some of
which are rather unique. A few such differences include the presence of vasopressin in
auditory nuclei such as the dorsal cochlear nucleus and periolivary region of the guinea
pig (Dubois-Dauphin et al., 1989); laterodorsal tegmental nuclei and vestibular nuclei of
the jerboa, a desert dwelling rodent (Lakhdar-Ghazal et al., 1995); and the facial nucleus,
pontine nuclei, and lateral geniculate of the Brazilian opossum (Iqbal and Jacobson,
1995). None of these regions appear to contain vasopressin immunoreactivity in the
mouse. Further, some hamster species do not produce vasopressin in the BNST or MeA,
and as a consequence, all regions that might be innervated by those nuclei, such as the
lateral septum and lateral habenula, do not appear to have vasopressin-ir fibers (DuboisDauphin et al., 1990; Miller et al., 1999). Another species, the naked mole rat, appears to
lack vasopressin production in the BNST, MeA, and the SCN (Rosen et al., 2007). As a
consequence, even more areas such as the subparaventricular zone and dorsomedial
hypothalmaus have reduced fibers.
Given the large number a similarities between the mouse vasopressin system and
other species, the functional information that can be learned from the vasopressin system
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in the mouse may have more general applicability. With this in mind, my examination of
the vasopressin system will hopefully provide greater insight into the role of vasopressin,
especially in behavior. In particular, there are a number of structural pathways that can
be delineated from the anatomical observations made above that highlight particular
functional systems. However, before beginning this discussion of structure and function,
there are a few potential limitations that must be considered. In the current study we
examined C57BL/6 mice. A particular concern for this study may be that distinct
differences in behavior occur across mouse strains and that these differences could reflect
differences in vasopressin innervation. For example, as compared to C57BL6 mice,
129S6/SvEv mice had lower levels of aggression and increased social interaction in one
study (Abramov et al., 2008). Although an increasing number of interstrain comparisons
have been made, the vasopressin system has not yet been examined across strains. I
would argue that even if vasopressin is not found in certain circuits within various strains
or species, the gross morphology of circuits is probably not as different. For example,
even though cells in the BNST do not produce vasopressin in the hamster as they do in
the rat, BNST cells still project to the lateral septum. Specifically, vasopressin in rats is
produced in a subset of galanergic cells that project to the septum (Miller et al., 1993).
Golden hamsters still have this population of galanergic neurons, but none produce
vasopressin (Miller et al., 1999). Understanding vasopressin function in a given pathway
in one species may increase our understanding of that pathway in general. A second
limitation is the fact that we examined a small number of animals in our study (three in
earnest and twelve more for corroboration). However, the observations made here do not
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contradict anything seen previously in C57BL6 mice in our lab and agree with Castel and
Morris (1988) and Abrahamson et al. (2001).
Two important aspects of the vasopressin system that must be addressed are the
site of origin of fibers and the trajectory of projections from the various vasopressin
producing nuclei. Multiple possible pathways can be inferred from descriptions given
above; although these inferences are only theoretical and must be validated by other
means as discussed below. For example, vasopressin-ir fibers from the SCN remain
close to the midline and appear to follow three major paths: 1) an anterodorsal path
toward the paraventricular thalamus, 2) a dorsal path through the subparaventricular zone
and PVN into the thalamus, and 3) a caudal path toward the dorsomedial hypothalamus.
These observation have also been noted in other species and in the mouse, and lesions of
the SCN actually decrease vasopressin immunoreactivity in the all these regions in the rat
and hamster (Hoorneman and Buijs, 1982; Delville et al., 1998). Likewise, multiple
pathways are suggested by the orientation of fibers near the PVN and SON. Most of
these fibers travel ventrolaterally and are thought to terminate in the neurohypophysis and
the median emminence ultimately. However, a number of vasopressin-ir fibers also
curve dorsally into the reticular thalamus. Medium fibers similar to those found near the
PVN and SON are also found in the midbrain and hindbrain, and these fibers appear to
follow a few distinct trajectories: 1) fibers pass dorsally along the third ventricle into the
PAG and travel caudally to the ventrolateral PAG and lateral parabrachial nucei where
they begin to branch out and have more boutons of passage and then continue caudally to
the locus coeruleus and finally to the caudal solitary nucleus; 2) fibers travel ventrally
through the interfascicular nucleus and caudal linear raphe into the raphe nuclei; and 3)
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fibers travel laterally and caudally over the substantia nigra toward the midbrain reticular
formation where they curve back toward the midline passing through the medial
parabrachial nucleus and into the rostral solitary nucleus or ventrally toward the ventral
medullary raphe nuclei. Rostrally, many medium fibers are found in the forebrain, but
the most distinct pathway is the group of medium axons passing in front of the anterior
commissure and reaching through the median preoptic nucleus to the subfornical organ.
Small fibers in other brain regions appear to follow various paths as well.
Further, small fibers often seem to have continuous terminal fields that move through
multiple regions. One such path passes through the lateral preoptic area and becomes
rather dense in the ventral septal region (between the nucleus accumbens and diagonal
band) and curves dorsally and caudally into the lateral septum. Other pathways like this
occur in the extended amygdala toward the rostral amygdalar nuclei and from the rostral
peduncular lateral hypothalamus toward the caudal lateral hypothalamus. Other possible
small fiber pathways include vasopressin-ir fibers passing from the BNST into the stria
terminalis, dorsally through the rostral PAG, and caudally through the ventral tegmental
area (VTA) and interfascicular nuclei. This last pathway through the VTA and
interfascicular nuclei has similar terminal field characteristics to pathways in the
forebrain, such as the pathway through the ventral septal area.
The presence of vasopressin -ir fibers in various brain regions suggests an
anatomical link between the function of the brain region and vasopressin. For example,
small fiber pathways that seem to come from the SCN innervate midline regions such as
the periventricular nucleus, which is involved in neuroendocrine function; the
subparaventricular zone, which is important for sleep-wake cycles (Chou et al., 2003;
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Saper et al., 2005); and the dorsomedial hypothalamus, which has been implicated in
food intake, locomotor activity, and sleep wake cycles (Chou et al., 2003). Hindbrain
sites innervated by medium fibers, such as the solitary nucleus are important in
autonomic functions (Pittman and Franklin, 1985), whereas regions in the tegmentum and
raphe nuclei innervated by small and medium fibers are involved in emotional and
behavioral state functions (Beiderbeck et al., 2007; Michelsen et al., 2007). Finally, areas
such as the ventral pallidum and mediodorsal thalamus, which contain small fibers, are
involved in basal ganglia circuits that regulate limbic system information (Chauveau et
al., 2005; Antoniadis and McDonald, 2006; Mitchell et al., 2007).
Although suppositions can be made about the site of origin of fibers, the trajectory
of various fiber pathways can be outlined, and sweeping functional generalizations can be
suggested, a simple descriptive analysis as done here is not sufficient to draw complete
and accurate conclusions about the vasopressin system. This is made clear by past
attempts to credit innervation of the lateral septum and lateral habenular nuclei to the
suprachiasmatic nucleus based solely on fiber size and following the course of fibers in
consecutive sections (Buijs, 1978; Castel and Morris, 1988; Abrahamson and Moore,
2001), when in fact the innervation to the lateral septum comes from the BNST (De Vries
and Buijs, 1983). However, the scope of this study was to document the fibers in the
mouse brain and fill in gaps and refine descriptions created by other authors. Future
studies in this dissertation will attempt to further elucidate the sites of origin of the fibers
described here.
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2.5 Figure legends
Figure 2.1: Paraventricular nucleus
A) Bregma -0.46. Vasopressin-ir neurons in the PaAP (10x). B) Bregma -0.70.
Magnocellular neurons are located close to the third ventricle in the PaMM and PaV
(10x). C) Bregma -0.82. Magnocellular neurons in the PaLM, and parvocellular neurons
in the PaMP medially near the ventricle (10x). D) Magnocellular neurons in the PaLM
part persist as other cell groups end caudally (10x). 3V, third ventricle; f, fornix; PaAP,
anterior parvocellular PVN; PaLM, lateral magnocellular PVN; PaMM, medial
magnocellular PVN; PaMP, medial parvocellular PVN; PaV, ventral PVN
Figure 2.2: Supraoptic nucleus
A) Bregma -0.58. Vasopressin-ir cells are first seen in the episupraoptic nucleus
just above the tip of the optic tract (10x). B) Bregma -0.82. Cells begin to form an
extremely dense cluster above and lateral to the optic tract (10x). C) Bregma -0.94.
Cells continue to form a dense cluster over the lateral edge of the optic tract, but many
cells are also seen along the ventral brain surface closer to the midline (10x). D) Bregma
-1.06. A few cells are seen lateral to the optic tract at the caudal edge of the supraoptic
nucleus (10x). f, fornix; opt, optic tract
Figure 2.3: Suprachiasmatic nucleus
A) Bregma -0.34. Rostral suprachiasmatic nucleus (SCN; 10x). B) Bregma 0.58. Middle SCN (10x). C) Bregma -0.82. Caudal SCN (10x). Vasopressin-ir cells in
the SCN form a shell around a vasopressin cell free core. The rostral and caudal sections
pass through this outer shell; whereas, the middle section nicely shows the core, which
contains many fibers but few cells.
Figure 2.4: Accessory nuclei
A) Vasopressin-ir cells in the anterior hypothalamus (20x) amongst fibers of
passage from other regions. B) Cells in the perifornical lateral hypothalamus (10x) sit
amongst fibers that appear to come from the direction of the PVN. C) Cells near the
cerebral peduncle in the caudal peduncular lateral hypothalamus (10x). D) The nucleus
circularis (40x) of the mouse is composed of a small cluster of neurons found in the
anterior hypothalamus. f, fornix; opt, optic tract
Figure 2.5: Other hypothalamic nuclei
A) Vasopressin-ir cells are located in the striohypothalamic nucleus (20x) rostral
to the paraventricular hypothalamus and directly ventral to the fornix. B) Cells are found
amidst the vasopressinergic pathway to the pituitary in the retrochiasmatic supraoptic
nucleus (10x) in the tuberal lateral hypothalamus. C) Cells in the ventrolateral preoptic
nucleus (20x) lie along the ventral surface of the preoptic area. f, fornix; opt, optic tract
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Figure 2.6: BNST and medial amygdala
A) Bregma -0.10. Vasopressin-ir cells are found above the fibers of the stria
terminalis in the medial STMPM (10x). The bounding box represents the magnified area
in the panel to the right for all panels in this diagram. Arrows point to specific cells. B)
Cells in the STMPM (20x). C) Bregma -0.22. Cells are also found in the STMPL (10x)
slightly caudal to those cells in the STMPM. D) Cells in the STMPL (20x). E) Bregma 1.34. Cells are found at the dorsolateral edge of the MePD (4x). F) Cells in the rostral
MePD (20x). G) Bregma -1.46. Cells in the caudal MePD (4x). H) Cells in the caudal
MePD (20x). f, fornix; ic, internal capsule; MePD, posterodorsal medial amygdala; opt,
optic tract; STMPL, medial posterolateral BNST; medial posteromedial, STMPM
Figure 2.7: Small versus medium fibers
A) Small vasopressin-ir fibers in the lateral setptum (20x). B) Medium
vasopressin-ir fibers in the ventrolateral periqueductal gray (20x). Small fibers are
thinner than medium fibers and have terminal fields that consist of punctate staining.
Often, the fibers associated with puncta are barely noticeable. In contrast, medium fibers
often have distinct "boutons of passage" with visible stalks. Arrows in B point to boutons
of passage.
Figure 2.8: Cortex and hippocampus
A) Bregma 1.98. Prelimbic cortex (10x). Arrows point to fibers. B) Bregma
1.10. Cingulate cortex (10x). C) Insular cortex (20x). D) Bregma -2.54. Entorhinal
cortex (4x). E) Bregma -2.92. Phase contrast image of CA1 region of the ventral
hippocampus (4x). F) Brightfield image of E showing small fibers (10x). G) Bregma 3.28. Phase contrast image of CA1 region of the ventral hippocampus (4x). H)
Brightfield image of G showing medium fibers (20x).
Figure 2.9: Basal ganglia and ventral forebrain
A) Bregma 0.98. Small vasopressin fibers are found in the VP and VS in the
rostral forebrain (4x). Medium fibers are found in the nucleus accumbens core. B)
Bregma 0.62. Caudally, small fibers are found in the VP, SI, and VS (4x). Vasopressinir fibers seem to avoid the diagonal band, islands of calleja, and shell of the nucleus
accumbens. ac, anterior commissure; AcbC, core of the nucleus accumbens; AcbSh,
shell of the nucleus accumbens; ICjM, islands of calleja; HDB, horizontal diagonal band;
LV, lateral ventricle; MPA, medial preoptic area; SI, substantia innominata; VDB,
vertical diagonal band; VP, ventral pallidum; VS, ventral septum
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Figure 2.10: Septal complex
A) Bregma 0.86. The rostral lateral septum contains sparse medium fibers (4x
magnification). B) Bregma 0.62. Small vasopressin fibers are found in the ventral and
intermediate lateral septum (4x). C) Bregma 0.38. The caudal part of the ventral and
intermediate lateral septum contains a very dense small fiber innervation (4x). D)
Bregma -0.10. As the fimbria becomes prominent the vasopressin fibers diminish.
Medium fibers are seen in the subfornical organ. E) Higher magnification of the ventral
lateral septum in B (10x). F) Magnification of pericellular baskets in ventral lateral
septum (20x). Arrow points to one such basket. ac, anterior commissure; cc, corpus
callosum; f, fornix; MS, medial septum; LSD, dorsal lateral septum; LSI, intermediate
lateral septum; LSV, ventral lateral septum; LV, lateral ventricle; SFi, septofimbrial
nucleus; SFO, subfornical organ
Figure 2.11: Bed nuclei of the stria terminalis
A) Bregma 0.50. Rostral bed nuclei of the stria terminalis (BNST). Small and
medium vasopressin-ir fibers are found in the STMA and medium fibers in the STMV.
B) Bregma 0.02. Caudally small fibers begin to appear more in the STLV. Medium
fibers are prominent in the STMV C) Bregma -0.10. The STMPM has two separate small
fiber plexuses and a number of medium fibers. STLV still has small fibers and the
STMV medium. D) Bregma -0.34. BNST cells become prominent in the STMPL and
small fibers can be seen entering the stria terminalis. E) Bregma -0.46. Dense small
fibers are seen under the stria medullaris. Otherwise innervation of the caudal BNST
becomes less dense. 3V, 3rd ventricle; ac, anterior commissure; f, fornix; D3V, dorsal
3rd ventricle; ic, internal capsule; sm, stria medullaris; SM, nucleus of the stria
medullaris; STLV, ventrolateral BNST; STMA, anteromedial BNST; STMPM, medial
posteromedial BNST; STMPL, lateral posteromedial BNST; STMV, ventromedial BNST
Figure 2.12: Amygdala
A) Bregma -0.58. Diffuse small fibers found in the AA and EA (4x). B)
Magnification from A (10x). Shows small fibers in the distinct EA between the densely
innervated PLH and globus pallidus. C) Bregma -0.70. Small fibers are found in the AA
and ACo, but not in the LOT (4x). D) Magnification of C (10x) showing LOT and ACo.
E) Bregma -1.34. Medium fibers are seen in central amygdala (20x). F) Bregma -1.58.
A dense small fiber plexus is found in the MePD. G) Bregma -2.18. Small fibers are
found in the caudal BLP (4x). H) Magnification of G showing fibers in the BLP. AA,
anterior amygdaloid area; ACo, anterior cortical amygdaloid area; BLP, posterior
basolateral amygdala; EA, extended amygdala; f, fornix; GP, globus pallidus; HDB,
nucleus of the horizontal limb of the diagonal band; LOT, nucleus of the lateral olfactory
tract; opt, optic tract; PLH, peduncular part of lateral hypothalamus; sm, stria medullaris
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Figure 2.13: Preoptic area
A) Bregma 0.38. Small vasopressin-ir fibers are found in the MPA. Medium
fibers are seen in the VOLT and MnPO (4x). B) Bregma 0.26. Magnification (10x) of
the MnPO. Medium fibers are oriented vertically in the plane of section. C) Bregma
0.14. A dense small fiber plexus is seen in the PS ventral to the STMV (20x). D)
Magnification of E. Scattered small and medium fibers are found in the MPOM (20x).
The AVPe contains many small fibers and some medium fibers. E) Bregma -0.10. Sparse
small and medium fibers are seen in the caudal LPO and StHy. ac, anterior commissure;
AVPe, anteroventral periventricular nucleus; HDB, nucleus of the horizontal limb of the
diagonal band; LPO, lateral preoptic area; MnPO, median preoptic nucleus; MPA, medial
preoptic area; MPOM, medial preoptic nucleus, medial part; PS, parastrial nucleus;
STHy, striohypothalamic nucleus; STMV, ventromedial BNST; VOLT, vascular organ of
the lamina terminalis
Figure 2.14: Anterior hypothalamus
A) Bregma -0.58. Small fibers are seen in the AHA ventral to the fornix and in
and dorsal to the SCN adjacent to the third ventricle (4x). Medium fibers stretch between
the PVN and SON through the more ventral AHA. B) Bregma -0.82. Small fibers are
found only in the SCN and along the third ventricle dorsal into the PVN (4x). Medium
fibers dominate the AHC and numerous medium fibers pass over the fornix into the PLH.
C) Bregma -0.94. Caudally fewer medium fibers pass through the AHC, but many still
pass into the PLH. Large amounts of small fibers are still found along the third ventricle.
The dotted line indicates the approximate location of the sagittal section seen in D and E.
D) In a sagittal section taken just lateral to the third ventricle, large fibers can be seen
amongst the many PVN neurons (10x). A dense haze of small fibers is also visible. E) In
the same sagittal section as in D, the dense small fibers of the SCN are seen. Fibers can
be seen passing in all direction with the largest groups passing dorsocaudal and
rostrodorsal. 3V, 3rd ventricle; AHA, anterior hypothalamic area, anterior part; AHC,
anterior hypothalamic area, central part; f, fornix; LA, lateroanterior hypothalamic
nucleus; och, optic chiasm; opt, optic tract; PLH, peduncular part of lateral
hypothalamus; PVN, paraventricular hypothalamus; SCN, suprachiasmatic nucleus; SPa,
subparaventricular zone
Figure 2.15: Dorsomedial hypothalamus
A) Bregma -1.46. Small and medium fibers are found in the DM and Arc (4x).
Many medium fibers are found in the TuLH. The VMH contain almost no fibers. B)
Bregma -1.82. Small and medium fibers are seen in the DM (4x). The MTu contains
fewer medium fibers than the TuLH in rostral areas. The ME is located at the ventral
midline. C) Magnification (20x) of the DM from B. D) Magnification (20x) of the
median eminence from D. Note dense staining in dorsal ME (to posterior pituitary) and
less dense staining in the ventral part (local release). 3V, 3rd ventricle; Arc, arcuate
hypothalamic nucleus; DM, dorsomedial hypothalamic nucleus; f, fornix; ME, median
eminence; MTu, medial tuberal nucleus; TuLH, tuberal region of lateral hypothalamus;
VMH, ventromedial hypothalamic nucleus
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Figure 2.16: Lateral hypothalamus and mammillary bodies
A) Bregma -0.82. Small fibers are found amongst medium fibers passing through
the PLH (20x). B) Bregma -1.22. Fewer small fibers are seen in the caudal PLH, but a
dense array of medium fibers is observed (10x). C) Bregma -2.46. Many small fibers are
seen in the PeLH and DTM spreading around the fornix. Scattered small and medium
fibers are seen in the PMV and PH (4x). D) Bregma -2.54. No fibers are found in the
MB (4x). Dense small fibers are seen just ventral to MB and fornix. Only scattered
small fibers are seen in the PMV, and RMM has medium and small fibers. E) Bregma 2.80. No fibers in MB (4x). Dense small fibers in VTM, and scattered small and
medium fibers in RMM. 3V, 3rd ventricle; DTM, dorsal tuberomammillary nucleus; f,
fornix; MB, mammillary bodie; MRe, mammillary recess of the 3rd ventricle; mt,
mammillothalamic tract; opt, optic tract; PeLH, perifornical part of lateral hypothalamus;
PH, posterior hypothalamus; PLH, peduncular part of lateral hypothalamus; pm, principal
mammillary tract; PMV, premammillary nucleus, ventral part; RMM, retromammillary
nucleus, medial part; VTM, ventral tuberomammillary nucleus
Figure 2.17: Thalamus
A) Bregma -0.34. Many small fibers are seen in the PVA (4x). The PT has small
fibers around its periphery. A dense cluster of fibers sits dorsal to the PT between the
PVA and the stria medullaris. B) Bregma -0.58. A very dense plexus of small fibers is
found in the MD (4x). Less dense fibers are seen in the CM and PC surrounding the PT.
C) Bregma -0.94. Dense small fibers are found in the MD (4x). Less dense small fibers
are found in the PV, CM, and Rh. Medium fibers are also seen in the PV and Rh. D)
Bregma -1.22. Small fibers are seen in the LHb and IAD and in the PV just below the
dorsal third ventricle (10x). E) Bregma -1.22. Small fibers are seen in the Xi just dorsal
to the third ventricle (10x). F) Magnification (20x) of MD from B. G) Bregma -1.58.
Dense small fibers are found in the LHb (10x). Only a few small fibers are found in PV
and IMD. H) A sagittal section (lateral 0.48mm) shows the pathway of vasopressin-ir
fibers arching dorsally just ventral to the stria medullaris (4x). The dense plexuses of the
LHb and MD can be seen. I) Bregma -0.58. Small fibers in the ZI (10x). J) Bregma 1.82. In caudal thalamus scattered small fibers are seen in LHb, but PV contains
primarily medium fibers (10x). 3V, 3rd ventricle; ac, anterior commissure; CM, central
medial thalamic nucleus; D3V, dorsal 3rd ventricle; f, fornix; fr, fasciculus retroflexus;
IMD, intermediodorsal thalamic nucleus; LHb, lateral habenular nucleus; MD,
mediodorsal thalamic nucleus; mt, mammillothalamic tract; PC, paracentral thalamic
nucleus; PT, paratenial thalamic nucleus; PV, paraventricular thalamic nucleus; PVA,
paraventricular thalamic nucleus, anterior part; Re, reuniens thalamic nucleus; Rh,
rhomboid thalamic nucleus; sm, stria medullaris; Xi, xiphoid thalamic nucleus; ZI, zona
incerta
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Figure 2.18: Tegmentum
A) Bregma -3.08. Small fibers are found in the VTA, IF and ventromedial tip of
the SNR. Some medium fibers are also present in these areas (10x). B) Bregma -3.52.
Small fibers surround the IPR in the IF and PIF (10x). C) Bregma -4.04. In the caudal
tegmentum, medium fiber form a dense plexus in the mRt and RRF just dorsal to the
SNR (10x). There are some small fibers here too. D) Bregma -4.04. Fibers in the CLi
between the scp. E) Bregma -4.04. Fibers in the caudal part of the IP (20x). 3n,
oculomotor nerve; CLi, caudal linear nucleus of the raphe; cp, cerebral peduncle; fr,
fasciculus retroflexus; IF, interfascicular nucleus; IPF, interpeduncular fossa; IP,
interpeduncular nucleus; IPR, interpeduncular nucleus, rostral subnucleus; MB,
mammillary bodies; ml, medial lemniscus; mlf, medial longitudinal fasciculus; mRT,
mesencephalic reticular formation; PBP, parabrachial pigmented nucleus of the VTA;
PIF, parainterfascicular nucleus of the VTA; RMC, red nucleus, magnocellular part;
RRF, retrorubral field; SNR, substantia nigra, reticular part; scp, superior cerebellar
peduncle; SubB, subbrachial nucleus; VTA, ventral tegmental area; vtgx, ventral
tegmental decussation
Figure 2.19: Periaqueductal gray and dorsal raphe nuclei
A) Bregma -2.30. Just rostral to the PAG small and medium fibers ascend
dorsally between the fasciculus retroflexus (4x). B) Bregma -3.52. Medium fibers are
seen in ventral parts of the PAG and small fibers are seen in the DMPAG (4x). C)
Magnification (20x) of small fibers in the DMPAG. D) Bregma -4.36. Dense clusters of
small fibers are seen in the DRL, and medium fibers are seen in the VLPAG with some
overlap (4x). E) Bregma -4.60. A dense plexus of small fibers is seen in the DRD at the
midline. Medium fibers in a medial to lateral orientation are seen in the VLPAG. F)
Magnification (20x) of the DRL from D. G) Magnification (20x) of the DRD from E. H)
Bregma -5.02. Small fibers are found in the DRC, and medium fibers continue to be
found in the VLPAG (4x). Some medium fibers also enter the DMPAG at this point. I)
Magnification (20x) of medium fibers in the VLPAG. J) Sagittal section near the midline
showing pathways travelling dorsally toward the PAG and caudally through the IF
toward the dorsal raphe (4x). 2Cb, lobule 2 of the cerebellar vermis; 4N, trochlear
nucleus; 4n, trochlear nerve; Aq, aqueduct; csc, commissure of the superior colliculus;
DMPAG, dorsomedial PAG; DRC, caudal dorsal raphe; DRD, dorsal dorsal raphe; DRL,
lateral dorsal raphe; fr, fasciculus retroflexus; IF, interfascicular nucleus; IPR,
interpeduncular nucleus, rostral subnucleus; mlf, medial longitudinal fasciculus; PAG,
periaqueductal gray; pc, posterior commissure; VLPAG, ventrolateral periaqueductal
gray; xscp, decussation of the superior cerebellar peduncle
Figure 2.20: Caudal mesencephalic nuclei
Bregma -5.52. Medium fibers are shown in the LPB, LC, and Bar. No fibers
were observed in the adjacent LDTg (10x). Bar, Barrington's nucleus; LC, locus
coeruleus; LDTg, laterodorsal tegmental nucleus; LPB, lateral parabrachial nucleus; scp,
superior cerebellar peduncle; vsc, ventral spinocerebellar tract
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Figure 2.21: Metencephalon and myelencephalon
A) Bregma -4.36. Small fibers in the ATg at the intersection of the decussation of
the superior cerebellar peduncle and the tectospinal tract (10x). B) Bregma -4.72. Small
fibers in the MnR at the level of the pons (20x). C) Bregma -5.52. Medium fibers in the
IRt (10x). D) Magnification (10x) of medium fibers in the Sol from E (10x). E) Bregma
-6.36. Medium fibers are found in Sol and in RMg and GiA (4x). F) Lateral -0.04.
Sagittal section near the midline (4x). Dense medium fibers are found in the Sol.
Scattered medium fibers are seen in the medullary raphe nuclei, including ROb, RMg,
and RPa. G) Magnification (10x) of medium fibers in Sol. H) Magnification (10x) of
medium fibers in the raphe. I) Lateral 1.2. Medium fibers in the LRT (4x). J) Lateral
1.56. Medium fibers in the Sp5C (4x). 7n, facial nerve; 12N, hypoglossal nucleus; ATg,
anterior tegmental nucleus; IO, inferior olivary nucleus; IRt, intermediate reticular
nucleus; LSO, lateral superior olive; mlf, medial longitudinal fasciculus; PnC, pontine
reticular nucleus, caudal part; py, pyramidal tract; RMg, raphe magnus nucleus; ROb,
raphe obscurus nucleus; RPa, raphe pallidus nucleus; Sol, solitary nucleus; sp5, spinal
trigeminal tract; Sp5C, spinal trigeminal nucleus, caudal part; SPO, superior paraolivary
nucleus; ts, tectospinal tract; xscp, decussation of the superior cerebellar peduncle

56

Figure 2.1: Paraventricular nucleus
f

3V

f

3V

PaMM

PaAP

PaV
200 μm

A
PaLM

B
PaLM

3V

3V

PaMP

C

D

57

Figure 2.2: Supraoptic nucleus
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Figure 2.3: Suprachiasmatic nucleus
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Figure 2.4: Accessory nuclei
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Figure 2.5: Other hypothalamic nuclei
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Figure 2.6: BNST and medial amygdala
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Figure 2.7: Small versus medium fibers
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Figure 2.8: Cortex and hippocampus
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Figure 2.9: Basal ganglia and ventral forebrain
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Figure 2.10: Septal complex
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Figure 2.11: Bed nuclei of the stria terminalis
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Figure 2.12: Amygdala
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Figure 2.13: Preoptic area
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Figure 2.14: Anterior hypothalamus
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Figure 2.14: Anterior hypothalamus (Continued)
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Figure 2.15: Dorsomedial hypothalamus
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Figure 2.16: Lateral hypothalamus and mammillary bodies
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Figure 2.17: Thalamus
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Figure 2.17: Thalamus (Continued)
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Figure 2.18: Tegmentum
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Figure 2.18: Tegmentum (Continued)
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Figure 2.19: Periaqueductal gray and dorsal raphe nuclei
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Figure 2.19: Periaqueductal gray and dorsal raphe nuclei (Continued)
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Figure 2.20: Caudal mesencephalic nuclei
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Figure 2.21: Metencephalon and myelencephalon
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Figure 2.21: Metencephalon and myelencephalon (Continued)
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CHAPTER 3
PROJECTIONS OF THE BNST AND MEDIAL AMYGDALA

3.1 Introduction
Vasopressin is produced in a number of nuclei within the diencephalon and
telencephalon of the mouse brain and is found in neuronal fibers and terminals in various
brain regions throughout the rostral to caudal extent of the brain (Castel and Morris,
1988; Abrahamson and Moore, 2001). In order to truly understand the function of the
various vasopressin cell groups, it is important to know the origin of each projection site.
This task has been approached with some success in the rat. Retrograde tracing and
electrolytic lesions implicated the bed nuclei of the stria terminalis (BNST) as a major
source of innervation to areas such as the lateral septum, lateral habenula, periaqueductal
gray, and raphe nuclei (De Vries and Buijs, 1983). Similar studies implicated the
suprachiasmatic nucleus (SCN) in the innervation of the paraventricular thalamus,
dorsomedial hypothalamus, preoptic area, and subparaventricular zone, and the medial
amygdala (MeA) in the innervation of the lateral septum and ventral hippocampus
(Hoorneman and Buijs, 1982; Caffe et al., 1987). Lesions studies have also implicted the
paraventricular nucleus of the hypothalamus (PVN) in vasopressin-ir projections to the
hindbrain (De Vries et al., 1983). In the mouse, the site of origin of vasopressin-ir fibers
has yet to be examined, although up until this point it has been almost universally
assumed to be similar to the rat.
Interestingly, vasopressin-immunoreactive (-ir) fibers and terminals have
qualitative differences in physical characteristics such as fiber size and terminal
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distribution (Castel and Morris, 1988; Abrahamson and Moore, 2001), which is one clue
to identifying the different vasopressinergic afferent pathways. These characteristically
different projections innervate specific and often mutually exclusive regions of the brain.
Early descriptions of vasopressin anatomy attempted to use fiber characteristics to
identify site of origin (Buijs, 1978; Castel and Morris, 1988; Abrahamson and Moore,
2001). In general, small fibers were assumed to derive from the SCN and medium or
large fibers form the PVN. More extensive work in rats, as mentioned above, has
corroborated that same observation in regard to the PVN. However, these studies also
indicate that the BNST and MeA are major sources of small fibers in addition to the SCN
(De Vries and Buijs, 1983; Caffe et al., 1987). Thus, merely identifying projections by
physical characteristics is not sufficient to identify site of origin and other methods must
be employed.
The projections of the BNST and MeA are the focus of this study. Vasopressin
produced by these brain regions has been directly and indirectly implicated in
thermoregulation during fever, social recognition, and aggression in the rat and pairbonding, parental behavior, and partner preference in the prairie vole (Ferris et al., 1984;
Banet and Wieland, 1985; Naylor et al., 1985; Dantzer et al., 1987; Koolhaas et al., 1990;
Insel et al., 1994; Wang et al., 1994; Lim et al., 2004). In addition, recent studies have
suggested that altering expression of the V1a receptor, the most abundantly expressed
vasopressin receptor in the brain, can affect social behavior. For example, mice with a
prairie vole V1a receptor transgene have increased affiliative behavior (e.g., increased
olfactory investigation and grooming of stimulus animal; (Young et al., 1999), simlar to
that of prairie voles. In addition, V1a knockout mice have impaired social recognition
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(Bielsky et al., 2004; Bielsky et al., 2005), although a different V1a knockout mouse
shows no such deficits (Wersinger et al., 2007).
One of the unique features of the BNST and MeA vasopressin system is its
dependence on circulating gonadal steroids. In the absence of testoserone or estradiol,
the BNST and MeA appear to stop producing vasopressin, leading to an eventual
depletion of vasopressin in their numerous projection sites in rats and mice (de Vries et
al., 1984; Mayes et al., 1988; Miller et al., 1992; De Vries et al., 1994; Wang and De
Vries, 1995). In addition, vasopressin expression in the BNST and MeA is organized by
testosterone perinatally resulting in a sexual dimorphism (De Vries et al., 1983; Wang et
al., 1993; Han and De Vries, 2003); males typically have more cells than females in the
BNST and MeA and a greater density of fibers in known projection sites such as the
lateral septum and lateral habenula (de Vries et al., 1981; Miller et al., 1989; De Vries
and al-Shamma, 1990; Wang and De Vries, 1995; Rood et al., 2008). The function of sex
differences in the vasopressin system is not well understood. In some cases, the female
vasopressin system does not respond as the male system does. For example, social
recognition cannot be blocked by vasopressin antagonists in females as it is in males
(Bluthe and Dantzer, 1990), and vasopressin is not released and V1a antagonists do not
delay defervescence in females during fever as occurs in males (Landgraf et al., 1990;
Chen et al., 1997). Currently, there are few hypotheses explaining the function of sex
differences in vasopressin; one interesting hypothesis is that sex differences in
vasopressin may actually serve to compensate for other sex differences in behavior or
physiology resulting in more equivalent behavior in males and females (De Vries, 2004).
Finally, the sex difference in the vasopressin system originating in the BNST and MeA
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has been described as one of the most consistently observed sex differences among
vertebrates (De Vries and Panzica, 2006). For example, in mice, a sex difference in cell
number in the BNST and MeA has been observed (Rood et al., 2008). In addition, male
mice have a greater vasopressin-immunoractive-ir fiber density than females in a number
of brain regions, such as the lateral septum, mediodorsal thalamus, lateral habenula, and
medial amygdala (De Vries et al., 2002; Bakker et al., 2006; Gatewood et al., 2006; Rood
et al., 2008). However, the vast vasopressin innervation of the mouse brain remains
largely unexplored. Therefore in addition to understanding which fibers derive from the
BNST and MeA, the occurrence of sex differences is also a focus of this study.
In the current study, we used a simple strategy to determine the location of
projections from the BNST and MeA: gonadectomy. As described above the expression
of vasopressin is dependent on the presence of circulating gonadal steroids, and loss of
these hormones leads to a loss of vasopressin expression in the BNST and MeA, but not
in other vasopressin producing sites in rats and mice (de Vries et al., 1984; Mayes et al.,
1988; Miller et al., 1992). Using this principle we examined vasopressin
immunoreactivity in the brains of male and female mice that had been gonadectomized or
sham operated to confirm that only BNST and MeA vasopressin production depends on
circulating gonadal steroids and to test the following hypotheses: 1) a subset of small
vasopressin-ir fibers and terminals in the forebrain, midbrain, and hindbrain derive from
the BNST and MeA and 2) vasopressin-ir projections that originate in the BNST or MeA
and not in other vasopressin producing areas are sexually dimorphic with males having a
greater vasopressin-ir fiber density than females.
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3.2 Methods
3.2.1 Animals
Male and female C57BL6 mice were studied in this experiment. Animals were
derived from a breeding colony at the University of Massachusetts. Following weaning,
animals were group-housed (5 or less per cage) with same-sex siblings under a 14:10
light cycle with lights on at 6:00 am. Animals had ad libitum access to food and water.
All procedures conformed to NIH guidelines and were in accordance with a protocol
approved by the University of Massachusetts.
Brains from three gonadectomized male mice were used for qualitative analyses.
Corroboration of qualitative results and quantitative analyses of gonadal hormone
dependence and sex differences were examined in male and female mice that were either
gonadectomized (12 males and 12 females) or sham operated (12 males and 10 females).
Vasopressin immunoreactivity in certain projections dissipates over a number of weeks
following gonadectomy and is virtually undetectable around 12 to 15 weeks following
surgery (Mayes et al., 1988). We therefore chose a 15 week survival time following
surgery. During this period one male sham animal and three female sham animals died
for unknown reasons. Furthermore, after decoding and analyzing the data one
"gonadectomized" female was found to have vasopressin immunoreactivity
indistinguishable from intact females suggesting that at least one ovary was left intact.
Because the quantitative measures of this subject were well within the range of intact
females this subject was included as a "sham female." Thus our quantitative measures for
the sham groups include results from only 11 males and 8 females.
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3.2.2 Gonadectomy surgeries
At approximately 60 days of age, all animals underwent bilateral gonadectomy
under isoflurane anesthesia (2% in oxygen by inhalation; Halocarbon Laboratories, River
Edge, NJ). Male gonadectomy was carried out through an incision at the midline of the
scrotum. Testes were exposed, the blood supply and vas deferens were ligated with
suture, and testes were excised. Sham animals received incisions to exposes the testes,
but the blood supply and testes were left intact. Wounds were closed with surgical
staples. Female gonadectomy was carried out through incisions on each flank located
between the rib cage and pelvis. Ovaries were exposed, the blood supply and fallopian
tubes were ligated with suture, and ovaries were excised. Sham females underwent an
identical procedure except the blood supply and ovaries were left intact. The muscle wall
of the body cavity was sutured closed, and the skin was closed with surgical staples. All
animals were given a single injection of buprenorphine (0.05 mg/Kg; Bedford
Laboratories, Bedford, OH) immediately following surgery.
3.2.3 Tissue collection and processing
Fifteen weeks following gonadectomy, animals were euthanized using CO 2
asphyxiation followed by rapid decapitation. Brains were removed rapidly and placed in
5% acrolein in 0.1 M phosphate buffer. Fixation lasted for four hours at which time
brains were transferred to 30% sucrose in 0.1M phosphate buffer and stored at 4° C until
sectioning. For gonadectomized animals used in qualitative analyses, each brain was
sectioned at 30 Pm in a different plane: coronal, sagittal, or horizontal. For each brain,
every other section was collected for vasopressin immunohistochemistry. Alternate
sections were mounted on slides and Nissl stained. Brains used for quantitative analyses
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were sectioned in the coronal plane and every third section was collected for vasopressin
immunocytochemistry. All brain sections were stored in cryoprotectant at -20° C until
staining.
3.2.4 Immunohistochemistry
Immunohistochemical methods used in this experiment are identical to those
described in CHAPTER 2.2.4.
3.2.5 Qualitative and quantitative fiber density analysis
Qualitative descriptions were carried out using a bright field microscope.
Quantitative analyses were carried out on images of selected representative areas
illustrated in Figure 3.1 captured using a SPOT camera and software driver on a
brightfield microscope equipped with a 20x objective. Fibers were analyzed in each
picture using ImageJ (NIH). Briefly, each picture was modified using the "sharpen" tool.
Then gray-level thresholding was carried out to determine the number of pixels covered
by staining. Thresholding was done by eye by a trained experimenter to ensure the most
accurate measurement of fibers in all sections. All slides were coded prior to analysis, so
that the experimenter was blind to treatment groups.
3.2.6 Statistics
Quantitative results were analyzed with two-factor ANOVAs. The factors were
sex (male or female) and surgery (sham or gonadectomy). Fisher's least squared
difference tests were used to determine group differences where appropriate. A p-value
of 0.05 or less was considered to be significant throughout. Statistical values for all
quantitative measures are listed in Table 3.1.
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3.3 Results
Steroid-sensitive vasopressin-ir projections were defined as regions in which
vasopressin-ir fibers and terminals decreased or disappeared altogether following
gonadectomy. In some regions gonadectomy resulted in a complete loss of
immunoreactiviy. It is not known whether or not there is an actual loss of axons and
terminal boutons themselves. Decreases in medium or large fibers were not observed in
any brain region, but small fibers and terminals disappeared in numerous nuclei
throughout the brain.
Further, quantitative analyses were made for 84 distinct regions of the brain. In
general brain regions were chosen because they had a quantifiable vasopressin
innervation (i.e., at least scattered fibers) and could be accurately located in almost all
subjects using a variety of anatomical criteria. Many of these areas contained small
fibers. Areas in which medium fibers predominate are often too sparsely and
unpredictably innervated for analysis. However, a number of the more heavily
innervated medium fiber sites are included. Strikingly, gonadectomy did not cause an
increase in vasopressin-ir fibers in any area where a change was observed (N = 60).
Please see Table 3.1 for all statistical values associated with figures below.
3.3.1 Telencephalon
3.3.1.1 Steroid-sensitive vasopressin projections
Vasopressin immunoreactivity appeared to decrease following castration in 32 of
55 brain regions throughout the telencephalon that have previously been shown to contain
vasopressin-ir fibers. Qualitative results for the telencephalon are summarized in Table
3.2.

90

In the cortex, gonadectomy reduced vasopressin-ir fiber density in the dorsolateral
entorhinal cortex and ventral endopririform claustrum. In the hippocampus, the oriens
and molecular layers of CA1 contain vasopressin fibers that disappeared following
gonadectomy, although some dense tangles of medium to large fibers remain in the
caudal molecular layer of CA1 (see figure 2.8H). In the basal ganglia, the ventral
pallidum lost vasopressin immunoreactivity following gonadectomy, but the nucleus
accumbens did not. Other basal ganglia nuclei do not contain vasopressin. The ventral
forebrain lost immunoreactivity in the navicular postolfactory cortex located near the
rostral midline, the substantia innominta, and the ventral septal area.
The septal complex has one of the densest vasopressin-ir innervations in the brain,
and gonadectomy eliminated all small fiber immunoreactivity in the lateral septum,
septofimbrial nucleus, and septohypothalamic nucleus leaving only the sparse medium
fibers. Innervation of the dorsal division of the lateral septum, the most rostral parts of
the lateral septum, triangular nucleus, and subfornical organ did not change.
The bed nuclei of the stria terminalis have a complex array of fibers of various
types. In the anterior nuclei, only the anteromedial (STMA) and lateroventral (STLV)
nuclei had a decrease in vasopressin-ir fibers; these nuclei are also the only ones that
contained small fibers in intact animals. Laterodorsal nuclei had virtually no fibers to
begin with and medioventral nuclei did not have a qualitative reduction in the medium
fibers found there. It is notable that despite the decrease in small fibers in the
anteromedial nucleus and others, a number of medium fibers remained. In the
posteromedial BNST, all three regions (i.e., medial, intermediate, and lateral) lost
vasopressin-immunoreactivity. However, some medium fibers were still observed in
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each. Further, vasopressin immunoreactivity in small fibers persisted in the dorsal part of
the medial posteromedial BNST (STMPM), whereas immunoreactivity in fibers in the
ventral portion of the STMPM disappeared following gonadectomy. The nucleus of the
stria medullaris also had decreased immunoreactivity following gonadectomy.
Every vasopressin innervated nucleus within the amygdala lost vasopressin
immunoreactivity following gonadectomy with the exception of the central nucleus, in
which medium fibers remained. Some stray medium fibers also remained in the
posteromedial and basomedial nuclei and in anteromedial regions adjacent to the
supraoptic nucleus in gonadectomized animals.
3.3.1.2 Sex differences and interactions
As mentioned above, all areas with small fibers examined in the telencephalon
had decreased vasopressin immunoreactivity following gonadectomy. In addition, a
number of these regions were also sexually dimorphic with more vasopressin-ir fibers
observed in males. The decrease in vasopressin immunoreactivity was generally seen in
both sexes; however, in many cases, larger decreases in males led to significant sex-bysurgery interactions. Exceptions to these general trends are noted below.
Of the 24 areas examined in the telencephalon sex differences were found in 15.
All 15 areas had decreased vasopressin immunoreactivity following gonadectomy and
significant sex-by-surgery interactions due to a larger decrease in immunoreactivity in
males than females with one exception, the rostral medioventral BNST (STMV), for
which details are described below. An additional eight areas were steroid sensitive, but
not sexually dimorphic. Finally, one region was neither steroid sensitive nor sexually
dimorphic
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(see Table 3.1 for statistics, Figures 3.1 for the location of regions analyzed, and Figures
3.2 to 3.4 for data).
In the lateral septum (Figure 3.2), the densely innervated ventral part and the
caudal part where the fibers of the fimbria begin to enter were strongly sexually
dimorphic. On the other hand, the intermediate part in a more rostral area was not.
In the anterior BNST (Figure 3.3A), only the STMA and STLV nuclei contain
small fibers. There was a small but significant decrease in immunoreactivity in the
STMA of males and females, but in the STLV a decrease was observed only in males.
Interestingly, intact females did not differ from gonadectomized animals in the STLV.
Surprisingly, in the rostral medioventral (STMV) BNST, females had a significantly
greater vasopressin-ir fiber density than males, and this difference was not present in
castrated animals. Typically sex differences in vasopressin-ir fiber density are in the
male greater than female direction as was observed here, but, as described below, a
number of regions in the mouse brain show a similar "atypical" sex difference as seen in
the rostral STMV.
The posteromedial BNST nuclei are innervated primarily by small fibers, and this
innervation is sexually dimorphic and steroid dependent (Figure 3.3B). Males had more
vasopressin-ir fibers than females in the medial and lateral parts of the posteromedial
BNST and in the nucleus of the stria medullaris, and fibers decreased drastically in both
sexes following gonadectomy.
All regions quantified in the amygdala, including multiple rostral to caudal levels
through some regions, contained almost exclusively small fibers. Although all regions
responded to gondectomy with a massive decrease in vasopressin immunoreactivity, sex
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differences were only observed in a subset of regions. Specifically, the rostral and caudal
extended amygdala (Figure 3.4A), caudal anterodorsal medial amygdala (Figure 3.4C),
posteroventral medial amygdala (Figure 3.4D), posterior basolateral amygdala (Figure
3.4E), and all levels of the posterodorsal medial amygdala (MePD; Figure 3.4F) all had
significantly more vasopressin-ir fibers in intact males than females. Notably, in the
caudal MePD females did not differ from gonadectomized animals. In contrast, no sex
differences were observed in the rostral or caudal anterior cortical amygdala (Figure
3.4B), rostral anterodorsal medial amygdala (Figure 3.4C), anteroventral medial
amygdala (Figure 3.4D), basomedial amygdala, or ventral basolateral amygdala (Figure
3.4E).
3.3.2 Diencephalon
3.3.2.1 Hypothalamus
3.3.2.1.1 Steroid-sensitive vasopressin projections
The hypothalamus contains most of the vasopressin-producing nuclei in the brain,
and accordingly has by far the densest and most complex patterns of innervation of the
entire brain. A decrease in small fiber immunoreactivity was observed in 15 out of 39
brain regions throughout the hypothalamus following gonadectomy. Notably and in
contrast to the telencephalon, some regions actually retained small fibers following
gonadectomy. Qualitative results for the hypothalamus are summarized in Table 3.3 and
are described below.
In the preoptic region, small fibers disappeared from the lateral preoptic area,
medial preoptic area, parastrial nucleus, medial part of the medial preoptic nucleus, and
to a very small extent the median preoptic nucleus. Many regions retained medium
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fibers. In addition a number of regions also had some small fibers especially near the
midline in the anteroventral periventricular nucleus and periventricular region.
In the medial regions of the hypothalamus at the levels of the anterior and
dorsomedial hypothalamic nuclei, there are very dense vasopressin-ir projections, which
can be seen exiting the PVN. However, with the exception of a small terminal field in
the most rostral part of the anterior hypothalamus, none of these regions lose vasopressin
immunoreactivity following gonadectomy.
In contrast, the peduncular lateral hypothalamus, which is often referred to as just
lateral hypothalamus, contains small fibers and terminals that disappear following
gonadectomy at all rostral to caudal levels. This innervation is most pronounced in the
rostral lateral hypthalamus and decreases caudally, until almost no small fibers can be
seen. However, at the level of the mammillary bodies, a dense small fiber plexus is
observed in the perifornical lateral hypothalamus.
In addition to the lateral hypothalamic regions, small fibers immunoreactivity
disappears following gonadectomy from nuclei closer to the midline at the level of the
mammillary bodies. In particular, the dorsal tuberomammillary nucleus near the third
ventricle and the ventral tuberomammillary region located ventral to the mammillary
bodies lose immunoreactivity following gonadectomy. The same is true for the posterior
hypothalamus, ventral premammillary nucleus, and retromammillary nucleus also have a
sparse to scattered innervation. Each of these areas also contains a modest innervation be
medium fibers that persist following gonadectomy.
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3.3.2.1.2 Sex differences and interactions
Unlike the telencephalon, there are many regions in the hypothalamus with
medium to large fibers, and a number of these regions are included in quantitative
measures of vasopressin immunoreactivity. Of the 27 regions examined in the
hypothalamus, 13 regions were sexually dimorphic. Five of these were atypical sex
differences (i.e., female greater than male) and were not affected by gonadectomy. Other
details regarding sex differences are described below. Five other regions had reduced
vasopressin immunoreactivity following goandectomy, but no sex differences. Nine
areas were not affected by gonadectomy and were not sexually dimorphic (see Table 3.1
for statistics, Figure 3.1 for the location of regions analyzed, and Figure 3.5 for data).
In the preoptic region, the medial preoptic area and the middle and caudal parts of
the medial preoptic nucleus (MPOM) were sexually dimorphic (Figure 3.5A and B);
intact males had a greater fiber density than females. In each of these areas, which
contain other gonadal-steroid independent vasopressin fibers, the female did not differ
from gonadectomized animals. Other regions such as the median preoptic nucleus,
vascular organ of the lamina terminalis, and the rostral part of the MPOM were not
sexually dimorphic or responsive to gonadal hormones. Despite the decrease of small
fibers in males in the MPOM some small fibers remained.
In the anterior hypothalamus (AH; Figure 3.5C), there were no sex differences or
effect of gonadectomy in the central part of the AH through which fibers of the PVN
pass. However, in the anterior part of the AH, where small fibers are noted, a small
decrease was observed in males following gonadectomy suggesting and confirming the
presence of a small BNST or MeA input.

96

Similar to results in the central AH, medium fibers in the tuberal lateral
hypothalamus and medial tuberal hypothalamus were not sexually dimorphic or affected
by gonadal steroids (Figure 3.5F). In contrast nuclei closer to the midline such as the
dorsomedial hypothalamus (Figure 3.5G), periventricular area (Figure 3.5E), and
retrochiasmatic area (Figure 3.5H) were sexually dimorphic although in the "atypical"
fashion: females greater than males. None of these regions were affected by
gonadectomy, and each appears to receive both small fiber and medium fiber
innervation. On the other hand the subparaventricular zone, which contains mostly small
fibers was neither sexually dimorphic nor affected by gonadectomy (Figure 3.5E).
In the peduncular lateral hypothalamus (PLH; Figure 3.5D), as well as the caudal
perifornical region (Figure 3.5H), there were effects of gonadectomy in all but the caudal
PLH, but only the dense terminal field in the rostral part of the PLH has a typical sex
difference: males had more fibers than females (Figure 3.5D). Interestingly, the caudal
PLH, where very few small fibers are observed, an atypical sex differences was found:
females greater than males.
At the level of the mammillary bodies, gonadectomy reduced small fiber
immunoreactivity in the ventral tuberomammillary nucleus and ventral premammillary
nucleus (PMV); Figure 3.5H), as well as in the retromammillary nucleus (RMM), which
was examined at three levels (Figure 3.5I). The only sex difference was found in the
caudal RMM. At this level, males had more fibers than any other group, and females did
not differ from gonadectomized animals. Although there were no sex differences in
intact animals in the PMV and rostral RMM; a significant interaction between sex and
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hormonal status was present because gonadectomized males had significantly less
vasopressin-ir fibers than other groups (Figure 3.5H and I).
3.3.2.2 Thalamus
3.3.2.2.1 Steroid-sensitive vasopressin projections
The majority of vasopressin immunoreactivity in the thalamus is found in small
fibers and terminals. Invariably, however, some medium fibers find their way into both
lateral and medial nuclei. Only the most caudal parts of the midline thalamus rostral to
the periaqueductal gray (PAG) and the reticular thalamus contain medium fibers in the
absence of small fibers. Of the 14 areas containing vasopressin-immunoreactive fibers in
the thalamus, eight appeared to have decreased immunoreactivity following
gonadectomy. Qualitative results for the thalamus are summarized in Table 3.4.
Gonadectomy caused a near total elimination of vasopressin-ir fibers in the
thalamus, including the central medial, interanterodorsal, interanteromedial, mediodorsal,
paracentral, rhomboid, paratenial, and lateral habenular nuclei. No qualitative changes
were observed in the paraventricular, reuniens, xiphoid, or reticular thalamic nuclei
suggesting a site of origin other than the BNST or MeA. However, as described below
quantitative results suggest a small decrease in the rostral paraventricular nucleus
following gonadectomy.
3.3.2.2.2 Sex differences and interactions
Quantitative data show that areas where fiber immunoreactivity disappeared in the
thalamus were generally sexually dimorphic as well: male greater than female (see Table
3.1 for statistics, Figure 3.1 for the location of regions analyzed, and Figure 3.6 for data).
This was true for the multiple rostral to caudal levels through the mediodorsal (Figure
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3.6C), central medial (Figure 3.6E), and lateral habenular nuclei (Figure 3.6F), except the
caudal lateral habenula where there was an effect of gonadectomy, but not sex. The
paratenial and rostral paraventricular nucleus were affected modestly by gonadectomy,
but fiber-immunoreactivity was not sexually dimorphic in these areas (Figure 3.6A and
B). In the dorsal part of the anterior paraventricular thalamus at the level where the
paratenial nucleus emerges there was a decrease in vasopressin-ir fiber density only in
males following castration (Figure 3.6A). An interesting feature of this area is the
emergence of a dense plexus of gonadal steroid-dependent fibers adjacent to the stria
medullaris. This plexus may have contributed to gonadal status effects in the anterior
paraventricular and paratenial nuclei. Further caudal in the paraventricular nucleus
(Figure 3.6D), there were no effects of gonadal status or sex.
3.3.3 Mesencephalon
3.3.3.1 Steroid-sensitive vasopressin projections
Unlike the thalamus, which is innervated almost entirely by small fibers, the
mesencephalon contains regions of small and medium fiber innervation. Eighteen of the
31 brain regions containing vasopressin-ir fibers in the mesencephalon appeared to have a
decrease in vasopressin immunorecativity following gonadectomy. Qualitative results for
the thalamus are summarized in Table 3.5.
In the most rostral part of the PAG a number of small and medium fibers can be
seen ascending toward the aqueduct into the PAG. Most of these remain following
castration and fibers can be seen in gonadectomized males throughout the PAG. Most of
the fibers seen throughout the PAG of gonadectomized animals are short segments
suggesting that they are fibers travelling somewhat rostral-to-caudal (i.e., orthogonal to
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the plane of the section). Rostrally, small fibers, which appear to arrive via the ascending
projection through the rostral PAG, end in the dorsomedial PAG and at the midline in the
commissure of the superior colliculus. These small fibers and terminals lose vasopressin
immunoreactivity following gonadectomy.
Caudally at the level of the trochlear nucleus, a dense plexus of small fibers and
terminals begins to form in the dorsal raphe nuclei. At the same level medium axons
curve laterally into the plane of section in the ventrolateral PAG (VLPAG) and then pass
into the lateral parabrachial nucleus (LPB). The small fibers in the dorsal raphe nuclei
(e.g., dorsolateral, dorsal, and caudal) lose immunoreactivity following gonadectomy.
Medium fibers in the VLPAG and LPB do not lose immunoreactivity. These fibers
appear continuous with fibers further caudal in the locus coeruleus and Barrington's
nucleus that also retain immunoreactivity following gonadectomy. From this point on
some fibers continue orthogonal to the section adjacent to the fourth ventricle in both
sham and castrated animals.
Ventrally in the tegmentum, a number of brain regions are innervated by small
fibers from the BNST and MeA. Gonadectomy reduces vasopressin immunoreactivity in
the ventral tegmental area (VTA), parabrachial pigmented nucleus of the VTA,
interfascicular, and parainterfascicular nuclei in more rostral and medial parts of the
midbrain. Laterally, small fiber immunoreactivity disappears from the ventromedial tip
of the substantia nigra pars reticulata, the caudal substantia nigra pars compacta, and the
retrorubral field. The small fibers that pass through the VTA into the interfascular
nucleus appear to continue on through the caudal linear raphe into the dorsal raphe
nuclei. These fibers are lost following gonadectomy. There is also a group of medium
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fibers that travel through the VTA, interfascicular nucleus, and caudal linear raphe in a
similar path. In addition, there is a lateral path of medium fibers that are not hormonedependent and travel dorsal to the substantia nigra into the midbrain reticular formation.
As these fibers pass the substantia nigra there is an increase in branching and boutons.
This fiber pathway appears to curve through the medial parabrachial nucleus into the
solitary nucleus in the medulla.
3.3.3.2 Sex differences and interactions
All of the regions with small fibers in the mesencephalon that were analyzed
showed a decrease following gonadectomy (N = 11). Eight of these 11 were also
sexually dimorphic, although one was only sexually dimorphic in gonadectomized
animals. Five additional areas had atypical sex difference, but were not affected by
gonadectomy. Finally, one region was not sexually dimorphic or steroid-sensitive (see
Table 3.1 for statistics, Figure 3.1 for the location of regions analyzed, and Figure 3.7 for
data).
The small fibers of the mediodorsal PAG and dorsal and caudal aspects of the
dorsal raphe (DRC) were sexually dimorphic: males greater than females (Figure 3.7A
and C). The dorsolateral dorsal raphe showed no sex differences although fiber density
was decreased in gonadectomized animals (Figure 3.7C). In the DRC intact females
were not different from gonadectomized males or females. In the ventrolateral PAG,
there was a decrease in fibers at the most rostral level, but no sex differences. The level
of vasopressin immunoreactivity in the middle VLPAG was similar in all groups.
However, caudally, there were atypical sex differences in the caudal VLPAG, LPB, and
medial parabrachial nuclei: females greater than males (Figure 3.7B and F).
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In ventral regions, males had greater fiber densities than females in the VTA
(Figure 3.7D), interfascicular nuclei (Figure 3.7E), and parainterfascicular nuclei (Figure
3.7D). There was no sex difference in the substantia nigra pars reticulata even though
this area was affected by gonadectomy (Figure 3.7D). The sex difference in the caudal
interfascicular nucleus was found only in gonadectomized animals because males had
less vasopressin-ir fibers than females following gonadectomy (Figure 3.7E). Finally, an
atypical sex difference was observed in the midbrain reticular formation at the top of the
substantia nigra where the medium fibers begin to increase in number (Figure 3.7F).
3.3.4 Metencephalon and myelencephalon
3.3.4.1 Steroid-sensitive vasopressin projections
Qualitative results for the metencephalon and myelencephalon are summarized in
Table 3.6. There are very few innervated regions in the metencephalon. However, small
fibers are found in the median raphe nucleus and the anterior tegmental nucleus, which
are found between the tectospinal tract and pontine reticular formation. Both of these
regions have no fibers at all following gonadectomy. A few medium fibers are seen
dorsally just below the fourth ventricle and laterally in the subcoeruleus and intermediate
reticular formation. These medium fibers seem to pass through the metencephalon on
their way to innervate a number of regions throughout the medulla.
In the medulla itself, medium fibers are observed in the solitary nucleus through
its entire rostal to caudal extent, especially in caudal regions (noted in sagittal sections;
Figure 2.21F). Vasopressin-ir fibers are found, ventrally, in the medullary raphe nuclei
(e.g., raphe magnus, raphe pallidus, raphe obscurus, and raphe interpositus); laterally, in
the alpha part and ventral part of the gigantocellular reticular nuclei, and caudally in the
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lateral reticular formation and the most caudal parts of the spinal trigeminal nucleus.
Fibers are observed in all of these areas following gonadectomy with no apparent
decreases.
3.3.4.2 Sex differences and interactions
Quantitative data were collected for the anterior tegmental nucleus and median
raphe (see Table 3.1 for statistics, Figure 3.1 for the location of regions analyzed, and
Figure 3.8 for data). Sex differences were observed in both areas: males greater than
females (Figure 3.8). No region of the medulla appeared to receive steroid-sensitive
vasopressin innervation. Quantitative analyses were not carried out for any area in the
myelencephalon.
3.4 Discussion
In rats, vasopressin cells in the bed nuclei of the stria terminalis (BNST) and
medial amygdala (MeA) require gonadal hormones, in particular estrogens (De Vries et
al., 1994), for vasopressin production. Similar to rats, gonadectomy decreases
vasopressin immunoreactivity in a number of brain regions (DeVries et al., 1985) some
of which, at least in the rat, are known to derive their vasopressin innervation from the
BNST or MeA (De Vries and Buijs, 1983; Caffe et al., 1987). Given that some steroidsensitive vasopressin-ir projections in the rat are known to come from the BNST or MeA
and the gross similarities between rat and mouse vasopressin systems, we believe that the
loss of vasopressin immunoreactivity in a given brain area following gonadectomy in the
mouse strongly suggests that that area receives vasopressin innervation from the BNST or
MeA. Conversely, areas that retain vasopressin immunoreactivity following
gonadectomy presumably receive their innervation from other nuclei, most likely the
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various hypothalamic nuclei such as the suprachiasmatic, supraoptic, pareventricular, or
various accessory nuclei, which are the only other nuclei that produce vasopressin. In the
current study, brain regions throughout the telenencephalon, diencephalon,
mesencephalon, and metencephalon lost vasopressin immunoreactivity following
gonadectomy. This subset of brain regions as detailed above comprises the likely output
of the BNST and MeA. Furthermore, many of these brain regions (25 of the 39
quantified) have a sexually dimorphic vasopressin input. In these cases males have
significantly more vasopressin-ir fibers and terminals than females in the given brain
region. Interestingly and quite unexpectedly, vasopressin-ir fibers from other sources
(i.e., fibers did not decrease following gonadectomy) were also sexually dimorphic.
However, this sex difference was atypical in that females had a greater vasopressin-ir
fiber density (i.e., more fibers) than males.
Before drawing too many conclusions from the results of this study, it is
important to keep a few limitations in mind. First and foremost is the quantity of data.
While a somewhat exhaustive approach is beneficial in providing a great many things to
think about, it also greatly amplifies the opportunity for statistical error. While this is of
theoretical concern, in this particular situation the presence or absence of small fibers in a
region is almost always able to corroborate the statistical data. Areas where no small
fibers were observed were not affected by gonadectomy as shown when you compare the
qualitative and quantitative data. Furthermore, sex differences in the expected direction
only occurred in areas with small fibers, which fits with the fact that the BNST and MeA
are sexually dimorphic and the source of small fibers in many brain regions. Perhaps the
most interesting statistical question is the presence of atypical sex differences. A couple
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of areas in which this occurred could be expected based on statistical error, but there were
10 different brain region in which females had a greater vasopressin-ir fiber density than
males. Furthermore, these 10 areas were all comparable in that they contained almost
exclusively medium fibers. Finally, not one region that changed following gonadectomy
had an increase in vasopressin-ir fibers, which would be expected by chance given the
number of observations made.
Aside from the number of tests, it is important to note that within each brain
region the data can be quite variable. Individual data points are illustrated in Figure 4.2
for the caudal lateral septum of intact males. The subject with the lowest value has a
value that is only 18% of the highest animal (a 5-fold difference). However, despite this
variability we saw sex differences in many brain regions where one would expect to find
a sex difference based on data from other species (De Vries and Panzica, 2006).
Finally, as with any study, we must be careful to not generalize too far. We have
thoroughly examined sex differences in the vasopressin system of only one mouse strain.
It is possible that other strains may have differences in the amount of fibers projecting to
different brain regions and that sex differences in these other strains could be bigger,
small, or non-existent. However, our data seem to fit well with what is known about the
rat and sex differences in vasopressin expression observed in other species. Furthermore
the quantitative results presented here corroborate results found in mice previously (Rood
et al., 2008). Despite the limitations of this study, we have presented a significant pool of
data that provide the foundation for hypotheses regarding the function and possible
sexual dimorphisms in function of the vasopressin system.
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Unfortunately, an exhaustive functional review of each brain region is beyond the
scope and purpose of the current project; however, a brief overview of a few functional
systems highlights the widespread potential impact of vasopressinergic innervation
deriving from the bed nuclei of the stria terminalis. Systems involved in arousal and
awareness, behavioral state, and emotional control and cognition all contain vasopressin,
often at multiple levels of the circuits involved. Below, I introduce some of the various
functional circuits that contain vasopressin innervation, which presumably comes from
the BNST or MeA. Interestingly, the collection of areas discussed below suggests that
vasopressin may be involved in regulating the behavioral state of an animal in addition to
or instead of regulating individual behaviors.
One such region involved in controlling behavioral state hat contains vasopressin
in the mouse is the midbrain raphe: dorsal and median raphe nuclei. These regions
produce serotonin. Drugs that lead to an increase in serotonin neurotransmission have an
anxiolytic effect. Conversely, low levels of serotonin lead to an increase in anxiety. Low
serotonin levels are also associated with higher levels of aggression in humans (Berman
et al., 1997). The influence of serotonin on aggression has been reviewed elsewhere
(Veenema and Neumann, 2007), but briefly research indicates that various forms of
aggression can be correlated with both low and high levels of serotonin in different rat
and mouse strains. In the brain, serotonin is produced primarily in hind brain nuclei
including the dorsal and median raphe nuclei (Michelsen et al., 2007). Each of these
brain regions in the mouse contains sexually-dimorphic vasopressin-ir fibers from the
BNST and MeA. The presence of vasopressin in the raphe, especially the very dense
innervation of the dorsal raphe, suggests a functional link between vasopressin release

106

and serotonin neurons, although it must be noted that no direct evidence to this effect has
yet been reported.
In addition to direct projections to the serotonin system, a dense plexus of
vasopressin-ir fibers is found in the lateral habenular nucleus. This innervation is also
sexually dimorphic except possibly in more caudal regions of the nucleus. The lateral
habenular nucleus plays a key role in information flow through the "dorsal diencephalic
conduction system (Sutherland, 1982)." This title refers to a pathway from the forebrain
to the hindbrain that passes through the stria medullaris into the habenular complex, the
neurons of which send axons through the fasciculus retroflexus to the hindbrain (Wang
and Aghajanian, 1977; Sutherland, 1982). In fact, the neurons in the lateral habenula
project directly to the dorsal raphe nucleus and inhibit serotonergic neurons (Wang and
Aghajanian, 1977; Reisine et al., 1982). The purpose and function of vasopressin at each
of these levels (i.e., the dorsal raphe and lateral habenular nucleus) is currently unknown.
In addition to the dorsal raphe, the lateral habenular nucleus has projections to the
ventral tegmental area (VTA) and substantia nigra pars compacta (Christoph et al., 1986;
Hikosaka et al., 2008). Similar to the effect on the raphe, stimulation of the lateral
habenula inhibits dopamine neurons in both the VTA and substantia nigra (Reisine et al.,
1982; Christoph et al., 1986). Dopaminergic neurons in the VTA and substantia nigra
project extensively to the basal ganglia (de Olmos and Heimer, 1999). These
connections, in particular those from VTA, suggest that vasopressin is anatomically
linked to another important regulatory system, namely, the "ventral striatopallidal system
(de Olmos and Heimer, 1999)." Structures in this pathway are also referred to as the
"limbic loop of the basal ganglia." Briefly, the VTA projects to the ventral striatum (i.e.,
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nucleus accumbens), which then projects to the ventral pallidum or substantia
innominata. Neurons in the ventral pallidum project to the mediodorsal thalamic nucleus,
which then projects to specific brain regions, which in turn project to the ventral striatum
among other regions. Interestingly, vasopressin-ir fibers from the BNST and MeA
intersect this "limbic loop" at multiple levels including the VTA, ventral pallidum,
mediodorsal thalamus, and interfascicular nucleus, which also contains dopaminergic
neurons with forebrain projections. A functional link has yet to be made between
vasopressin and most of these brain region; however, one region, the ventral pallidum,
has been implicated in affilitive behavior and pair-bonding in the monogamous prairie
vole. Overexpression of the V1a receptor, the primary vasopressin receptor in the brain,
in the ventral forebrain including the ventral pallidum increases affiliative behavior and
partner preference in both socially monogamous (i.e., prairie vole) and promiscuous
species (i.e., meadow voles; (Pitkow et al., 2001; Lim et al., 2004). Further, Fos
expression increases in the ventral pallidum, mediodorsal thalamus, and medial amygdala
following mating stimuli, and injections of a V1a receptor antagonist into the ventral
pallidum, but not the lateral ventricle, medial amygdala, or mediodorsal thalamus,
inhibits partner preference formation (Lim and Young, 2004).
While in mice the densest BNST / MeA projections within the thalamus innervate
the mediodorsal thalamus ("limbic loop") and the lateral habenula ("dorsal diencephalic
conduction system"), vasopressin-ir fibers are also found in a number of midline and
intralaminar nuclei, including the central medial, paracentral, and interanterodorsal
nuclei. The afferent and efferent projections of these nuclei are reviewed in (Van der
Werf et al., 2002). In general, the interanterodorsal nucleus appears to be connected to
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the amygdala and limbic frontal cortex. The central medial nucleus receives inputs from
a number of regions including reticular formation, serotonin neurons, superior colliculus,
and hindbrain cholinergic nuclei. The paracentral nucleus receives multimodal sensory
information from the auditory and visual systems. These nuclei with their diverse inputs
and outputs appear to play a role in attention and awareness. Based on the patterns of
inputs, it appears likely that these nuclei integrate sensory and limbic system information
with midbain and hindbrain activational systems, such as the serotonergic and cholinergic
nuclei.
Perhaps the most commonly studied area in terms of vasopressin function is the
lateral septum. This brain region receives massive topographic projections from the
hippocampus, and projects to regions throughout the brain in a region specific manner
(Swanson and Cowan, 1979; Risold and Swanson, 1997). The ventral lateral septum and
caudal lateral septum, which contain one of the largest and densest vasopressin terminal
fields, project to the medial preoptic region (ventral lateral septum) and the lateral
preoptic area and lateral hypothalamus (caudal lateral septum). These areas themselves
have vasopressin innervation from the BNST or MeA and are thought to be involved in a
host of behaviors, including reproductive and aggressive behaviors, both of which require
social interaction. Vasopressin in the lateral septum has been studied in regard to social
memory, aggression, parental behavior, partner preference, thermoregulation, and anxiety
(Bernardini et al., 1983; Naylor et al., 1985; Dantzer et al., 1988; Insel et al., 1994; Wang
et al., 1994; Everts and Koolhaas, 1999; Bielsky et al., 2005). Currently, functional
evidence most strongly supports a role for vasopressin in social recognition memory,
particularly in male rats (Dantzer et al., 1987; Bluthe et al., 1990). Vasopressin receptor
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(V1a) antagonists, antisense, and null mutations all disrupt social recognition memory
(Dantzer et al., 1987; Dantzer et al., 1988; Landgraf et al., 1995; Bielsky et al., 2004). In
V1a knock-out animals, rescue of V1a receptors in the lateral septum alone with the use
of viral vectors restored social recognition memory (Bielsky et al., 2005). In addition,
V1a agonists injected into the lateral septum facilitate social recognition memory
(Dantzer et al., 1987; Dantzer et al., 1988).
Clearly, given the anatomical location of vasopressin in the mouse brain, this
peptide is likely to affect a number of brain pathways that mediate particular aspects of a
behavioral response to stimuli. However, surprisingly few data have been generated to
this effect. If links between brain areas and functions are summarized, our knowledge
would look like this: social recognition = lateral septum; pair-bonding = ventral pallidum;
thermoregulation in response to fever = ventral septal area; flank-marking = anterior
hypothalamus; and aggression = lateral septum / raphe nuclei / anterior hypothalamus
(Ferris et al., 1984; Naylor et al., 1985; Dantzer et al., 1988; Lim and Young, 2004;
Bielsky et al., 2005; Beiderbeck et al., 2007). However, as outlined above, a number of
brain regions that constitute major modulatory systems are innervated by the vasopressin
producing cells of the BNST and MeA. I hypothesize that stimulation of the BNST /
MeA vasopressin system initiates a brain wide mobilization of systems that guide the
animal toward making ethologically relevant and "correct" behavioral responses to
specific behavioral stimuli. For example, when presented with a reproductively receptive
female, a male mouse should most likely respond with affiliative and mating behavior
rather than a display of offensive aggression. Examining such a hypothesis will require a
more global approach to thinking about vasopressin function compared to the relatively
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narrow conclusions drawn thus far. Nevertheless, the pieces of the puzzle that we do
have give credence to the idea that research into vasopressin function will greatly
increase our understanding of animal and perhaps human social behavior.
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Table 3.1: Statistics for quantitative analyses
Statistical values are given below for all quantitative comparisons made
throughout CHAPTER 3. Data are grouped by brain region and overall effect and
alphabetized within each section.
Telencephalon
Brain Region
Sex and surgery difference
Anterodorsal medial amygdala,
caudal (MeAD)
Extended amygdala, rostral (EA)
Extended amygdala, caudal (EA)
Lateral amygdala, caudal (LA)
Lateral septal nucleus, ventral
part (LSV)
Lateral septal nucleus, ventral &
intermediate part (LSV&I)
Lateroventral BNST (STLV)
Nucleus of the stria medullaris
(SM)
Posterolateral medial BNST
(STMPL)
Posteromedial BNST (STMPM)
Posterodorsal medial amygdala,
rostral (MePD)
Posterodorsal medial amygdala,
middle (MePD)
Posterodorsal medial amygdala,
caudal (MePD)
Posteroventral medial amygdala
(MePV)
Surgery difference only
Anterior cortical amygdala,
rostral (ACo)
Anterior cortical amygdala,
caudal (ACo)
Anterodorsal medial amygdala,
rostral (MeAD)
Anteromedial BNST (STMA)
Anteroventral medial amygdala
(MeAV)
Basolateral Amygdala, Ventral
(BLV)
Basomedial amygdala (BMA)
Lateral septal nucleus,
intermediate part (LSI)

F

Sex
p

(1, 35)
0.406
(1, 38)
1.896
(1, 36)
1.178
(1, 27)
10.876
(1, 33)
14.836
(1, 36)
11.826
(1, 35)
12.991
(1, 38)
8.355
(1, 38)
9.934
(1, 34)
29.307
(1, 34)
6.733
(1, 33)
18.475
(1, 27)
18.079
(1, 33)
12.893

0.528

(1, 35)
0.599
(1, 34)
0.579
(1, 34)
0.004
(1, 36)
1.009
(1, 34)
3.928
(1, 34)
0.457
(1, 34)
0.438
(1, 35)
1.636

0.444

0.177
0.285
0.003
0.001
0.001
0.001
0.006
0.003
<0.001
0.014
<0.001
<0.001
0.001

0.452
0.953
0.322
0.056
0.504
0.512
0.209
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F

Surgery
p

(1, 35)
67.23
(1, 38)
62.158
(1, 36)
119.13
(1, 27)
49.121
(1, 33)
65.154
(1, 36)
93.193
(1, 35)
23.5
(1, 38)
45.062
(1, 38)
59.137
(1, 34)
83.218
(1, 34)
154.22
(1, 33)
88.758
(1, 27)
35.85
(1, 33)
90.295

<0.001

(1, 35)
55.195
(1, 34)
51.211
(1, 34)
62.062
(1, 36)
8.163
(1, 34)
13.902
(1, 34)
36.411
(1, 34)
54.079
(1, 35)
58.771

<0.001

<0.001
<0.001
<0.001
<0.001
<0.001

<0.001
<0.001
<0.001
<0.001
<0.001
<0.001
<0.001
<0.001

<0.001
<0.001
0.007
0.001
<0.001
<0.001
<0.001

Interaction
F
p
(1, 35)
7.077
(1, 38)
6.012
(1, 36)
5.834
(1, 27)
12.241
(1, 33)
15.635
(1, 36)
12.092
(1, 35)
10.627
(1, 38)
9.733
(1, 38)
10.682
(1, 34)
36.622
(1, 34)
6.381
(1, 33)
23.147
(1, 27)
14.478
(1, 33)
17.641

0.012

(1, 35)
0.269
(1, 34)
1.449
(1, 34)
0.859
(1, 36)
0.594
(1, 34)
0.634
(1, 34)
0.639
(1, 34)
3.168
(1,35)
1.792

0.607

0.019
0.021
0.002
<0.001
0.001
0.002
0.003
0.002
<0.001
0.016
<0.001
0.001
<0.001

0.237
0.361
0.446
0.431
0.43
0.084
0.189

Table 3.1: Statistics for quantitative analyses (continued)
Telencephalon (Cont.)
Brain Region
Female > Male sex difference
Medioventral BNST, rostral
(STMV)
No differences
Medioventral BNST, caudal
(STMV)

F

Central medial n., middle (CM)
Central medial n., caudal (CM)
Lateral habenula, rostral (LHb)
Lateral habenula, middle (LHb)
Medial preoptic area (MPA)
Medial part of medial preoptic
nucleus, middle (MPOM)
Medial part of medial preoptic
nucleus, caudal (MPOM)
Medial retromammillary
nucleus, rostral (RMM)
Medial retromammillary
nucleus, caudal (RMM)
Mediodorsal thalamus, rostral
(MD)
Mediodorsal thalamus, middle
(MD)
Mediodorsal thalamus, caudal
(MD)
Peduncular part of the lateral
hypothalamus, rostral (PLH)
Premammillary nucleus, ventral
(PMV)
Surgery difference only
Anterior paraventricular
thalamus, rostral (PVA)
Lateral habenula, caudal (LHb)

F

Surgery
p

Interaction
p

0.016

(1, 36)
1.227

(1, 34)
0.302

0.587

(1, 34)
0.298
1.117
Surgery
F
p

(1, 34)
0.829
0.047
Interaction
F
p

(1, 36)
3.515
(1, 37)
2.205

0.069

(1, 36)
5.303
(1, 37)
4.111

0.027

(1, 37)
26.613
(1, 37)
99.574
(1, 38)
37.335
(1, 38)
122.43
(1, 36)
418.97
(1, 26)
7.018
(1, 32)
9.844
(1, 33)
21.667
(1, 31)
12.405
(1, 21)
29.648
(1, 38)
85.293
(1, 37)
125.23
(1, 38)
85.469
(1, 36)
101.93
(1, 28)
1.313

<0.001

(1, 37)
6.140
(1, 37)
4.822
(1, 38)
7.712
(1, 38)
13.371
(1, 36)
62.069
(1, 26)
4.791
(1, 32)
5.377
(1, 33)
19.521
(1, 31)
0.964
(1, 21)
15.412
(1, 38)
17.364
(1, 37)
8.910
(1, 38)
15.584
(1, 36)
9.210
(1, 28)
6.472

0.018

(1, 37)
13.514
(1, 36)
35.342

0.001

(1, 37)
1.249
(1, 36)
0.198

0.271

F

Sex
p

(1, 36)
2.379
(1, 37)
3.5

0.132

(1, 37)
4.682
(1, 37)
2.969
(1, 38)
6.836
(1, 38)
12.585
(1, 36)
53.061
(1, 26)
0.48
(1, 32)
6.664
(1, 33)
9.991
(1, 31)
4.253
(1, 21)
7.975
(1, 38)
4.753
(1, 37)
7.2
(1, 38)
9.453
(1, 36)
6.715
(1, 28)
1.045

0.037

(1, 37)
0.005
(1, 36)
0.409

0.945

0.069

0.093
0.013
0.001
<0.001
0.494
0.015
0.003
0.048
0.01
0.036
0.011
0.004
0.014
0.315

0.527
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0.275

F

(1, 36)
6.422

Diencephalon
Brain Region
Sex and surgery difference
Anterior hypothalamus, anterior
(AHA)
Anterior paraventricular
thalamus, caudal and dorsal
(PVA)
Central medial n., rostral (CM)

Sex
p

0.146

<0.001
<0.001
<0.001
<0.001
0.014
0.004
<0.001
0.001
<0.001
<0.001
<0.001
<0.001
<0.001
0.262

<0.001

(1, 36)
10.9

0.002

0.05

0.034
0.008
0.001
<0.001
0.038
0.027
<0.001
0.334
0.001
<0.001
0.005
<0.001
0.004
0.017

0.659

Table 3.1: Statistics for quantitative analyses (continued)
Diencephalon (Cont.)
Brain Region
Surgery difference only
Medial retromammillary
nucleus, middle (RMM)
Paratenial Nucleus (PT)
Peduncular part of the lateral
hypothalamus, middle1 (PLH)
Peduncular part of the lateral
hypothalamus, middle2 (PLH)
Perifornical lateral
hypothalamus (PeFLH)
Ventral Tuberomammillary
Nucleus (VTM)
Female > Male sex difference
Dorsomedial Hypothalamus
(DM), rostral
Dorsomedial Hypothalamus
(DM), caudal
Peduncular part of the lateral
hypothalamus, caudal (PLH)
Periventricular Hypothalamic
Nucleus (Pe)
Retrochiasmatic area (RCh)
No differences
Anterior hypothalamus, central,
rostral (AHC)
Anterior hypothalamus, central,
caudal (AHC)
Anterior paraventricular
thalamus, caudal and ventral
(PVA)
Medial part of medial preoptic
nucleus, rostral (MPOM)
Medial tuberal hypothalamus
(MTu)
Median preoptic nucleus
(MnPO)
Paraventricular thalamus, rostral
(PV)
Paraventricular thalamus, caudal
(PV)
Subparaventricular zone (SPa)
Tuberal region of hypothalamus
(TuLH), rostral
Tuberal region of hypothalamus
(TuLH), caudal
Vascular organ of the lamina
terminalis (VOLT)

F

Sex
p

(1, 32)
0.363
(1, 38)
3.393
(1, 35)
0.965
(1, 37)
0.842
(1, 30)
0.006
(1, 32)
0.269

0.551

(1, 36)
11.815
(1, 37)
21.123
(1, 37)
12.883
(1, 36)
5.321
(1, 35)
10.227

0.001

(1, 35)
2.235
(1, 37)
3.561
(1, 38)
1.751

0.144

(1, 35)
2.985
(1, 37)
0.161
(1, 31)
0.235
(1, 36)
0.072
(1, 36)
2.571
(1, 33)
0.204
(1, 37)
0.718
(1, 38)
3.751
(1, 31)
1.166

0.093

0.073
0.333
0.365
0.941
0.608

<0.001
0.001
0.027
0.003

0.067
0.194

0.691
0.631
0.79
0.118
0.654
0.402
0.06
0.289
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F

Surgery
p

(1, 32)
14.575
(1, 38)
19.564
(1, 35)
16.604
(1, 37)
7.166
(1, 30)
38.848
(1, 32)
60.969

0.001

(1, 36)
0.124
(1, 37)
3.09
(1, 37)
0.032
(1, 36)
0.046
(1, 35)
0.425

0.727

(1, 35)
0.319
(1, 37)
0.77
(1, 38)
0.018

0.576

(1, 35)
2.573
(1, 37)
0.943
(1, 31)
2.984
(1, 36)
1.185
(1, 36)
2.075
(1, 33)
2.668
(1, 37)
0.569
(1, 38)
.624
(1, 31)
1.71

0.118

<0.001
<0.001
0.11
<0.001
<0.001

0.087
0.859
0.831
0.519

0.782
0.894

0.338
0.094
0.284
0.158
0.112
0.455
0.435
0.201

F

Interaction
p

(1, 32)
2.276
(1, 38)
1.965
(1, 35)
0.22
(1, 37)
0.319
(1, 30)
0.529
(1, 32)
2.063

0.141

(1, 36)
0.005
(1, 37)
0.052
(1, 37)
0.053
(1, 36)
1.529
(1, 35)
0.194

0.946

(1, 35)
0.494
(1, 37)
0.469
(1, 38)
1.063

0.487

(1, 35)
2.884
(1, 37)
1.659
(1, 31)
2.243
(1, 36)
3.131
(1, 36)
0.023
(1, 33)
0.165
(1, 37)
<0.001
(1, 38)
0.002
(1, 31)
0.604

0.098

0.169
0.642
0.575
0.473
0.161

0.821
0.82
0.224
0.662

0.498
0.309

0.206
0.144
0.085
0.881
0.688
0.997
0.966
0.443

Table 3.1: Statistics for quantitative analyses (continued)
Mesencephalon
Brain Region
Sex and surgery difference
Dorsomedial PAG (DMPAG)
Dorsal raphe, dorsal (DRD)
Dorsal raphe, caudal (DRC)
Interfascicular nucleus (IF),
rostral
Interfascicular nucleus (IF),
middle
Interfascicular nucleus (IF),
caudal
parainterfascicular nucleus (PIF)
Ventral tegmental area (VTA)
Surgery difference only
Dorsal raphe, dorsolateral
(DRDL)
Substantia nigra pars reticulata
(SNR)
Ventrolateral PAG (VLPAG),
rostral
Female > Male sex difference
Lateral parabrachial nucleus
(LPB)
Medial parabrachial nucleus
(MPB)
Midbrain reticular formation
(mRT)
Ventrolateral PAG (VLPAG),
caudal
No differences
Ventrolateral PAG (VLPAG),
middle

F
(1, 37)
25.392
(1, 36)
14.012
(1, 37)
8.966
(1, 33)
17.284
(1, 38)
3.207
(1, 38)
7.074
(1, 37)
2.919
(1, 34)
1.489

Anterior tegmental nucleus
(ATg)

<0.001
0.001
0.005
<0.001
0.081
0.011
0.096
0.231

(1, 37)
0.057
(1, 34)
0.377
(1, 37)
1.212

0.813

(1, 36)
9.366
(1, 36)
13.907
(1, 38)
7.936
(1, 35)
4.261

0.004

(1, 36)
0.31

0.581

Metencephalon
Brain Region
Sex and surgery difference
Median raphe nucleus (MnR)

Sex
p

F
(1, 36)
7.199
(1, 37)
13.499

0.543
0.278

0.001
0.008
0.046

Sex
p
0.011
0.001
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F

Surgery
p

(1, 37)
89.961
(1, 36)
113.42
(1, 37)
28.34
(1, 33)
67.777
(1, 38)
84.42
(1, 38)
29.832
(1, 37)
63.963
(1, 34)
124.38

<0.001
<0.001
<0.001
<0.001
<0.001
<0.001
<0.001
<0.001

(1, 37)
72.525
(1, 34)
37.615
(1, 37)
16.301

<0.001

(1, 36)
0.002
(1, 36)
0.417
(1, 38)
0.067
(1, 35)
2.457

0.964

<0.001
<0.001

0.523
0.797
0.126

F

Interaction
p

(1, 37)
33.832
(1, 36)
15.886
(1, 37)
8.438
(1, 33)
27.318
(1, 38)
8.252
(1, 38)
0.074
(1, 37)
11.229
(1, 34)
13.978

<0.001
<0.001
0.006
<0.001
0.007
0.787
0.002
0.001

(1, 37)
2.846
(1, 34)
3.621
(1, 37)
<0.001

0.1

(1, 36)
0.172
(1, 36)
1.044
(1, 38)
0.218
(1, 35)
0.164

0.681

0.066
0.996

0.314
0.643
0.688

(1, 36)
0.804
0.063
Surgery
F
p

(1, 36)
0.988
<0.001
Interaction
F
p

(1, 36)
56.013
(1, 37)
48.195

(1, 36)
7.131
(1, 37)
12.298

<0.001
<0.001

0.011
0.001

Table 3.2: Vasopressin-ir fibers in the telencephalon
Summary of vasopressin-ir fibers throughout the telencephalon.
Data are grouped by region and then by sensitivity to steroids. Vasopressin
immunoreactivity either decreased or did not change following
gonadectomy (GDX). A qualitative increase in vasopressin-ir fibers was not
observed in any area. In the intact and GDX columns, letters indicate the
relative density of staining: F, fibers; T, terminals; sp, sparse; sc, scattered;
m, moderate; d, dense; -0-, no fibers observed.

Cortex

Intact

GDX

Steroid-Sensitive: Decrease in Vasopressin Immunoreactivity
Dorsolateral entorhinal
F(sp-sc)
F(sp)
cortex
Ventral endopiriform
claustrum (VEn)

F(sp-sc)

F(sp)

No Change in Vasopressin Immunoreactivity
Cingulate Cortex
F(sp)
F(sp)
Dorsal endopiriform
F(sp)
F(sp)
nucleus (DEn)
Dorsal peduncular cortex
(DP).

F(sp)

F(sp)

Ectorhinal cortex.
Frontal cortex
Infralimbic (IL)
Insular Cortex
Medial orbital cortex
(MO)

F(sp)
F(sp)
F(sp)
F(sp)
F(sp)

F(sp)
F(sp)
F(sp)
F(sp)
F(sp)

Piriform cortex (Pir)
Prelimbic cortex (PrL)

F(sp)
F(sp)

F(sp)
F(sp)

Hippocampus

Intact

GDX

Steroid-Sensitive: Decrease in Vasopressin Immunoreactivity
Lacunosum moleculare
F(sp-sc)
F(sp)
(LMol)
Oriens layer
hippocampus

F(sc)

-0-

Ventral Subiculum

F(sp-sc)

-0-

Fimbria

No Change in Vasopressin Immunoreactivity
F(sp)
F(sp)
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Table 3.2: Vasopressin-ir fibers in the telencephalon (Continued)
Basal
Ganglia

Intact

GDX

Steroid-Sensitive: Decrease in Vasopressin Immunoreactivity
Ventral Pallidum (VP)
F(sp-d)
F(sp)
No Change in Vasopressin Immunoreactivity
Nucleus Accumbens
F(sp-sc)
F(sp-sc)

Septal
Complex

Intact

GDX

Steroid-Sensitive: Decrease in Vasopressin Immunoreactivity
Lateral septal nucleus,
F(sc-d)
F(sp-sc)
intermediate part (LSI)
T(sc-d)
Lateral septal nucleus,
ventral part (LSV)

F(sc-d)
T(sc-d)

F(sp-sc)

Septofimbrial nucleus
(SFi)

F(sp-sc)

F(sp)

Septohypothalamic
nucleus (SHy)

F(sc-m)
T(sc-m)

F(sp-sc)

No Change in Vasopressin Immunoreactivity
Lateral septal nucleus,
F(sp)
F(sp)
dorsal part (LSD)
Rostral lateral septum
(LSD, I, & V)

F(sp-sc)

F(sp-sc)

Subfornical organ (SFO)
Triangular septal nucleus
(TS)

F(sp)
F(sp)

F(sp)
F(sp)

Ventral
Forebrain

Intact

GDX

Steroid-Sensitive: Decrease in Vasopressin Immunoreactivity
Navicular postolfactory
F(sp-sc)
F(sp)
cortex (Nv)
Substantia Innominata
(SI)

F(sp-d)

F(sp)

Ventral Septal Area
F(m-d)
F(sp)
No Change in Vasopressin Immunoreactivity
Dorsal tenia tecta
F(sp-sc)
F(sp-sc)
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Table 3.2: Vasopressin-ir fibers in the telencephalon (continued)

BNST

Intact

GDX

Steroid-Sensitive: Decrease in Vasopressin Immunoreactivity
Anteromedial BNST
F(m)
F(sc)
(STMA)
T(m)
Lateroventral BNST
(STLV)

F(sp-sc)
T(sc)

F(sp-sc)

Posterointermediate
BNST (STMPI)

F(sc-m)
T(sc-m)

F(sp)

Nucleus of the stria
medullaris (SM)

F(sc)

F(sp)

Posterolateral medial
BNST (STMPL)

F(sc-m)
T(sc-m)

F(sp-sc)

Posteromedial BNST
(STMPM)

F(m-d)
T(m-d)

F(sc)
T(sc)

No Change in Vasopressin Immunoreactivity
IPAC
F(sp)
F(sp)
Juxtacapsular BNST
F(sp)
F(sp)
(STLJ)
Laterodorsal BNST
(STLD)

F(sp)

F(sp)

Lateroposterior BNST
(STLP)

F(sp)

F(sp)

Medioventral BNST
(STMV)

F(sc-m)

F(sc-m)
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Table 3.2: Vasopressin-ir fibers in the telencephalon (continued)

Amygdala

Intact

GDX

Steroid-Sensitive: Decrease in Vasopressin Immunoreactivity
Anterior amygdaloid area F(sp-sc)
F(sp)
(AA)
Anterior cortical
amygdala (ACo)

F(sc-m)
T(sc-m)

F(sp)

Anterodorsal medial
amygdala (MeAD)

F(m-d)
T(m-d)

F(sp)

Anterolateral
amygdalohippocampal
area (AHiAL)
Anteroventral medial
amygdala (MeAV)

F(m)
T(m)

-0-

F(sc)
T(sc)

F(sp)

Basomedial amygdala
(BMA)

F(sc)
T(sc)

F(sp)

Basolateral, posterior
(BLP)

F(sp-sc)
T(sp-sc)

-0-

Extended amygdala (EA)

F(m)
T(m)

F(sp)

Intraamygdalar division
of stria terminalis (STIA)

F(sp)
T(sp)

F(sp)

IPACM / IPACL
Posterodorsal medial
amygdala (MePD)

F(sp) T(sp)
F(m-d)
T(m-d)

F(sp)
F(sp)

Posterolateral cortical
amygdala (PLCo)

F(sc)
T(sc)

F(sp)

Posteroventral medial
amygdala (MePV)

F(sc-m)
T(sc-m)

F(sp)

No Change in Vasopressin Immunoreactivity
Central amygdala (CeA)
F(sp)
F(sp)
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Table 3.3: Vasopressin-ir fibers in the diencephalon: Hypothalamus
Summary of vasopressin-ir fibers throughout the diencephalon:
hypothalamus. Data are grouped by region and then by sensitivity to
steroids. Vasopressin immunoreactivity either decreased or did not change
following gonadectomy (GDX). A qualitative increase in vasopressin-ir
fibers was not observed in any area. In the intact and GDX columns, letters
indicate the relative density of staining: F, fibers; T, terminals; sp, sparse;
sc, scattered; m, moderate; d, dense; -0-, no fibers observed.

Hypothalamus

Intact

GDX

Steroid-Sensitive: Decrease in Vasopressin Immunoreactivity
Preoptic Region
Lateral preoptic area
F(sp-m)
F(sp)
(LPO)
T(sp-m)
Medial part of medial
preoptic nucleus
(MPOM)
Medial preoptic area
(MPA)

F(sc-m)
T(sc-m)

F(sp-sc)
T(sp)

F(sc-m)
T(sc-m)

F(sp)

Median preoptic nucleus
(MnPO)

F(m)
T(m)

F(sp-m)

Parastrial nucleus (PS)

F(d)
T(d)

F(sp-sc)

Anterior Hypothalamic Region
Anterior hypothalamus,
F(sp-d)
F(sp-sc)
anterior (AHA)
T(sp-m)
Mammillary Body Region
Dorsal tuberomammillary F(d)
F(sc)
nucleus (DTM)
T(d)
T(sp)
Medial retromammillary
nucleus (RMM)

F(sc)
T(sc)

F(sp-sc)

Perifornical nucleus
(PeF)

F(m-d)
T(m-d)

F(sc-m)

Posterior hypothalmaus
(PH)

F(sp-sc)

F(sp)

Ventral premammillary
nucleus (PMV)

F (sp-sc)
T (sp)

F(sp)

Ventral
tuberomammillary
nucleus (VTM)

F(d)
T(d)

F(sp-sc)
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Table3.3: Vasopressin-ir fibers in the diencephalon: Hypothalamus (Continued)
Hypothalamus
Cont.

Intact

GDX

Lateral Hypothamalic Region
Lateral hypothalamus
F(sc-d)
F(sp-sc)
(LH)
T(sc-d)
Peduncular part of the
lateral hypothalamus
(PLH)
Perifornical lateral
hypothalamus (PeFLH)

F(m-d)
T(m-d)

F(sp-d)

F(m-d)
T(m-d)

F(sp-sc)

No Change in Vasopressin Immunoreactivity
Preoptic Region
Anteroventral
F(sc-d)
F(sc-d)
periventricular Area
T(sc-d)
T(sc-d)
(AVPe)
Periventricular
F(sc-d)
F(sc-d)
hypothalamic nucleus
T(m-d)
T(m-d)
(Pe)
Striohypothalamic
F(sc)
F(sc)
nucleus (StHy).
T(sc)
T(sc)
Vascular organ of the
lamina terminalis
(VOLT)
Ventrolateral preoptic
area (VLPO)

F(sc)

F(sc)

F(sc)
T(sc)

F(sc)
T(sc)

Ventromedial preoptic
nucleus (VMPO)

F(sc)

F(sc)

Anterior Hypothalamic Region
Anterior hypothalamus,
F(m-d)
F(m-d)
central (AHC)
Lateroanterior
hypothalamus (LA)

F(sp-sc)

F(sp-sc)

Paraventricular nucleus
(PVN)

F(m-d)
T(sc-m)

F(m-d)
T(sc-m)

Parvicellular
paraventricular
hypothalamus (PaAP)
Periventricular region
(Pe)

F(d)
T(d)

F(d)
T(d)

F(d)
T(d)

F(d)
T(d)

Retrochiasmatic area
(RCh)

F(sc-d)
T(sc-d)

F(sc-d)
T(sc-d)

Subparaventricular zone
(SPa).

F(d)
T(d)

F(d)
T(d)

Suprachiasmatic nucleus
(SCN)

F(m-d)
T(m-d)

F(m-d)
T(m-d)
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Table 3.3: Vasopressin-ir fibers in the diencephalon: Hypothalamus (Continued)
Hypothalamus
Cont.

Intact

GDX

Supraoptic commissure
(sox)

F(sc)

F(sc)

Tuberal lateral
hypothalamus (TuLH)

F(m-d)

F(m-d)

Dorsomedial Hypothalamic Nucleus
Arcuate nucleus (Arc)
F(sp-sc)
F(sp-sc)
T(sp-sc)
T(sp-sc)
Dorsomedial
hypothalamus (DMH)

F(sc-d)
T(sc-d)

F(sc-d)
T(sc-d)

Medial tuberal
hypothalamus (MTu)

F(sp-d)

F(sp-d)

Ventromedial
hypothalamus (VMH)

F(sp)

F(sp)

Zona incerta (ZI)

F(sp)
F(sp)
Mammillary Body Region
Dorsal hypothalamic area F(sp)
F(sp)
(DA)
Lateral retromammillary
nucleus (RML)

F(sp-sc)

F(sp-sc)

Endopeduncular nucleus
(EP)

F(sp-sc)

F(sp-sc)
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Table 3.4: Vasopressin-ir fibers in the diencephalon: Thalamus
Summary of vasopressin-ir fibers throughout the diencephalon:
thalamus. Data are grouped by sensitivity to steroids. Vasopressin
immunoreactivity either decreased or did not change following
gonadectomy (GDX). A qualitative increase in vasopressin-ir fibers was not
observed in any area. In the intact and GDX columns, letters indicate the
relative density of staining: F, fibers; T, terminals; sp, sparse; sc, scattered;
m, moderate; d, dense; -0-, no fibers observed.

Thalamus

Intact

GDX

Steroid-Sensitive: Decrease in Vasopressin Immunoreactivity
Central medial thalamic
F(sc-m)
F(sp)
nucleus (CM)
T(sc-m)
Interanterodorsal
thalamic nucleus (IAD)

F(m)
T(m)

-0-

Interanteromedial
thalamic nucleus (IAM)

F(m)
T(m)

-0-

Lateral habenular nucleus
(LHb)

F(sc-d)
T(sc-d)

-0-

Mediodorsal thalamic
nucleus (MD)

F(d)
T(d)

F(sp)
T(sp)

Paracentral thalamus
(PC)

F(m)
T(m)

-0-

Paratenial thalamus (PT)

F(sp-sc)
T(sp-sc)

F(sp)
T(sp)

Rhomboid thalamic
nucleus (Rh)

F(sp-sc)
T(sp-sc)

F(sp)

No Change in Vasopressin Immunoreactivity
Paraventricular thalamic
F(sc-d)
F(sc-d)
nucleus, anterior (PVA)
T(sc-d)
T(sc-d)
Paraventricular thalamic
nucleus, middle (PV)

F(sc-m)
T(sc-m)

F(sc-m)
T(sc-m)

Paraventricular thalamic
nucleus, posterior (PVP)

F(sp-sc)
T(sp-sc)

F(sp-sc)
T(sp-sc)

Reticular nucleus (Rt)
Reuniens thalamic
nucleus (Re)

F(sp)
F(sp-sc)
T(sp)

F(sp)
F(sp-sc)
T(sp)

Xiphoid nucleus (Xi)

F(sc-m)
T(sc-m)

F(sc-m)
T(sc-m)
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Table 3.5: Vasopressin-ir fibers in the mesencephalon
Summary of vasopressin-ir fibers throughout the mesencephalon.
Data are grouped by region and then by sensitivity to steroids. Vasopressin
immunoreactivity either decreased or did not change following
gonadectomy (GDX). A qualitative increase in vasopressin-ir fibers was not
observed in any area. In the intact and GDX columns, letters indicate the
relative density of staining: F, fibers; T, terminals; sp, sparse; sc, scattered;
m, moderate; d, dense; -0-, no fibers observed.
PAG and
dorsal raphe

Intact

GDX

Steroid-Sensitive: Decrease in Vasopressin Immunoreactivity
Commissure of the
F(sp-sc)
F(sp)
superior colliculus (csc)
T(sp-sc)
Dorsal raphe, caudal
(DRC)

F(sp-m)
T(sp-m)

F(sp-m)

Dorsal raphe, dorsal
(DRD)

F(sp-d)
T(sp-d)

F(sp-sc)

Dorsolateral PAG
(DLPAG)

F(sp-sc)
T(sp-sc)

F(sp-sc)

Dorsomedial PAG
(DMPAG)

F(m-d)
T(m-d)

F(sp-sc)

Periaqueductal gray,
rostral (PAG)

F(sp-sc)
T(sp)

F(sp-sc)

Ventrolateral dorsal raphe
(DRVL)

F(m-d)
T(m-d)

F(sp-sc)

Ventrolateral PAG
(VLPAG)

F(sc-d)
T(sp-sc)

F(sc-d)

No Change in Vasopressin Immunoreactivity
Dorsal raphe,
F(sp-sc)
F(sp-sc)
interfascicular (DRI)
Dorsal raphe, ventral
(DRV)

F(sp-sc)

F(sp-sc)

Lateral PAG (LPAG)

F(sp-sc)

F(sp-sc)

Tegmentum

Intact

GDX

Steroid-Sensitive: Decrease in Vasopressin Immunoreactivity
Caudal linear raphe (CLi) (Fsp-m)
F(sp-sc)
Interfascicular nucleus
F(sc-d)
F(sp)
(IF)
T(sc-d)
Medial retromammillary
nucleus (RMM)

F(sp-sc)
T(sp-sc)
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F(sp)

Table 3.5: Vasopressin-ir fibers in the mesencephalon (continued)
Tegmentum
Cont.

Intact

GDX

Parabrachial pigmented
nucleus of the VTA
(PBP)
Parainterfascicular
nucleus (PIF)

F(sp-sc)
T(sp)

F(sp-sc)

F(sp-d)
T(sp-d)

F(sp-sc)

Retrorubral field (RRF)

F(sp-m)
T(sp-m)

F(sp-sc)

Substantia nigra pars
compacta (SNC)

F(sc-m)
T(sp-m)

F(sp-sc)

Substantia nigra, lateral
part (SNL)

F(sc-m)
T(sp-m)

F(sp-sc)

Substantia nigra pars
reticulata (SNR) ventromedial tip
Ventral tegmental area
(VTA)

F(sp-sc)
T(sp-sc)

F(sp)

F(sc-m)
T(sc-m)

F(sp-sc)

No Change in Vasopressin Immunoreactivity
Barrington's nucleus
F(sc-m)
F(sc-m)
(Bar)
Lateral parabrachial
(LPB)

F(sc-m)

F(sc-m)

Locus coeruleus (LC)
Medial parabrachial
(MPB)

F(sc-m)
F(sp-sc)

F(sc-m)
F(sp-sc)

Midbrain reticular
formation (mRt)

F(sp-sc)

F(sp-sc)

Parasubthalamic nucleus
(PSTh)

F(sp-sc)

F(sp-sc)

Peripeduncular nucleus
(PP)

F(sp)

F(sp)

Rostral linear raphe (RLi)
Subthalamic nucleus
(STh)

F(sp)
F(sp)

F(sp)
F(sp)

Zona incerta (ZI)

F(sc)

F(sc)
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Table 3.6: Vasopressin-ir fibers in the metencephalon and myelencephalon
Summary of vasopressin-ir fibers throughout the metencephalon
and Myelencephalon. Data are grouped by region and then by sensitivity to
steroids. Vasopressin immunoreactivity either decreased or did not change
following gonadectomy (GDX). A qualitative increase in vasopressin-ir
fibers was not observed in any area. In the intact and GDX columns, letters
indicate the relative density of staining: F, fibers; T, terminals; sp, sparse;
sc, scattered; m, moderate; d, dense; -0-, no fibers observed.

Metencephalon

Intact

GDX

Steroid-Sensitive: Decrease in Vasopressin Immunoreactivity
Anterior tegmental
F(sp-sc)
-0nucleus (ATg)
T(sp-sc)
Median raphe (MnR)

F(sp-sc)
T(sp-sc)

Myelencephalon

-0-

Intact

GDX

No Change in Vasopressin Immunoreactivity
Gigantocellular reticular
F(sp-sc)
F(sp-sc)
nucleus, alpha part (GiA)
Gigantocellular reticular
n., ventral part (GiV)

F(sp-sc)

F(sp-sc)

Intermediate reticular
formation (IRt)

F(sp-sc)

F(sp-sc)

Lateral reticular n. (LRt)
Parvicellular reticular n.,
alpha part (PCRtA)

F(sp-m)
F(sp)

F(sp-m)
F(sp)

Raphe interpositus
nucleus (RIP)

F(sp)

F(sp)

Raphe magnus nucleus
(RMg)

F(sp-sc)

F(sp-sc)

Raphe obscurus nucleus
(ROb)

F(sp)

F(sp)

Raphe pallidus nucleus
(RPa)

F(sp-sc)

F(sp-sc)

Spinal trigeminal n.,
caudal part (Sp5C)

F(sp-m)

F(sp-m)

Solitary nucleus (Sol)
Subcoeruleus nuclei
(SubC)

F(sc-d)
F(sp)

F(sc-d)
F(sp)

Supermedullary vellum
(SMV)

F(sp)

F(sp)
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3.5 Figure legends
Figure 3.1: Regions chosen for quantitative analysis
All regions analyzed were chosen based on characteristic corresponding to atlas
images images from The Mouse Brain (Franklin and Paxinos, 2008). Modified images
from that atlas are used to illustrate regions analyzed. Location associated figure (graph)
is given for each area.
2Cb, lobule 2 of the cerebellar vermis; 3V, 3rd ventricle; 4V, 4th ventricle; ac,
anterior commissure; Aq, aqueduct; cp, cerebral peduncle; D3V, dorsal 3rd ventricle; f,
fornix; fr, fasciculus retroflexus; ic, internal capsule; IPF, interpeduncular fossa; LV,
lateral ventricle; mcp, middle cerebellar peduncle; ml, medial lemniscus; mlf, medial
longitudinal fasciculus; MRe, mammillary recess of the 3rd ventricle; mt,
mammillothalamic tract; opt, optic tract; pm, principal mammillary tract; scp, superior
cerebellar peduncle; sm, stria medullaris; SNR, substantia nigra, reticular part; ts,
tectospinal tract; xscp, decussation of the superior cerebellar peduncle
A)

B)

C)
D)
E)
F)
G)
H)
I)

J)

J)

K)

i. medioventral BNST ..................................................................................3.3A
ii. median preoptic nucleus ..........................................................................3.5A
iii. vascular organ of the lamina terminalis..................................................3.5A
iv. medial preoptic area...............................................................................3.5A
i. lateral septum, intermediate........................................................................3.2
ii. lateral septum, ventral.................................................................................3.2
iii. anteromedial BNST ................................................................................3.3A
i. medioventral BNST ..................................................................................3.3A
ii. medial part of medial preoptic nucleus....................................................3.5B
i. lateral septum, caudal ..................................................................................3.2
i. lateroventral BNST ...................................................................................3.3A
ii. medial part of medial preoptic nucleus....................................................3.5B
i. medial part of medial preoptic nucleus.....................................................3.5B
i. medial posteromedial BNST.....................................................................3.3B
i. medial posterolateral BNST......................................................................3.3B
ii. anterior paraventricular nucleus ..............................................................3.6A
i. anterior paraventricular nucleus, dorsal....................................................3.6A
ii. mediodorsal thalamus, rostral..................................................................3.6C
iii. paratenial thalamus .................................................................................3.6B
iv. anterior paraventricular thalamus. ventral ..............................................3.6A
i. nucleus of the stria medullaris ..................................................................3.3B
ii. extended amygdala, rostral ......................................................................3.4A
iii. peduncular lateral hypothalamaus ..........................................................3.5D
iv. anterior hypothalamus, anterior ..............................................................3.5C
i. peduncular lateral hypothalamus ..............................................................3.5D
ii. anterior hypothalamus, central.................................................................3.5C
iii. subparaventricular zone.......................................................................... 3.5E
i. extended amygdala ...................................................................................3.4A
ii. anterodorsal medial amygdala .................................................................3.4C
iii. anterior cortical amygdala ......................................................................3.4B
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L)

M)

N)
O)

P)

Q)

R)
S)
T)
U)

V)
W)

X)
Y)
Z)
AA)

BB)
CC)

DD)
EE)
FF)

i. paraventricular thalamus...........................................................................3.6D
ii. mediodorsal thalamus ..............................................................................3.6C
iii. central medial thalamus .......................................................................... 3.6E
i. mediodorsal thalamus ...............................................................................3.6C
ii. paraventricular thalamus..........................................................................3.6D
iii. central medial thalamus ......................................................................... 3.6E
i. peduncular lateral hypothalamus ..............................................................3.5D
ii. anterior hypothalamus, central.................................................................3.5C
i. mediodorsal thalamus ...............................................................................3.6C
ii. paraventricular thalamus..........................................................................3.6D
iii. central medial thalamus .......................................................................... 3.6E
i. tuberal lateral hypothalamus..................................................................... 3.5F
ii. periventricular nucleus............................................................................. 3.5E
iii. retrochiasmatic nucleus ..........................................................................3.5H
i. basomedial amygdala................................................................................ 3.4E
ii. anterodorsal medial amygdala .................................................................3.4C
iii. anterior cortical amygdala ......................................................................3.4B
iv. anteroventral medial amygdala...............................................................3.4D
i. tuberal lateral hypothalamus..................................................................... 3.5F
i. lateral habenula ......................................................................................... 3.6F
ii. interanterodorsal thalamus....................................................................... 3.6E
i. dorsomedial hypothalamus .......................................................................3.5G
i. ventral basolateral amygdala .................................................................... 3.4E
ii. posterodorsal medial amygdala ............................................................... 3.4F
iii. posteroventral medial amygdala.............................................................3.4D
i. lateral habenula ......................................................................................... 3.6F
i. peduncular lateral hypothalamus ..............................................................3.5D
ii. dorsomedial hypothalamus ......................................................................3.5G
iii. tuberal lateral hypothalamus................................................................... 3.5F
i. posterodorsal medial amygdala ................................................................ 3.4F
i. lateral habenula ......................................................................................... 3.6F
i. posterior basolateral amygdala ................................................................. 3.4E
ii. posterodorsal medial amygdala ............................................................... 3.4F
i. medial retromammillary nucleus ............................................................... 3.5I
ii. ventral premammillary nucleus ...............................................................3.5H
iii. perifornical lateral hypothalamus ...........................................................3.5H
i. medial retromammillary nucleus ............................................................... 3.5I
ii. ventral tuberomammillary nucleus ..........................................................3.5H
i. substantia nigra pars reticulata..................................................................3.7D
ii. ventral tegmental area..............................................................................3.7D
iii. interfascicular nucleus ............................................................................ 3.7E
iv. medial retromammillary nucleus ............................................................. 3.5I
i. interfascicular nucleus .............................................................................. 3.7E
ii. parainterfascicular nucleus ......................................................................3.7D
i. dorsomedial periaqueductal gray ..............................................................3.7A
i. midbrain reticular formation..................................................................... 3.7F
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GG)
HH)
II)
JJ)
KK)
LL)

i. interfascicular nucleus .............................................................................. 3.7E
i. anterior tegmental nucleus ...........................................................................3.8
i. ventrolateral periaqueductal gray..............................................................3.7B
ii. dorsolateral raphe nucleus .......................................................................3.7C
i. median raphe nucleus...................................................................................3.8
i. ventrolateral periagueductal gray..............................................................3.7B
ii. dorsal raphe, dorsal part...........................................................................3.7C
i. ventrolateral periaqueductal gray..............................................................3.7B
ii. dorsal raphe, caudal .................................................................................3.7C
iii. lateral parabrachial nucleus .................................................................... 3.7F
iv. medial parabrachial nucleus.................................................................... 3.7F

Figure 3.2: Quantitative results: Lateral septum
Significant main effects are shown with labeled bars. In cases where post-hoc
tests were carried out, letters are used to illustrate significant differences between groups
(p < 0.05). Different letters indicate group differences.
Figure 3.4: Quantitative results: Amygdala
Significant main effects are shown with labeled bars. In cases where post-hoc
tests were carried out, letters are used to illustrate significant differences between groups
(p < 0.05). Different letters indicate group differences.
Figure 3.5: Quantitative results: Hypothalamus
Significant main effects are shown with labeled bars. In cases where post-hoc
tests were carried out, letters are used to illustrate significant differences between groups
(p < 0.05). Different letters indicate group differences.
Figure 3.6: Quantitative results: Thalamus
Significant main effects are shown with labeled bars. In cases where post-hoc
tests were carried out, letters are used to illustrate significant differences between groups
(p < 0.05). Different letters indicate group differences.
Figure 3.7: Quantitative results: Mesencephalon
Significant main effects are shown with labeled bars. In cases where post-hoc
tests were carried out, letters are used to illustrate significant differences between groups
(p < 0.05). Different letters indicate group differences.
Figure 3.8: Quantitative results: Metencephalon
Significant main effects are shown with labeled bars. In cases where post-hoc
tests were carried out, letters are used to illustrate significant differences between groups
(p < 0.05). Different letters indicate group differences.
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Figure 3.1: Regions chosen for quantitative analysis
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Figure 3.1: Regions chosen for quantitative analysis (Continued)
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Figure 3.1: Regions chosen for quantitative analysis (Continued)
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Figure 3.1: Regions chosen for quantitative analysis (Continued)
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Figure 3.1: Regions chosen for quantitative analysis (Continued)
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Figure 3.2: Quantitative results - Lateral septum
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Figure 3.3: Quantitative results - BNST
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Figure 3.4: Quantitative results - Amygdala
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Figure 3.4: Quantitative results - Amygdala (Continued)
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Figure 3.5: Quantitative results - Hypothalamus
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Figure 3.5: Quantitative results - Hypothalamus (Continued)
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Figure 3.5: Quantitative results - Hypothalamus (Continued)
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Figure 3.6: Quantitative results - Thalamus
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Figure 3.6: Quantitative results - Thalamus (Continued)
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Figure 3.7: Quantitative results - Mesencephalon
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Figure 3.7: Quantitative results - Mesencephalon (Continued)
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Figure 3.8: Quantitative results - Metencephalon
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CHAPTER 4
INTRACRANIAL STEROID IMPLANTS AS AN ANATOMICAL TOOL

4.1 Introduction
Vasopressin neurons in the BNST and MeA project to numerous distinct areas
throughout the brain. Many of these projections are sexually dimorphic and project to
brain regions implicated in the control or modulation of social behavior (reviewed briefly
in CHAPTER 3). Using the steroid-dependent nature of neurons in the BNST and MeA,
we have identified a subset of brain regions innervated by these two nuclei, creating a
more well-defined picture of the telencephalic vasopressin system as a whole. However,
delineation of the independent projections of the BNST and MeA remains to be
elucidated.
In the rat, the BNST and MeA are both sensitive to circulating gonadal steroid
hormones, and gonadectomy results in a loss of immunoreactivity in their projections (de
Vries et al., 1984; De Vries and al-Shamma, 1990; De Vries et al., 1994). A similar
gonadal steroid dependence is likely for the BNST and MeA of the mouse. Thus other
approaches must be taken to isolate each region's independent subset of projection sites.
One such approach used with some success historically is brain lesions. In particular,
large unilateral electrolytic lesions of the medial amygdala eliminated vasopressin
immunoreactivity in the ventral hippocampus and decreased immunoreactivity in the
lateral septum (Caffe et al., 1987). In addition, these lesions did not appear to impact
vasopressin immunoreactivity in the lateral habenula, mediodorsal thalamus, ventral
tegmental area, central gray, dorsal raphe nuclei, or locus coeruleus (Caffe et al., 1987).
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Unilateral electrolytic lesions of the BNST in rats led to a decrease in vasopressin
immunoreactivity in the lateral septum, ventral diagonal band, anterior amygdala, lateral
habenula, periventricular gray and locus coeruleus (De Vries and Buijs, 1983). One
caveat with electrolytic lesions is the destruction of fibers of passage. This is especially
poignant when discussing the BNST and MeA, which share extensive bidirectional
projections (Simerly, 2002; Cooke and Simerly, 2005). Thus vasopressin-ir fibers
passing through either of these areas would be damaged during lesioning and site of
origin could be misinterpreted. This caveat could be avoided by using excitoxic lesions,
which spare fibers of passage. However, vasopressin cells in the BNST, especially, are
spread across a large region. In order to kill the correct cells, a large region must be
damaged, and the potential for spread of neurotoxin would be high.
Given the potential problems with using lesions to determine BNST and MeA
projections, we returned to the idea that the steroid sensitivity of BNST or MeA neurons
can be manipulated. Even though gross hormone manipulations, such as gonadectomy,
would not be effective for sorting projections of the medial amygdala and BNST, we
reasoned that hormones delivered locally could rescue vasopressin immunoreactivity in
one nucleus (i.e., BNST or MeA) without affecting the other in a gonadectomized animal.
Previous research showed that testosterone melted into a cannula aimed at the BNST is
able to restore vasopressin gene expression unilaterally in the BNST as measured by
vasopressin mRNA expression (Brot et al., 1993). In another study carried out in musk
shrews, local steroid implants made of steroid hormone, bone wax, and graphite were
placed in specific brain regions in order to examine regional effects of hormones on sex
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behavior. In this experiment, spread of hormone was demonstrated to be local and
unilateral at one week following implantation (Veney and Rissman, 2000).
In the current study, we used steroid hormone implants similar to those used by
Veney and Rissman (2000) in an attempt to selectively restore vasopressin expression to
the BNST following long-term gonadectomy. We predicted that steroid hormones
delivered directly to the BNST would result in a restoration of vasopressin
immunoreactivity in a subset of fibers known to be innervated by the BNST or MeA.
Surprisingly testosterone proprionate implants did not restore vasopressin
immunoreactivity after a survival time of four weeks post-implantation. This unforeseen
result forced us to reevaluate our implant strategy. Below we chronicle the work carried
out to optimize the implantation of steroid hormones in the BNST.
4.2 Methods
4.2.1 Animals
Male C57BL6 mice were studied in this experiment. Animals were derived from
a breeding colony at the University of Massachusetts. Following weaning, animals were
group-housed (5 or less per cage) with same-sex siblings under a 14:10 light cycle with
lights on at 6:00 am. Animals had ad libitum access to food and water. All procedures
conformed to NIH guidelines and were in accordance with a protocol approved by the
University of Massachusetts.
4.2.2 Gonadectomy surgeries
At approximately 60 days of age, animals underwent bilateral gonadectomy.
Surgical procedures were similar to those described above (see CHAPTER 3.2.2).
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4.2.3 Intracranial implants
Animals were anesthetized with 2% isoflurane (Halocarbon Laboratories, River
Edge, NJ) prior to being placed in a Kopf stereotaxic apparatus and received 2%
isoflurane for the duration of the surgery. After exposing the skull, a hole was drilled at
0.1 mm to the right of the midline and 0.03mm caudal to bregma (Experiment 1) or 0.09
mm to the right and 0.05mm (Experiments 3a-3c). A 26 gauge stainless steel cannula
that projected 4 mm below a plastic pedestal (Plastics One, Roanoke, VA) was used to
deliver implants. Implants were a mix of bone wax (Lukens, Reading, PA), graphite, and
steroid hormone (implant specifications are given below with experimental designs). To
place the implant, the cannula was lowered until the pedestal touched the skull, and a 33
gauge inner cannula, which projected 1mm past the end of the guide, was used to
dislodge the implant from the guide. Immediately after placing the implant, the guide
and inner cannula were removed, the hole in the skull was patched with bone wax, and
the wound was sutured closed. Animals received an injection of buprenorphine (0.05
mg/Kg; Bedford Laboratories, Bedford, OH) immediately following surgery.
4.2.4 Subcutaneous implants
Animals were anesthetized with 2% isoflurane throughout the procedure. Briefly,
a small incision was made at the nape of the neck and a small silicone implant containing
either testosterone or estradiol (implant specifications are given below with experimental
designs) was placed under the skin. The wound was closed with a surgical staple.
Animals received an injection of buprenorphine (0.05 mg/Kg ) immediately following
surgery.
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4.2.5 Tissue collection and processing
One to four weeks following implant surgery, animals were sacrificed using CO 2
asphyxiation followed by rapid decapitation. For immunohistochemistry, brains were
removed rapidly and placed in 5% acrolein in 0.1 M phosphate buffer. Fixation lasted for
four hours at which time brains were transferred to 30% sucrose in 0.1M phosphate
buffer and stored at 4° C until sectioning. Brains were sectioned in the coronal plane at
30 Pm using a freezing microtome, and every third section was collected and stored in
cryoprotectant at -20° C prior to vasopressin immunohistochemistry. In addition, an
alternate series of sections were mounted on gel coated slides, allowed to dry at least
overnight, and Nissl stained. For in situ hybridization (Experiment 3c), brains were
removed rapidly and placed in 2-methyl butane, which had been stored on dry ice, for
approximately 10 sec and then stored at -80° C until sectioning. Brains were sectioned in
the coronal plane at 20 Pm using a cryostat. Every third section was collected and stored
at -80° C until processing for vasopressin in situ hybridization.
4.2.6 Nissl staining
Nissl staining methods are identical to those described in CHAPTER 2.2.3
4.2.7 Immunohistochemistry
Immunohistochemical methods used in this experiment are identical to those
described in CHAPTER 2.2.4 except the antibody used was from a new lot and a
concentration of 1:8000 was used.
4.2.8 In situ hybridization
Prior to hybridization, slides were soaked in the following rinses under gentle
agitation: 1) 4% paraformaldehyde in 0.1M sodium phosphate buffer at 4° C for 15 min;
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2) 0.1M phosphate buffered saline at 4° C for 2 min; 3) 0.1M triethanolamine buffer (pH
8.0) for 1 min at room temperature (remainder of rinses were done at room temperature
also); 4) 0.1M triethanolamine buffer (pH 8.0) with 2.5ul / ml acetic anhydride for 10
min; 5) 2x standard sodium citrate buffer (SSC, 0.3 M sodium chloride and 0.03 M
sodium citrate in distilled water, pH 7.0) for 1 min; 6) 70% ethanol for 2 min; 7) 100%
ethanol for 2 min; 8) chloroform for 5 min; 9) 100% ethanol for 2 min Hybridization was
carried out by adding 60 Pl of [35S] labeled probe in hybridization buffer (50%
formamide, 10% dextran sulfate, 0.3M NaCl, 10mM Tris, 1mM EDTA, 1x Denhardt’s
solution, 10 mM dithiothreitol) to each slide, covering the mixture with parafilm, and
incubating it at 37° C for 18 hours. All solutions for pre-hybridization steps were made
with DEPC-treated water. Following hybridization, slides were dipped in 1x SSC to
remove parafilm and hybridization buffer. Sections were rinsed in 1x SSC for 4 x 15 min
at 55° C. Subsequent rinses were done at room temperature in the following order: 1) 1x
SSC for 3 x 35 min; 2) 70% ethanol for 2 min; 3) 95% ethanol for 2 min; 4) 100%
ethanol for 2 min.
After verifying the hybridization by placing test slides against film, slides were
dipped in emulsion (NTB2, Kodak, Rochester, NY) and preheated for 1 hour in a 42° C
water bath. Once slides were dry, they were stored at 4° C in light tight boxes containing
desiccant capsules. Twenty-four days later, slides were developed in the following
solutions at 14° C: 1) Dektol-19 developer (Kodak, Rochester, NY) for 2 min; 2) distilled
water for 30 seconds; 3) fixer (Kodak, Rochester, NY) for 5 min; 4) distilled water for 5
min. Brain sections were then counterstained with methyl green: 1) slides were rinsed
under running water for 3 min; 2) 2% methyl green for 30 seconds; 3) running water for 1
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min; and 4) 2 rapid dips into 50% ethanol. Finally, slides were coverslipped using
Cytoseal (Richard Allen Scientific, Kalamazoo, MI).
4.2.9 Experimental designs
4.2.9.1 Experiment 1
Between 15 and 18 weeks following gonadectomy, animals received either
testosterone proprionate (TP; Sigma-Aldrich, St. Louis, MO) or control intracranial
implants. TP implants were made from bone wax, graphite, and TP (3:1:1 by weight).
Control implants contained bone wax and graphite (3:1 by weight). After mixing, the
wax mixture was pressed thin between two glass slides. Implant pellets were formed by
tapping a cannula into the wax five times.
Animals were euthanized at either two (n=4 TP and n=2 control) or four weeks
(n=4 TP and n=2 control) following implant surgery. Brains were collected and
processed for vasopressin immunohistochemistry as described above.
4.2.9.2 Experiment 2
Fifteen weeks following gonadectomy, animals received subcutaneous implants
of either testosterone (T) or estradiol (E 2) . T implants were made from silicone tubing
(0.062” ID / 0.125” OD, Helix Medical, Carpinteria, CA), totaled 7 mm in length, were
loaded with 3mm of T (Sigma-Aldrich, St. Louis, MO), and sealed with medical grade
silicone adhesive (Dow Corning, Midland, MI). E 2 implants were made from Silastic
tubing (1.57mm ID / 2.41mm OD, Dow Corning, Midland, MI), totaled 9 mm in length,
were packed with 5 mm of a 1:1 mixture of 17- estradiol and cholesterol, and sealed
with medical grade silicone adhesive (Dow Corning, Midland, MI).
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Animals were euthanized at either one (n=2 T and n=2 E 2 ), two (n=2 T and n=2
E 2) , or four weeks (n=2 T and n=2 E 2 ) following implant surgery. Brains were collected
and processed for vasopressin immunohistochemistry as described above.
4.2.9.3 Experiment 3a
Twenty weeks following gonadectomy, animals received either E 2 or control
intracranial implants. E 2 implants were made from bone wax, graphite, and E 2 (3:2:1 by
weight). Control implants contained bone wax and graphite (3:2 by weight). After
mixing, the wax mixture was pressed thin between two glass slides. Implant pellets were
formed by tapping a cannula into the wax five times.
Animals were euthanized four weeks following implant surgery (n=6 E 2 and n=2
control). Brains were collected and processed for vasopressin immunohistochemistry as
described above.
4.2.9.4 Experiment 3b
Twenty weeks following gonadectomy, animals received E 2 intracranial implants.
E 2 implants were made as described in experiment 3a except pellets were formed by
tapping a cannula a single time into the wax mixture.
Animals were euthanized one week following implant surgery (n=3 E 2 ). Brains
were collected and processed for vasopressin immunohistochemistry as described above.
4.2.9.5 Experiment 3c
Twelve months following gonadectomy, animals received either concentrated or
dilute E 2 intracranial implants. E 2 implants were made from bone wax, graphite, and E 2
(3:2:1 by weight for concentrated pellets and 3:2:0.1 by weight for dilute implants).
Implant pellets were formed by tapping a cannula into the wax mixture a single time.
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Animals were euthanized two weeks following implant surgery (n=3 E 2 ). Brains
were collected and processed for either vasopressin immunohistochemistry (n=1
concentrated ( 3:2:1) E 2 and n=2 dilute (3:2:0.1) E 2 ) or vasopressin in situ hybridization
(n=2 concentrated ( 3:2:1) E 2 and n=4 dilute (3:2:0.1) E 2 ) as described above.
4.3 Results and Conclusions
4.3.1 Experiment 1: Intracranial TP implants
As expected animals receiving control implants did not have any small caliber
fibers in the lateral septum, mediodorsal thalamus, or lateral habenula. In each case
implants were located near the BNST (Figure 4.1). TP was expected to cause an increase
in small vasopressin-ir fibers in the lateral septum, mediodorsal thalamus, and lateral
habenula; however, only a tiny fraction of normal immunoreactivity was restored. All TP
implants were located directly adjacent to or near the BNST (Figure 4.1). Animals killed
at both 2 weeks and 4 weeks had a few small faint fibers in the three areas examined.
However, as quantitative measures of vasopressin-ir fiber density for the caudal lateral
septum show, none of the males had a fiber density that reached the minimum for intact
males (see Figure 4.2 for data and photomicrographs). Data for intact males were
obtained from experiments described in CHAPTER 3. The most impressive subject had
only lightly stained fibers in the lateral septum (Figure 4.2C), lateral habenula, and
mediodorsal thalamus.
Although a small amount of immunoreactivity was observed following implant
surgery at both two and four weeks, it was not enough to provide conclusive evidence of
BNST derived projections throughout the brain, which was the intended goal. This
limited effect raised the question, "Why did the TP not adequately increase vasopressin
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production?" Several explanations could have led to our results. It may not be possible
to completely reestablish vasopressin production after long-term castration in mice.
Alternatively, the release of steroid from the pellet may have been inadequate or too fast
(i.e., removed from the system too quickly). Finally, it is possible that TP was not
efficiently converted to estrogens in long-term gonadectomized animals, which is
required for vasopressin production (De Vries et al., 1994).
In subsequent experiments, we attempted to address some of these possibilities.
First, we used subcutaneous hormone implants to see if we could actually reinstate
adequate levels of vasopressin production after long-term castration. Second we
attempted to stimulate vasopressin production with E 2 implants placed directly in the
BNST. The results of these experiments are given below.
4.3.2 Experiment 2: Subcutaneous T or E 2 implants
Both T and E 2 rescued vasopressin immunoreactivity at 1, 2, and 4 weeks
following subcutaneous capsule implantation (Figure 4.3). However, the amount of
immunoreactivity was quite low at 1 week. In fact, vasopressin-ir fiber density analysis
of the caudal lateral septum indicates that immunoreactivity at one week was lower than
the lowest intact male in a previous study (Figure 4.3G). T treated animals appeared to
be within a normal range by 2 weeks following implantation. E 2 animals had less
immunoreactivity at 2 weeks, but were similar to T treated animals by 4 weeks.
Based on these results, we concluded that both T and E 2 have the ability to rescue
vasopressin immunoreactivity in fibers of the lateral septum two weeks following steroid
exposure. Therefore we know that long term gonadectomy does not eliminate the
capability of vasopressin neurons to make protein in response to hormones.
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However, we still cannot conclude whether or not TP would have acted
differently than T, and we still cannot determine whether intracranial implants would be
as effective as a subcutaneous implant. However, because E 2 was also able to reinstate
fiber immunoreactivity and is the hormone most directly responsible for vasopressin
expression (De Vries et al., 1994), we decided to test the effectiveness of intracranial E 2
implants in order to resolve the question about the efficacy of intracranial implants.
4.3.3 Experiment 3a: Large E 2 implants in the BNST
All animals that received E 2 implants had vasopressin fibers in the lateral septum
and mediodorsal thalamus four weeks following implantation (Figure 4.6B). The two
control animals did not have any vasopressin-immunoreactivity in the septum or
mediodorsal thalamus (Figure 4.5A). A few of the implants were located in the thalamus
at the caudal end of the PVN (Figure 4.4). Because these subjects still had
immunoreactivity in the LS, the implants likely supplied high doses of E 2 that had a large
diffusion range. In experiment 3b, we implanted subjects with a 1-tap pellet as opposed
to the 5-tap pellet used in the current experiment.
4.3.4 Experiment 3b: Small E 2 implants in the BNST
All three subjects had E 2 implants that were located in or adjacent to the BNST
(Figure 4.4). Despite the short one week survival period all subjects had vasopressin-ir
fibers in the lateral septum and mediodorsal thalamus (Figure 4.6C). However no
qualitative difference was observed between the side ipsilateral and contralateral to the
implant. Therefore, we believe that the spread of E 2 was still too large. In experiment
3c, we implanted subjects with a 10-fold lower dose of E 2 in a 1-tap implant.
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4.3.5 Experiment 3c: Dilute, small E 2 implants in the BNST
Three animals were examined using vasopressin immunohistochemistry. Six
other animals were examined using in situ hybridization to examine vasopressin mRNA
levels. These subjects had a two week survival period following steroid implantation.
Subject DB68 received a 3:2:1 implant similar to those in experiment 3b. This subject
had vasopressin fibers in the lateral septum, mediodorsal thalamus, medial amygdala, and
amygdalohippocampal zone. The other two subjects (DB67 and 71) received 3:2:0.1 E 2
implants. These animals had qualitatively lighter staining in the lateral septum. In fact
the level of vasopressin-ir fiber density was below the lowest intact male from
CHAPTER 3. It should be noted that for DB67, the implant was located caudally at the
level of the dorsomedial hypothalamus. The fact that there were fibers in the septum at
all suggests that either the amygdala, which occurs at this level, was actually being
stimulated, or the spread of hormone was still enough to reach the BNST, which was
about the same rostral distance from the implant as the amygdala was lateral. It is
possible that a better placed implant would be more efficacious. However, DB68 had an
implant that, while caudal to the BNST, was still much closer than DB67 and still
vasopressin immunoreactivity was low in the lateral septum.
None of the four subjects receiving 3:2:0.1 implants or the two subjects receiving
3:2:1 implants had silver grains in parvocellular cells of the BNST. Cells were observed
in other nuclei that are not dependent on gonadal steroids such as the PVN, SCN, and
accessory nuclei. This result suggests that at two weeks following implantation, the
implants are no longer providing adequate stimulation to increase vasopressin expression
in the BNST. Subsequent studies would be required to examine the time course of
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estradiol stimulation of vasopressin expression in the BNST. This result does not conflict
with immunohistochemical results, as it is known that peptide immunoreactivity is
present often long after hormones have been removed in the mouse, whereas vasopressin
mRNA levels decline within one day following hormone removal, gonadectomy (Mayes
et al., 1988; Miller et al., 1992).
4.4 Discussion
In the current study, we attempted to reinstate vasopressin specifically in the
BNST by implanting steroid containing micro-implants into the BNST. In our first
attempt, testosterone propionate implants failed to stimulate adequate vasopressin
immunoreactivity at 2 and 4 weeks post-implantation. Consequently, we implanted
animals with subcutaneous implants of estradiol or testosterone to show that we could
actually reinstate vasopresisn immunoreactivity. In fact, animals had a substantial
increase, and vasopressin immunoreactivity was similar to intact animals at 2-4 weeks
post implantation, although immunoreactivity was low at one week. Knowing that we
could reinstate vasopressin immunoreactivity, we then implanted estradiol implants.
Estradiol implants were able to raise vasospressin immunoreactivity to intact levels at 4
weeks post-implantation. However, the large concentrated (3:2:1) E 2 implants led to
increases in vasopressin immunoreactivity in BNST and medial amygdala cells both
ipsilateral and contralateral to the implant site. We thought that perhaps smaller and less
concentrated implants would prevent hormone from reaching the medial amygdala.
Small concentrated pellets were also able to increase vasopressin immunoreactivity even
at one week and two weeks. However small dilute implants did not raise vasopressin
immunoreactivity to intact male levels at two weeks. In addition, neither dilute nor
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concentrated small pellets appeared to stimulate vasopressin expression for two full
weeks as no mRNA positive cells were observed in the BNST after two weeks. Further
investigation would be required to determine the actual timecourse of E 2 action on
mRNA expression.
Our original goal was to identify vasopressin projections of the BNST versus the
medial amygdala by selectively stimulating expression of the BNST, but not the medial
amygdala and eventually the amygdala, but not the BNST. However, given the extensive
diffusion of concentrated estradiol implants and the inadequate vasopressin
immunoreactivity with smaller, less concentrated implants, it appears that this approach
is unlikely to effectively induce BNST, but not amygdala vasopressin production for our
purposes. However, the fact that estradiol implants (even the less concentrated dose) was
able to affect vasopressin production at all suggests that these types of implants may be
useful for studies examining functional actions of gonadal hormones on the BNST, but
not the medial amygdala. The small implant did increase vasopressin production as seen
by a small increase in vasopressin immunoreactivity in the lateral septum, but it did not
increase staining in the hippocampus, which in rats receives input from the amygdala
(Caffe et al., 1987).
Interestingly, at two weeks following intracranial estradiol implantation
vasopressin immunoreactivity was apparent. However, vasopressin mRNA expression
visualized by situ hybridization was not evident in the BNST, although cells were
observed in hypothalamic nuclei. This suggests that the steroid hormone estradiol
maintained expression for only a short time (i.e., less than two weeks). Further work
would be required to characterize the time course of estradiol release from the implants.
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This could be done using vasopressin mRNA expression as a bioassay for steroid
availability. In theory, the vasopressin cells in the BNST will produce as long as
estradiol is present.
As stated above, estradiol implants of the type used here are not likely to provide
reliable data on projections of the BNST or MeA, although others have had success in
delivering steroids to just the BNST with steroid packed canullae in rats (Brot et al.,
1993). Other methods may be more effective in pursuing the goal of identifying the
individual projections of the BNST and MeA. In particular, classical techniques such as
tract tracing and brain lesions could be useful despite their caveats. In particular, large
lesions are required to get all of the vasopressin cells ruling out excitotoxic strategies,
bilateral BNST lesions are fatal (De Vries and Buijs, 1983), and electrolytic lesions
damage reciprocal pathways from the BNST to the MeA (Simerly, 2002; Cooke and
Simerly, 2005). Tracing studies also present some unique challenges. Typically,
adequate staining of vasopressin cells in the BNST and medial amygdala cannot be
achieved without colchicine injections making a dual-label tracingimmunohistochemistry strategy difficult although not impossible (Caffe et al., 1987).
Despite these caveats lesions have been used successfully in rats (De Vries and Buijs,
1983; Caffe et al., 1987).
One of the rationales for studying the anatomy of the mouse vasopressin system is
the importance of the mouse model in the use of molecular transgenic and gene targeting
approaches. It may be that some of these more molecular tricks will actually allow us to
completely understand the anatomy. One molecular tool currently available is a chimeric
gene that codes for a glucocorticoid receptor / estrogen receptor. This chimera contains
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the DNA binding domain of the estrogen receptor and the ligand binding of the
glucocorticoid receptor (Kaufer et al., 2004). In rats, this chimeric gene has been
transfected into brains using viral vectors. When transfected into the hippocampus, the
effects of high levels of glucocorticoids fail to cause spatial memory impairment and
neuronal injury causes less hippocampal damage (Kaufer et al., 2004; Ferguson et al.,
2008). Presumably, glucocorticoids are acting on protective estrogenic mechanisms due
to the chimeric protein. Because vasopressin gene expression in the BNST and MeA is
most likely controlled by the estrogen receptor (De Vries et al., 1994), it is possible that
we could use a similar approach with the goal of using ubiquitous glucocorticoids to
drive expression of vasopressin mRNA in the BNST in long-term gonadectomized
animals. Other future alternatives could include vasopressin cell specific targeting
systems. Recently, viral vector systems have been created that combine the vasopressin
gene promoter with a reporter gene in an effort to track region specific gene expression
dependent upon the vasopressin promoter. However, at present expression of the reporter
gene has only been shown in cells of the PVN and SON (Dr. Valery Grinevich, personal
communications). Cell-type specific transgenic animals are also a possibility. However,
cell-type specific approaches, while interesting, are not currently available or or refined
enough to answer our questions about BNST versus MeA projections.
In summary, intracranial estradiol implants were able to restore vasopressin
immunoreactivity; however, implants capable of adequately restoring fibers for
anatomical investigations affected both the BNST and MeA as opposed to just the BNST.
This suggests that intracranial estradiol implants at present are not a viable method for
examining the unique projections of the BNST or MeA. In addition, testosterone
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propionate implants were unable to adequately restore vasopressin immunoreactivity
bringing into question the effectiveness of this modified steroid in the brain. Future
studies with different techniques, driving vasopressin expression with a chimeric GR /
ER receptor for example, will be required to delineate the separate projections of these
brain regions.
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4.5 Figure legends
Figure 4.1: Experiment 1 - Implant locations
Implant locations for experiment 1 are shown above. All implants were located
adjacent to or near the bed nuclei of the stria terminalis. Bregma coordinates are listed in
the top left corner of each panel. Control implants are marked with a "C". The
photomicrograph in the bottom right corner shows the implant location for animal DB1,
which received a control implant. Diagrams are modified from Franklin and Paxinos
(2008). ac, anterior commissure; f, fornix; LV, lateral ventricle; sm, stria medullaris
Figure 4.2: Experiment 1 - Data and photomicrographs
TP implants resulted in only a minimal increase in vasopressin immunoreactivity.
Photomicrographs above show vasopressin-immunoreactive (-ir) fibers in the caudal
lateral septum in animals that received control implants and were killed at 2 (A) or 4 (B)
weeks following implantation. These animals, as expected, did not have an increase in
vasopressin fibers. In addition, some animals received TP implants and were killed at 2
(C) or 4 (D) weeks following implantation. Vasopressin-ir fibers were present, but not in
large quantities. A scatter plot (E) shows the measured vasopressin-ir fiber density in the
caudal lateral septum for subjects under each condition. Each dot represents a single
subject. The "Mean" and "Min." lines indicate the mean and minimum values for
vasopressin-ir fiber density in intact male mice for the same region; these data are from
animals studied in CHAPTER 3 (see Figure 3.2).
Figure 4.3: Experiment 2 - Data and photomicrographs
Both estradiol (E 2 ) and testosterone (T) subcutaneous implants restored
vasopressin immunoreactivity to the lateral septum. However the response was much
lower at 1 week than at 2 or 4 weeks. Photomicrographs above show vasopressinimmunoreactive (-ir) fibers in male mice treated with E 2 and killed at 1 (A), 2 (B), or 4
(C) weeks following implantation and those treated with T and killed at 1 (D), 2 (E), or 4
(F) weeks following implantation. A scatter plot (G) shows the measured vasopressin-ir
fiber density in the caudal lateral septum for subjects under each condition. Each dot
represents a single subject. The "Mean" and "Min." lines indicate the mean and
minimum values for vasopressin-ir fiber density in intact male mice for the same region;
these data are from animals studied in CHAPTER 3 (see Figure 3.2). At 1 week,
vasopressin-ir fibers were fewer than in intact male mice, but by 2 and 4 weeks postimplantation values were within the normal range.
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Figure 4.4: Experiment 3 - Implant locations
Implant locations for experiment 3 are shown above. Implants were not as
consistently located as in experiment 1. Some implants were located near the caudal
BNST (Bregma -0.34), but others were as far caudal as the dorsomedial hypothalamus
(Bregma -1.34). Bregma coordinates are listed in the top left corner of each panel. The
particular experiment that each animal belonged to is demarcated by the letters "a-c"
except for numbered implants, which correspond to particular animals for which
photomicrographs of the caudal lateral septum are shown in Figures 4.5A-D. Diagrams
are modified from Franklin and Paxinos (2008). 3V, third ventricle; DM, dorsomedial
hypothalamus; EP, entopeduncular nucleus; f, fornix; ic, internal capsule; LV, lateral
ventricle; PVN, paraventricular hypothalamus; sm, stria medullaris
Figure 4.5: Experiment 3 - Data and photomicrographs
Large, concentrated estradiol implants (B) restored vasopressin immunoreactivity,
while control implants (A) had no effect. Small, concentrated implants (C) were also
able to increase vasopressin immunoreactivity in a surprisingly short time period (1
week). Finally, small, dilute implants (D) were only able to marginally increase
immunoreactivity, but not to levels of intact males. Placement of small, dilute implants
may be a factor as they were well caudal to the bed nuclei, which was their intended
target. A scatter plot (E) shows the measured vasopressin-ir fiber density in the caudal
lateral septum for subjects under each condition. Each dot represents a single subject.
The "Mean" and "Min." lines indicate the mean and minimum values for vasopressin-ir
fiber density in intact male mice for the same region; these data are from animals studied
in CHAPTER 3 (see Figure 3.2). Only animals with the large, concentrated implants
approached the mean value of intact males.
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Figure 4.1: Experiment 1 - Implant locations
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Figure 4.2: Experiment 1 - Data and photomicrographs
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Figure 4.3: Experiment 2 - Data and photomicrographs
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Figure 4.5: Experiment 3 - Data and photomicrographs
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CHAPTER 5
PROJECTIONS OF THE SUPRACHIASMATIC NUCLEUS

5.1 Introduction
The suprachiasmatic nucleus (SCN) contains a dense cluster of parvocellular
neurons that stain darkly for vasopressin immunohistochemistry. In the mouse, as in the
rat (Buijs, 1978; Abrahamson and Moore, 2001), vasopressin cells are found in the outer
shell of the suprachiasmatic nucleus (see Figure 2.3). These cells are surrounded by a
dense cloud of fibers and terminals. Within the coronal plane, many fibers can be seen
ascending into the subparaventricular zone and some appear to extend farther into the
paraventricular nucleus (PVN) and thalamus.
Prior to the discovery of vasopressin expression in the bed nuclei of the stria
terminalis (BNST) and medial amygdala (MeA), the SCN was thought to be the site of
origin for all small caliber vasopressin-immunoreactive (-ir) fibers and associated
terminal fields (Buijs, 1978; Sofroniew and Weindl, 1978b; de Vries et al., 1981).
However, lesions of the SCN in the rat resulted in a loss of vasopressin immunoreactivity
in only a subset of brain regions including the vascular organ of the lamina terminalis,
dorsomedial hypothalamus, and paraventricular nucleus of the thalamus (Hoorneman and
Buijs, 1982). Other regions such as the lateral septum, lateral habenula, and dorsal raphe
retained their vasopressin innervation. The subparaventricular zone, which is adjacent to
the SCN and contains dense terminal fields and small vasopressin-ir fibers was not
mentioned, however, photomicrographs suggest that this region was damaged in the
lesion process (Hoorneman and Buijs, 1982).
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Retrograde tracing of projections to the lateral septum implicated the BNST even
though vasopressin expression had not yet been described in this area (De Vries and
Buijs, 1983). The SCN and paraventricular nucleus did not appear to project to the
lateral septum at all suggesting the existence of other vasopressin producing sites
(Hoorneman and Buijs, 1982; De Vries and Buijs, 1983). The discovery of parvocellular
vasopressin-ir cells in the bed nuclei of the stria terminalis and the medial amygdala was
actually reported around the same time as the tracing and lesion studies (Caffe and van
Leeuwen, 1983; van Leeuwen and Caffe, 1983). Lesions of these sites has suggested that
in fact many of the regions throughout the brain with small caliber fibers and terminal
fields, including the lateral septum, receive their innervation from the BNST and MeA
(De Vries and Buijs, 1983; DeVries et al., 1985). However, even when these sources of
vasopressin are removed by removing circulating gonadal steroid hormones (e.g., through
gonadectomy), a diverse set of central vasopressin-immunoreactive (-ir) projections
remain (DeVries et al., 1985). Presumably, many of these derive from the SCN.
In the current study, we used electrolytic lesions of the SCN to eliminate fibers
derived from this nucleus. Lesions were carried out on gonadectomized animals.
Gonadectomy eliminates immunoreactivity in projections from the BNST and MeA,
which by decreasing the complexity of the overall vasopressin distribution increases the
resolution of SCN small caliber fibers. This made our results much easier to interpret.
We predicted that lesions to the SCN would eliminate the small fibers and terminal fields
after remaining after gonadectomy leaving behind only medium to large caliber fibers of
the PVN, SON and accessory nuclei.
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5.2 Methods
5.2.1 Animals
Male C57BL6 mice were studied in this experiment. Animals were derived from
a breeding colony at the University of Massachusetts. Following weaning, animals were
group-housed (5 or less per cage) with same-sex siblings under a 14:10 light cycle with
lights on at 6:00 am. Animals had ad libitum access to food and water. All procedures
conformed to NIH guidelines and were in accordance with a protocol approved by the
University of Massachusetts.
Fourteen male mice were used in this experiment. All 14 were gonadectomized.
After a number of months, 7 animals received lesions of the SCN, and 7 received sham
lesions.
5.2.2 Gonadectomy surgeries
At approximately 60 days of age, animals underwent bilateral gonadectomy.
Surgical procedures were similar to those described above (see section 3.2.2).
5.2.3 Suprachiasmatic nucleus lesions
Approximately 8 months following gonadectomy, male mice underwent
stereotaxic surgery and received either a lesion of the SCN or a sham lesion. Mice were
anesthetized with isoflurane (2% isoflurane, Halocarbon Laboratories, River Edge, NJ)
and positioned in a stereotaxic apparatus. A hole was drilled at bregma, and a plastic
coated tungsten electrode was lowered at the midline and 0.1 mm rostral to bregma to a
depth of 5.5 mm below the dura. An electrolytic lesion was made by applying a 0.5 mA
current to the electrode for 20 seconds; no current was applied during sham lesions. The
electrode was removed immediately following lesion-making, the hole in the skull was
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filled with bone wax, and the wound was sutured closed. All animals were given a single
injection of buprenorphine (0.05 mg/Kg; Bedford Laboratories, Bedford, OH)
immediately following surgery.
5.2.4 Tissue collection and processing
Three weeks following stereotaxic surgery, animals were sacrificed using CO 2
asphyxiation followed by rapid decapitation. Brains were removed rapidly and placed in
5% acrolein in 0.1 M phosphate buffer. Fixation lasted for four hours at which time
brains were transferred to 30% sucrose in 0.1M phosphate buffer and stored at 4° C until
sectioning. Brains were sectioned in the coronal plane at 30 Pm using a freezing
microtome, and every third section was collected and stored in cryoprotectant at -20° C
prior to vasopressin immunohistochemistry. In addition, every third section was mounted
on gel coated slides, allowed to dry at least overnight, and Nissl stained.
5.2.5 Nissl staining
Nissl staining methods are identical to those described in CHAPTER 2.2.3
5.2.6 Immunohistochemistry
Immunohistochemical methods used in this experiment are identical to those
described in CHAPTER 2.2.4 except the antibody used was from a new lot a
concentration of 1:8000 was used.
5.2.7 Analysis
The small number of subjects made a quantitative analysis impractical. Therefore
visual inspection was made of each of the animals receiving large SCN lesions as well as
several control animals. Qualitative observations are detailed below.
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5.3 Results
5.3.1 Location of SCN lesions
Seven gonadectomized males received lesions of the SCN. In two animals the
lesions were too far caudal resulting in an incomplete lesion of the SCN. In another
animal the lesion was quite small damaging vasopressin-ir neurons only at the medial
part of the SCN. These three animals were excluded from the study. Lesions of the
remaining subjects and one of the sham subjects are depicted in Figure 5.1. Subjects
DD33 and DD35, had extensive unilateral lesions with some contralateral damage.
Subjects DD37 and DD44 had extensive bilateral damage to the SCN.
5.3.2 Vasopressin immunoreactivity following SCN lesions
Sham lesioned animals had vasopressin-ir fibers in similar areas as compared to
gonadectomized mice described in CHAPTER 3. The four subjects with large lesions of
the SCN showed reduction in vasopressin-ir fibers in similar areas. However, the fiber
loss in subjects 37 and 44 was more complete. The remaining fibers in subjects DD33
and DD35 were mostly unilateral suggesting a more complete lesion on one side than the
other. In all cases where immunoreactivity disappears, it is likely there is actually a loss
of fibers as opposed to just vasopressin. The lesion of the SCN would destroy cell bodies
that support the vasopressin containing fibers. Qualitative observations are summarized
in Table 5.1.
SCN lesions affected only small fibers in the diencephalon and the medial
posteromedial bed nuclei of the stria terminalis (STMPM; Figure 5.2). This part of the
BNST is very close to the rostra-most anterior paraventricular thalamus and some fibers
could make their way into the STMPM from here.
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The small fiber innervation of the diencephalon is most extensive among midline
nuclei in the thalamus and periventricular nuclei in the hypothalamus. In cross sections,
the dense cloud of fibers surrounding the SCN does not appear to spread very far laterally
and many fibers can be seen extending dorsally (see Figure 2.14). In sagittal sections
fibers of the SCN appear to spread out in multiple directions including major rostral,
dorsal, and caudal projections (see figure 2.14D). Following SCN lesion a decrease in
small fibers in the diencephalon was observed. In fact, a virtual elimination of all small
fibers and terminal fields throughout the brain was observed in animals that were
gonadectomized with SCN lesions.
In the rostral hypothalamus (i.e., preoptic region), vasopressin immunoreactivity
disappears from the anteroventricular periventricular region, ventromedial preoptic area,
striohypothalamic nucleus, and the medial preoptic nucleus (Figure 5.3). All of these
nuclei are found adjacent to the third ventricle except the striohypothalamic nucleus,
which lies slightly more lateral ventral to the fornix. No qualitative changed was
observed in regions further forward such as the vascular organ of the lamina terminalis.
The SCN is situated at the transition of the anterior hypothalamus and preoptic
area, and the densest regions of SCN derived vasopressin are found here. The
subparaventricular zone (SPa) is easily the densest region as almost all vasopresin-ir
fibers emanating from the SCN pass through it. These fibers are eliminated following
SCN lesions (Figure 5.4); a number of them are destroyed directly by the lesion as well.
As the fibers ascend through the SPa some appear to stray laterally into the more medial
parts of the anterolateral hypothalamus and anterior hypothalamus. Indeed these these
regions showed a decrease in vasopressin-ir staining following SCN lesioning as well
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(Figure 5.4). Most of these ascending fibers appear to enter the PVN and some continue
into the thalamus.
One of the largest projections of the SCN is the ascending projection that leaves
the SCN in an anterodorsal path (see Figure 2.14D) and enters the anterior
paraventricular thalamus (PV; Figure 5.5). Many fibers can be seen passing through the
striohypothalamic area and parvicellular paraventricular hypothalamus between the third
ventricle and the fornix into the thalamus. There are also a number of fibers that appear
to cross the midline at this location. This large ascending projection is mostly confined to
the anterior PV, although there is some infiltration into the most rostral parts of the
mediodorsal and paratenial nuclei. Fibers in all of these locations lose immunoreactivity
following SCN lesion. Caudally, as the mediodorsal nucleus becomes prominent there is
almost no crossover of medial fibers into more lateral regions and all dorsal small
vasopressin-ir fibers in gonadectomized animals are found in the PV (Figure 5.6). A few
small fibers make their way back into the posterior PV as well. In the ventral thalamus,
there are small fibers in the xiphoid and reuniens nuclei (Figure 5.7). These nuclei lie
dorsal to the PVN, and the fibers that enter them appear to enter via the PVN below. As
in other areas, these small fibers disappear following SCN lesions.
Finally, some projections of the SCN pass caudally again following the midline.
Following SCN lesions, fiber immunoreactivity disappears from the arcuate nucleus,
periventricular area, retrochiasmatic area (Figure 5.8), and the dorsomedial nucleus (DM;
Figure 5.9). Some fibers appear to continue through the DM until the level of the
mammillary bodies as fibers in the dorsal tuberomammillary nucleus disappear as well,
although this innervation appears slight. Interestingly, areas that lose vasopressin

177

immunoreactivity often have medium caliber fibers that remain. This is especially true
for the DM, which has a moderate innervation of medium fibers even after SCN lesions.
5.4 Discussion
In the current study, we compared gonadectomized animals with or without a
lesion of the SCN in order to identify the projection sites of this nucleus. Gonadectomy
eliminates vasopressin expression in the BNST and MeA causing a subsequent decrease
in vasopressin immunoreactivity within the projections of those nuclei (de Vries et al.,
1984; DeVries et al., 1985; Mayes et al., 1988; Miller et al., 1992). This eliminates much
of the clutter of fibers throughout the brain presumably leaving behind only small caliber
fibers of the SCN. Cells from other nuclei have larger caliber fibers. Thus following
gonadectomy all remaining small caliber vasopressin-ir fibers should derive from the
SCN and be eliminated by SCN lesions. This was the case.
Interestingly, all of the nuclei that lost vasopressin-ir fibers were located at or near
the midline. The only projections ascribed to the SCN with a modest lateral spread of
small fibers were the medial preoptic nucleus and dorsomedial hypothalamus. Even the
projections to the thalamus maintain a strictly midline path innervating the PV and
xiphoid nuclei most strongly. By far the densest terminal field that is eliminated by SCN
lesions is the SPa, which is located just dorsal to the SCN itself.
One of the limitations of this study is the small number of subjects. Only two
animals had complete lesions of the SCN and even these appeared to have at least a few
cells that escaped lesion. This was likely due to a rather modest lesion size as most of the
lesions hit close enough to destroy part of the SCN on both sides. In a previous study in
rats, lesions were much larger extending well into the SPa almost to the PVN. However,
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the patterns of fiber loss were similar in each of the four animals examined and likely are
representative of the population of C57BL6 mice in our colony. Gonadectomized
controls that did not have lesions of the SCN had small caliber fibers in only a subset of
brain regions following gonadectomy. This subset of brain regions matches well with
areas where vasopressin was lost in the lesioned animals.
Our results mostly corroborate observations made in other species. Lesions of the
SCN in rats lead to a decrease in fibers in the paraventricular and dorsomedial
hypothalmaus as well as the vascular organ of the lamina terminalis (VOLT; (Hoorneman
and Buijs, 1982)). In the current study, no or extremely few small fibers made it to the
OVLT, although fibers do track rostrally in the periventricular region including the
anteroventral periventricular area and the ventromedial preoptic area. We describe a
number of regions in the mouse brain that were not mentioned studies using rats such as
the two just mentioned, the xiphoid nucleus, the arcuate nucleus, the PVN, and the
subparaventricular zone. SCN lesions in golden hamsters also affect vasopressin
immunoreactivity similar to the current study (Delville et al., 1998). Fibers were present
in intact hamsters and disappeared in lesioned hamsters from all the same nuclei as
reported here. This includes the VOLT, which also contained medium fibers that did not
disappear following SCN lesions in mice or in hamsters (Delville et al., 1998). Finally,
our results contradict the previous descriptions of vasopressin-ir projections of the SCN
for mice (Castel and Morris, 1988; Abrahamson and Moore, 2001). Through the use of
castration followed by SCN lesions, we have unequivocally determined which
vasopressin-ir fibers derive from the SCN, whereas in the aforementioned study, the
authors based the site of origin solely on fiber size and morphology and consequently
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misjudged the site of origin for a number of brain regions including the lateral septum
and lateral habenula. Work in this manuscript and others clearly demonstrate the BNST
or MeA as site of origin (Castel and Morris, 1988; Abrahamson and Moore, 2001).
The suprachiasmatic nucleus has been known as the master pacemaker of the
biological clock since the early 1970's (Stephan and Zucker, 1972), and the presence of
vasopressin in the SCN has been known for almost as long (Vandesande et al., 1975).
The function of vasopressin in the SCN has only been examined in a small number of
studies as the focus of circadian research has long been the mechanism of the biological
clock (Bittman, 2009). The anatomical data from the mouse suggest that vasopressin
fibers are well placed to affect neuroendocrine rhythms given the dense innervation of the
periventricular region. Projections to the paraventricular thalamus may be involved in
rhythms in arousal and behavioral state as this area receives multiple other inputs from
various monoaminergic cell groups involved in these functions (Van der Werf et al.,
2002). Projections to the subparaventricular zone and dorsomedial hypothalamus are
likely involved in regulating a large number of behavioral processes including sleep, food
intake, and locomotor activity (Chou et al., 2003; Saper et al., 2005). Lesions of the
dorsomedial hypothalamus lead to decreased circadian rhythms of wakefulness, food
intake, locomotor activity, and glucocorticoid levels (Chou et al., 2003; Kalsbeek et al.,
2008). A recent study provides the first solid evidence for a vasopressin function in
circadian rhythms. V1a receptor mRNA was shown to be expressed under circadian
control in the SCN even under constant darkness (Jin et al., 1999; Li et al., 2009).
Further, in a V1a receptor knock-out but not wild type mice lose periodicity in home cage
activity levels and wheel running during constant darkness. The rhythmic regulation of
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the protein prokineticin 2 was also disrupted in V1a knock-outs (Li et al., 2009). These
data suggest a role of vasopressin in the regulation of circadian rhythms, although the
actual circuitry and circuit level mechanism of action have yet to be identified.
Given the similarity to other species of the projections from the SCN to midline
regions of the diencephalon, it is possible that the function of these vasopressin
projections is rather well conserved across species. In general, the vasopressin fibers of
the SCN project to neuroendocrine, arousal, and behavioral control centers all of which
mediate functions with distinct biological rhythms. One final point should be made in
regard to vasopressin-ir projections. In this study, we eliminated vasopressin from the
bed nuclei of the stria terminalis, medial amygdala, and SCN by using a combination of
gonadecotmy and SCN lesions. The fibers that are left after this joint approach
presumably constitute the innervation from the paraventricular hypothalamus, supraoptic
nucleus, and a number of accessory nuclei located throughout the mouse hypothalamus as
these are the only other areas that show appreciable levels of vasopressin production.
Another somewhat daunting task is to isolate the projections of these different cell groups
in order to understand their individual functions. However, as discussed in CHAPTER 4,
certain viral vector and transgenic targeting approaches may be useful. In particular,
injections of a viral vector encoding the vasopressin promoter and a reporter gene have
been shown to be expressed only in neurons of the PVN or SON (Valery Grinevich,
personal communications). Thus, while not useful for separating BNST versus MeA
projections, this technique may prove extremely useful for delineating certain
hypothalamic projections.
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Table 5.1: Vasopressin-ir fibers following SCN lesions
Summary of vasopressin-ir changes in response to
suprachiasmatic nucleus lesions of gonadectomized (GDX) male mice. A
detailed summary is given for the diencephalon as this was the primary
region in which fibers were lost following lesioning. Areas are grouped by
effect of SCN lesion and then by region. A qualitative increase in
vasopressin-ir fibers was not observed in any area. In the "GDX / Sham
lesion" and "GDX / SCN lesion" columns, letters indicate the relative
density of staining: F, fibers; T, terminals; sp, sparse; sc, scattered; m,
moderate; d, dense; -0-, no fibers observed.
Telencephalon
Medial posteromedial
BNST (STMPM)

GDX /
Sham lesion
F(sc)

GDX /
SCN Lesion
F(sp)

Diencephalon:
GDX /
GDX /
Hypothalamus
Sham lesion
SCN lesion
Decreased following SCN Lesion
Preoptic Region
Anteroventral
periventricular Area
(AVPe)
Medial part of medial
preoptic nucleus
(MPOM)
Striohypothalamic
nucleus (StHy).

F(sc-d)
T(sc-d)

F(sp-sc)

F(sp-sc)
T(sp)

F(sp)

F(sc)
T(sc)

F(sc)

Ventromedial preoptic
nucleus (VMPO)

F(sc)

F(sp)

Anterior Hypothalamic Region
Anterior hypothalamus,
anterior (AHA)

F(sp-sc)
T(sc)

F(sp-sc)

Anterior hypothalamus,
central (AHC)

F(m-d)
T(sc)

F(m-d)

Lateroanterior
hypothalamus (LA)

F(sp-sc)
T(sc)

F(sp-sc)

Paraventricular nucleus
(PVN)

F(m-d)
T(sc-m)

F(sc)

Parvicellular
paraventricular
hypothalamus (PaAP)
Periventricular region
(Pe)

F(d)
T(d)

F(sp-sc)

F(d)
T(d)

F(sc)

Retrochiasmatic area
(RCh)

F(sc-d)
T(sc-d)

F(sc)
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Table 5.1: Vasopressin-ir fibers following SCN lesions (continued)
Diencephalon:
GDX /
GDX /
Hypothalamus
Sham lesion
SCN lesion
Decreased following SCN lesion
Anterior Hypothalamic Region
Subparaventricular zone
(SPa).

F(d)
T(d)

F(sp-sc)

Suprachiasmatic nucleus
(SCN)

F(m-d)
T(m-d)

Lesioned

Mammillary Body Region
Dorsal tuberomammillary
nucleus (DTM)

F(sc)
T(sp)

F(sp)

Dorsomedial Hypothalamus
Arcuate nucleus (Arc)

F(sp-sc)
T(sp-sc)

F(sp)

Dorsomedial
hypothalamus (DMH)

F(sc-d)
T(sc-d)

F(sp-m)

No change following SCN lesion
Preoptic Region
Lateral preoptic area
(LPO)

F(sp)

F(sp)

Medial preoptic area
(MPA)

F(sp)

F(sp)

Median preoptic nucleus
(MnPO).

F(sp-m)

F(sp-m)

Parastrial nucleus (PS).
Periventricular
hypothalamic nucleus
(Pe)
Vascular organ of the
lamina terminalis
(VOLT)
Ventrolateral preoptic
area (VLPO)

F(sp-sc)
F(sc-d)
T(m-d)

F(sp-sc)
F(sp)

F(sc)

F(sc)

F(sc)
T(sc)

F(sc)

Anterior Hypothalamic Region
Supraoptic commissure
(sox)

F(sc)

F(sc)

Tuberal lateral
hypothalamus (TuLH)

F(m-d)

F(m-d)

Lateral Hypothalamus
Endopeduncular nucleus
(EP)

F(sp-sc)

F(sp-sc)

Lateral hypothalamus
(LH)

F(sp-sc)

F(sp-sc)
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Table 5.1: Vasopressin-ir fibers following SCN lesions (continued)
Diencephalon:
GDX /
GDX /
Hypothalamus
Sham lesion
SCN lesion
No change following SCN lesion
Lateral Hypothalamus
Peduncular part of the
lateral hypothalamus
(PLH)
Perifornical lateral
hypothalamus (PeFLH)

F(sp-d)

F(sp-d)

F(sp-sc)

F(sp-sc)

Mammillary Body Region
Dorsal hypothalamic area
(DA)

F(sp)

F(sp)

Lateral retromammillary
nucleus (RML)

F(sp-sc)

F(sp-sc)

Medial retromammillary
nucleus (RMM)

F(sp-sc)

F(sp-sc)

Perifornical nucleus
(PeF)

F(sc-m)

F(sc-m)

Posterior hypothalmaus
(PH)

F(sp)

F(sp)

Ventral premammillary
nucleus (PMV)

F(sp)

F(sp)

Ventral
tuberomammillary
nucleus (VTM)

F(sp-sc)

F(sp-sc)

Dorsomedial Hypothalamus
Medial tuberal
hypothalamus (MTu)

F(sp-d)

F(sp-d)

Ventromedial
hypothalamus (VMH)

F(sp)

F(sp)

Zona incerta (ZI)

F(sp)

F(sp)
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Table 5.1: Vasopressin-ir fibers following SCN lesions (continued)
Diencephalon:
GDX /
GDX /
Thalamus
Sham lesion
SCN lesion
Decreased following SCN lesion
Mediodorsal thalamic
nucleus (MD)

F(sp)
T(sp)

-0-

Paratenial thalamus (PT)

F(sp)
T(sp)

F(sp)

Paraventricular thalamic
nucleus, anterior (PVA)

F(sc-d)
T(sc-d)

F(sp)

Paraventricular thalamic
nucleus, middle (PV)

F(sc-m)
T(sc-m)

F(sp)

Paraventricular thalamic
nucleus, posterior (PVP)

F(sp-sc)
T(sp-sc)

F(sp)

Reuniens thalamic
nucleus (Re)

F(sp-sc)
T(sp)

F(sp)

Xiphoid nucleus (Xi)

F(sc-m)
T(sc-m)

F(sp)

No change following SCN lesion
Central medial thalamic
nucleus (CM)

F(sp)

F(sp)

Interanterodorsal
thalamic nucleus (IAD)

-0-

-0-

Interanteromedial
thalamic nucleus (IAM)

-0-

-0-

Lateral habenular nucleus
(LHb)

-0-

-0-

Paracentral thalamus
(PC)

-0-

-0-

Reticular nucleus (Rt)

F(sp)

F(sp)

Rhomboid thalamic
nucleus (Rh)

F(sp)

F(sp)

Mesencephalon
Metencephalon
Myelencephlon

GDX /
Sham lesion
GDX /
Sham lesion
GDX /
Sham lesion
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GDX /
SCN lesion
GDX /
SCN lesion
GDX /
SCN lesion

5.5 Figure legends
Figure 5.1: Location of SCN lesions
Each row corresponds to one subject. The top row shows the SCN from a
representative sham lesioned animal. Lesions are shown for the four subjects used for
descriptive analyses in the bottom four rows. The columns depict lesions at rostral to
caudal levels of the SCN anatomically matched to the sham lesioned animal in the top
row.
Figure 5.2: Vasopressin -ir fibers in the STMPM
Vasopressin-ir fibers in the STMPM of gonadectomized mice with either a sham
lesion (A) or SCN lesion (B). Note the lack of small fibers in the dorsal STMPM
(indicated by arrows). ac, anterior commissure; f, fornix; ic, internal capsule; SCN,
suprachiasmatic nucleus; st, stria terminalis; STMPM, medial posteromedial bed nucleus
of the stria terminalis
Figure 5.3: Vasopressin -ir fibers in the preoptic area
Vasopressin-ir fibers in the preoptic area of gonadectomized mice with either a
sham lesion (A) or SCN lesion (B). Note the lack of small fibers in the AVPe and
VMPO (indicated by arrows) and the MPOM. 3V, 3rd ventricle; AVPe, anteroventral
periventricular nucleus; MPOM, medial preoptic nucleus, medial part; SCN,
suprachiasmatic nucleus; VMPO, ventromedial preoptic nucleus
Figure 5.4: Vasopressin -ir fibers in the subparaventricular zone
Vasopressin-ir fibers in the SPa of gonadectomized mice with either a sham lesion
(A) or SCN lesion (B). Note the lack of small fibers in the SPa (indicated by arrows).
3V, 3rd ventricle; AH, anterior hypothalamus; LA, lateroanterior hypothalamic nucleus;
SCN, suprachiasmatic nucleus; SPa, subparaventricular zone
Figure 5.5: Vasopressin -ir fibers in the anterior paraventricular thalamus
Vasopressin-ir fibers in the PVA of gonadectomized mice with either a sham
lesion (A) or SCN lesion (B). Note the lack of small fibers entering the PVA adjacent to
the third ventricle (indicated by arrows). 3;, 3rd ventricle, PVA, anterior paraventricular
thalamus; SCN, suprachiasmatic nucleus
Figure 5.6: Vasopressin -ir fibers in the paraventricular thalamus
Vasopressin-ir fibers in the PV of gonadectomized mice with either a sham lesion
(A) or SCN lesion (B). Note the lack of small fibers especially near the dorsal 3rd
ventricle. D3V, dorsal 3rd ventricle; PV, paraventricular thalamus; SCN,
suprachiasmatic nucleus
Figure 5.7: Vasopressin -ir fibers in the xiphoid nucleus
Vasopressin-ir fibers in the Xi of gonadectomized mice with either a sham lesion
(A) or SCN lesion (B). Note the lack of small fibers in and around the PVN adjacent to
the 3rd ventricle (indicated by arrows). 3V, 3rd ventricle; PVN; paraventricular
hypothalamus; Re, reuniens nucleus; SCN, suprachiasmatic nucleus; Xi, xiphoid nucleus
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Figure 5.8: Vasopressin -ir fibers in the retrochiasmatic area
Vasopressin-ir fibers in the RCh of gonadectomized mice with either a sham
lesion (A) or SCN lesion (B). Note the lack of small fibers around the 3rd ventricle in the
Pe and ventral in the RCh (indicated by arrows). 3V, 3rd ventricle; Pe, periventricular
hypothalamic nucleus; RCh, retrochiasmatic area; SCN, suprachiasmatic nucleus; VMH,
ventromedial hypothalamic nucleus
Figure 5.9: Vasopressin -ir fibers in the dorsomedial hypothalamus
Vasopressin-ir fibers in the DM of gonadectomized mice with either a sham
lesion (A) or SCN lesion (B). SCN lesioned animal had a unilateral lesion. Note the lack
of small fibers adjacent to the 3rd ventricle only on the right side (see arrows). 3V, 3rd
ventricle; DM, dorsomedial hypothalamus; SCN, suprachiasmatic nucleus; VMH,
ventromedial hypothalamic nucleus
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Figure 5.1: Location of SCN lesions
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Figure 5.2: Vasopressin -ir fibers in the STMPM
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Figure 5.3: Vasopressin -ir fibers in the preoptic area
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Figure 5.4: Vasopressin -ir fibers in the subparaventricular zone
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Figure 5.5: Vasopressin -ir fibers in the anterior paraventricular thalamus
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Figure 5.6: Vasopressin -ir fibers in the paraventricular thalamus
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Figure 5.7: Vasopressin -ir fibers in the xiphoid nucleus
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Figure 5.8: Vasopressin -ir fibers in the retrochiasmatic area
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Figure 5.9: Vasopressin -ir fibers in the dorsomedial hypothalamus
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CHAPTER 6
GENERAL DISCUSSION

6.1 General comments and conclusions
The studies presented in this manuscript provide a thorough examination of the
vasopressin anatomy of the mouse brain. Previous work described neurophysin II
immunoreactivity in Oxford University mice and vasopressin immunoreactivity in
C57BL6 mice (Castel and Morris, 1988; Abrahamson and Moore, 2001). However, each
study focused on the forebrain and did not give complete details, but simply described the
presence of immunoreactivity in, for instance, the amygdala. However, based on the
work presented above, it is clear that vasopressin is hardly ubiquitous in any given region
and often shows distinct regional innervation. One example in particular is the ventral
forebrain where vasopressin fibers innervate the region between the nucleus accumbens
and vertical limb of the diagonal band with virtually no fibers entering either nucleus
(Figure 2.9A). In this same fiber plexus, the islands of Calleja are also specifically
avoided demonstrating the rather specific nature of vasopressin innervation. Further,
previous attempts to describe the site of origin of vasopressin-ir fibers in the mouse were
based purely on fiber characteristics leading to a number of anatomical errors in
interpretation (Castel and Morris, 1988; Abrahamson and Moore, 2001).
As discussed in more detail above, estradiol-sensitive vasopressin-ir projections
reach a diverse and large subset of brain nuclei from the telencephalon to the
metencephalon. These areas probably receive vasopressin innervation from the bed
nuclei of the stria terminalis (BNST) or medial amygdala (MeA), as vasopressin
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expression in these areas, but not others, depends on circulating gonadal steroids (Miller
et al., 1992; Wang and De Vries, 1995; Rood et al., 2008). In addition, vasopresin-ir
fibers presumably from the BNST and MeA innervate brain regions with proposed
behavioral roles, the lateral septum and social memory for example (Dantzer et al., 1988;
Landgraf et al., 1995; Landgraf et al., 2003; Bielsky et al., 2005), as well as areas with
major modulatory functions (de Olmos and Heimer, 1999; Lecourtier and Kelly, 2007;
Michelsen et al., 2007; Hikosaka et al., 2008). In particular, the anatomical descriptions
above suggest an anatomical link between vasopressin-ir fibers and serotonin and
dopamine systems, as steroid-sensitive vasopressin innervation is found in the substantia
nigra and raphe nuclei. Serotonin plays a role in the regulation of behavioral state and
has been studied in great detail in relation to anxiety and depression (Michelsen et al.,
2007). Vasopressin innervation of the ventral tegmental area and interfascicular nucleus
suggests a link to the dopamine system involved in reward and ventral striatopallidal
circuits involved in emotion-regulated decision making (Lecourtier and Kelly, 2007;
Hikosaka et al., 2008). In addition, vasopressin is found in much of the extended
amygdala (de Olmos and Heimer, 1999), typically in rather discrete areas. Vasopressin
function in the lateral septum has perhaps been the most thoroughly studied, although a
clear functional role for lateral septum innervation has only been proven for social
recognition memory (Dantzer et al., 1988; Landgraf et al., 1995; Landgraf et al., 2003;
Bielsky et al., 2005).
Vasopressin cells in the SCN appear to innervate a number of midline regions
that, with the exception of the medial preoptic area and a small number of areas in the
most rostral parts of the thalamus, are mutually exclusive with projections from the
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BNST and MeA. This separation is readily apparent in the medial posteromedial BNST
(STMPM; see Figure 2.11C) and paraventricular thalamus (PV; see Figure 2.17C). In the
STMPM, small fibers from the SCN are usually observed in the dorsal region near the
dorsal third ventricle. On the other hand, vasopressin fibers from the BNST or MeA
reside ventrally near the stria terminalis. The thalamus contains a clear buffer zone, void
of vasopressin, between the dense innervation of the mediodorsal nucleus (which comes
from the BNST or MeA) and the less dense innervation of the PV (which comes from the
SCN). The hypothalamic regions innervated by the SCN include those involved in
neuroendocrine systems and various behavior regulation centers, such as the medial
preoptic nucleus (sex behavior) and the dorsomedial hypothalamus (sleep, food intake,
and locomotion; (Chou et al., 2003)).
One interesting observation is that practically all areas that receive small fibers
presumably from the SCN, BNST, and MeA also contain medium caliber fibers. Areas
such as the lateral septum, paraventricular thalamus, dorsomedial hypothalamus, raphe
nuclei, and ventral tegmental area all contain small numbers of medium caliber fibers
even though this innervation can be as little as a single fiber. Aside from this general
colocalization of fibers from the various anatomically and functionally distinct cell
groups, medium caliber fibers are also exclusively found in a number of other brain
regions. Although not the focus of this manuscript and thus not discussed in great detail,
these projections primarily innervate regions involved in autonomic function, such as the
solitary nucleus in the hindbrain, the central nucleus of the amygdala, and the lateral
parabrachial nucleus among others. Finally, the presence of mutiple fiber types in
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different areas such that different functional systems may each influence some brain
regions.
In future work, it will be important to ascertain the functional importance of the
various vasopressin circuits at both physiological and more global behavioral levels.
Electrophysiological data suggest that vasopressin leads to a net inhibition of cells in the
lateral septum (Allaman-Exertier et al., 2007) and a direct excitation in most other
neuronal populations examined (Charpak et al., 1989; Raggenbass et al., 1989;
Raggenbass et al., 1991). The direct mechanism of excitability has yet to be determined,
although the V1a receptor, which acts through the Gq receptor to stimulate phospholipase
C and increase intracellular calcium signaling, is known to be involved (Stephens and
Logan, 1986; Shewey and Dorsa, 1988; Morel et al., 1992). The inhibition in the lateral
septum was interpreted to be mediated by the excitation of a population of inhibitory
interneurons that inhibited septal projection neurons (Allaman-Exertier et al., 2007). In
addition to understanding the functional circuitry involved in vasopressin projections, it is
crucial that work be done to ascertain which stimuli elicit vasopressin release from the
BNST and MeA in the first place. Some work has been done to this effect using
microdialysis in researching aggression (Beiderbeck et al., 2007), but much more data on
the topic is required.
6.2 The human condition
One important question that has yet to be addressed is, "Are any of these
anatomical data relevant to the human condition?" First of all, is there vasopressin in the
human brain? Second, is there vasopressin outside of the PVN and SON, two nuclei that
contain vasopressin immunoreactivity in all other mammals studied? The answer to both
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questions is unequivocally, "Yes." Detection of vasopressin using radioimmunoassay
and tissue punches suggests that there are high levels of vasopressin in the hypothalamus,
which is to be expected, However, moderate levels of vasopressin were detected in other
regions such as the locus coeruleus, substantia nigra pars compacta, substantia nigra pars
reticulata, periaqueductal gray, and globus pallidus (Rossor et al., 1981; Jenkins et al.,
1984). In addition, a number of other regions contained vasopressin in some, but not all
individuals. These areas included nuclei such as the amygdala, lateral septum, nucleus
accumbens, and others (Rossor et al., 1981; Jenkins et al., 1984).
Currently, the most extensive immunohistochemical study of vasopressin in the
human brain reports only on small tissue blocks from the septal area, amaygdala,
hippocampus, and locus coeruleus (Fliers et al., 1986). Very few vasopressin-ir fibers
were found in the lateral septum, an area that is very densely innervated and sexually
dimorphic in most other species, and no sex differences were apparent. There was also
immunoreactivity in the diagonal band region, which may be the ventral septal area, as
this area is often referred to as the diagonal band, which in mice contains no vasopressin
fibers at all. In these sections, some small vasopressin-ir cells were observed in the
BNST of a few subjects. The amygdala contained almost no vasopressin except for a few
fibers at the tip of the lateral ventricle near the transition between the amygdala and
hippocampus. The locus coeruleus on the other hand was densely innervated and many
terminal swellings were observed (Fliers et al., 1986). Additionally, the
immunohistochemistry in this study was carried out on paraffin embedded tissue.
Paraffin embedding causes a reduction in immunoreactivity as compared to free floating
sections (compare, for example, (Buijs, 1978; DeVries et al., 1985)). Clearly, our
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knowledge of vasopressin in the human brain lags far behind our knowledge of other
species. The next closest species for comparison is the macaque, which likely does not
have much vasopressin in the lateral septum either, as it went unmentioned in the authors'
descriptions, even though they mention a moderate innervation of the medial septum
(Caffe et al., 1989). A number of other regions, however, are described to have a dense
innervation including the ventral and dorsal raphe, the ventral tegmental area, the lateral
and medial parabrachial nuclei, the solitary nucleus, and the periaqueductal gray. In
addition, midline nuclei in the diencephalon such as the subparaventricular zone, reuniens
of the thalamus, and paraventricular nucleus of the thalamus all have a dense innervation
(Caffe et al., 1989). Many of these regions have not been well studied in humans. Of
particular interest to the discussion presented earlier in this manuscript are the dorsal
raphe and ventral tegmental area. In the mouse and rat, these regions receive most of
their innervation from the BNST or MeA (DeVries et al., 1985). In macaques, we do not
currently have any evidence on site of origin, and in humans, we do not even have
immunhistochemical or radioimmunoassay data for these regions.
Behavioral data are also lacking in the human literature. Only two studies to date
appear to have shown a link between behavior and vasopressin. One study showed a
correlation between vasopressin levels in cerebrospinal fluid and a life history of
aggression (Coccaro et al., 1998). In a second study, intranasal administration of
vasopressin led to an increase in frowning in response to neutral faces in men, whereas
women had decreased frowning in response to angry faces and increased smiling in
response to neutral faces, suggesting a sex difference in vasopressin function (Thompson
et al., 2006). In addition, there has been a recent interest in examining the promoter
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region of the V1a receptor gene, which codes for the receptor most commonly found in
the brain. Interest in this topic came about from the discovery that microsatellite repeat
sequences in the promoter of the V1a receptor gene of the prairie vole were responsible
for highly differential receptor distribution between vole species (Hammock et al., 2005;
Hammock and Young, 2005). Further, transgenic mice with the prairie vole V1a
promoter region expressed V1a in a more prairie vole-like pattern and had altered social
behaviors compared to wild-type mice (Young et al., 1999). In humans, polymorphisms
have recently been found to correlate with differences in pre-pulse inhibition, an
autonomic response to conditioned sound stimuli that is often altered in certain
psychiatric illnesses (Levin et al., 2009). Researchers have also tried to find variation in
the V1a gene promoter than can account for some forms of autism, but results are quite
weak (Levin et al., 2009). Most relevant to behavior observed in rodents, polymorphism
in the V1a gene were related to marital satisfaction and marital status as measures of
pairbonding (Walum et al., 2008). All of the data are correlative, and, despite the
interest, we know surprisingly little about the actual brain anatomy in humans.
So after all of this, what do we know? Very little! We must certainly as a
research community work toward a better understanding of the anatomy of the
vasopressin system in the human brain. Without this, conjecturing about the relevance of
microsatellites and SNP's will do us little good. And what if the extra-hypothalamic
vasopressin innervation, which is so impressive in mice, is lacking or at least diminished
in humans? This is the case for some species such as golden hamsters and naked mole
rats (Miller et al., 1999; Rosen et al., 2007). This in my mind is the beauty of the
vasopressin system in the mouse. The diverse projections and dense innervation by
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vasopressinergic cells acts much like nature's highlighter, marking off brain regions and
circuits that are noteworthy to examine in the control of social behavior. Almost
certainly in the absence of vasopressin, the serotonergic system, extended amygdala,
ventral striatopallidal system, dorsal diencephalic conduction system, limbic loop, and
hippocampal-septal connections area are still present and functioning. In some species
they may just function a little different with vasopressin on board.
6.3 Conclusion
Vasopressin-ir fibers reach a number of brain regions that working in concert can
alter anxiety levels or behavioral state, regulate the integration of limbic system
information with decision making strategies in the forebrain, enhance memory functions,
and influence cells in behavioral control regions of the lateral hypothalamus. Taken
together, this information suggests that stimuli which lead to vasopressin
neurotransmission from the BNST and MeA may simultaneously alter circuits that
enhance or diminish the expression of various behaviors. Perhaps it is time that we
divorce ourselves from the idea that individual vasopressin projections directly regulate
specific social behaviors. Instead, we can explore the idea that vasopressin encourages a
specific behavioral state working through multiple interconnected pathways that
enhances some patterns of behavior while inhibiting others in a context and species
specific manner.
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